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Abstract 
 
The mouse embryonic stem cell (ESC) state depends upon a gene regulatory network 
centred on Oct4, Sox2 and Nanog (OSN). Notably, these and other key transcription 
factors (TFs) assemble in large, multi-protein complexes at enhancer loci to drive the 
high expression of target genes. It remains unclear, however, how each specific TF 
functions in transcription, and whether each depends on protein-protein interactions 
with other complexes. Furthermore, little is known about potential coregulators in ESCs 
that may regulate TF activity. To study the functional importance of TF-cofactor 
interactions in ESCs, work here was focused on the nuclear receptor Estrogen-related 
receptor beta (Esrrb). As with the core OSN triad, Esrrb is vital for the maintenance of 
ESC identity and self-renewal, as well as playing important roles in somatic cell 
reprogramming. Moreover, Esrrb was recently found to associate with components of 
the basal transcription machinery, hinting at a specific role for Esrrb in ESC transcription 
that remains to be characterised. Here, it was investigated how Esrrb function is 
conferred in ESCs, drawing on established knowledge of the regulation of estrogen-
related receptors (ERRs) in somatic contexts. Both on somatic cell targets as well as in 
ESCs, Esrrb transcriptional activity is found to be absolutely dependent upon its ligand-
binding domain (LBD) and AF-2 region. Functionally, inactivating the Esrrb AF-2 region 
mirrors Esrrb depletion itself, triggering differentiation and preventing Esrrb-dependent 
enhancement of self-renewal. Critically, Ncoa3 is discovered to be the key coactivator 
recruited to the Esrrb AF-2 region at ESC target genes. Ncoa3, like Esrrb, is essential for 
the maintenance of self-renewal and also enhances LIF-independence when stably 
overexpressed. Furthermore, Ncoa3 is highly upregulated in induced pluripotent stem 
cells (iPSCs), and its depletion inhibits somatic cell reprogramming. Genome-wide 
Ncoa3 ChIP-sequencing and DNA microarray analysis further demonstrate that Ncoa3 
co-operates with Esrrb and the OSN circuitry at active enhancers, driving the expression 
of self-renewal and germ cell related genes. Finally, Ncoa3 is shown to bind RNA 
polymerase II in ESCs, and bridges Esrrb via its AF-2 region to the general transcription 
machinery. This work reveals an integrated model of transcriptional and coactivator 
control, mediated by Ncoa3, for the maintenance of ESC self-renewal and 
reprogramming.  
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1.1 Preface 
In development, one single fertilised egg manages through a process of millions of 
divisions and cellular fate choices to give rise to an entire organism. The cells of the early 
embryo must therefore possess the unique property of pluripotency: the ability to 
eventually differentiate into any type of specialised adult cell within the organism. The 
study of early development has been invaluable both in providing clues as to how these 
early cellular fate choices are made, as well as furthering regenerative medicine. With 
important ethical and technical barriers to studying human embryogenesis, the mouse has 
provided an extremely useful model. It was also in a mouse model that scientists first 
discovered that through forced transcription factor expression, somatic cells could be 
coaxed into re-entering the pluripotent state, termed nuclear reprogramming. This 
groundbreaking study shortly preceded similar discoveries utilizing human skin cells. 
Such work has opened up an entire new area of research centred on the promise of 
patient-specific, ethically derived stem cells that scientists hope will one day revolutionise 
regenerative medicine.  
 
Key to the behaviour of any cell is the regulation of its genetic information. Each 
specialised cell type expresses a select repertoire of genes that acts to control its function, 
whether it be the ability of a muscle cell to contract, a pancreatic beta cell to produce 
insulin or a neuron to transmit electrical impulses. Pluripotent cells similarly have their 
own unique gene expression profile; they must express transcription factors that carefully 
guard an un-committed state while still being poised to differentiate. Much is still 
unknown about how this elegant system is maintained, making it vital to elucidate how 
gene expression is regulated in early development. The work described in this thesis 
focuses on the identification of a new axis of transcriptional regulation in pluripotent 
stem cells, the recruitment of the coactivator Ncoa3 to orphan nuclear receptor Esrrb, 
and the implications of this in controlling the embryonic stem cell (ESC) state. As 
background therefore, this chapter first outlines the key intrinsic factors that are 
responsible for maintaining ESCs, including Esrrb, as well as in inducing pluripotency 
upon reprogramming. Next, current knowledge concerning the genetic and epigenetic 
regulation of gene expression in maintaining and inducing pluripotency is discussed, 
including the important role of cell signalling in activating such networks. Finally, the 
canonical mechanisms of transcriptional regulation by nuclear receptors such as Esrrb as 
known from somatic cells are described. This leads onto the question of how Esrrb acts 
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in pluripotency to activate genes, and its particular roles in the ESC transcriptional 
network. 
1.2 Modelling pluripotency with embryonic stem cells 
1.2.1 Embryo-derived cell lines 
Within four days of fertilization, the one-cell zygote has developed into a blastocyst that 
already consists of two distinct cell populations. The outer layer is made up of the 
trophectoderm (TE), a layer of epithelial cells that by lineage tracing experiments have 
been shown to form the embryonic component of the placenta that later supports fetal 
development (Fleming 1987). Encased within this outer layer is the inner cell mass 
(ICM), where pluripotent cells develop. At implantation, the ICM is further segregated 
into cells that are now either restricted to an extra-embryonic, primitive endoderm (PrE) 
fate, while the remaining cells make up the epiblast. It is these epiblast cells that go on to 
develop into the embryo proper (Figure 1.1).  
 
Figure 1.1 Early mouse embryonic development 
Diagram illustrating the development of the early mouse blastocyst, commencing from the fertilised egg 
(zygote). Immediately prior to implantation, the blastocyst consists of an outer layer of trophoblast cells that 
surround the ICM – the cells that give rise to ESCs when cultured in vitro. In the post-implantation 
blastocyst, further cell fate restriction has already occurred and cells facing the blastocoel form the primitive 
endoderm (PrE) whilst the innermost cells make up the epiblast that generates the embryo proper. Three 
cell liens can be derived at this stage, EpiSCs, TS cells and XEN cells. EpiSCs derived from the epiblast are 
still pluripotent, though their inability to contribute efficiently to chimeras points towards a more 
advanced developmental state than ESCs. 
 
Arguably one of the most important findings for the study of mammalian development 
was the discovery that cells from distinct populations of the embryo can be cultured as 
stable lines in vitro.  In 1981, two groups first demonstrated that pluripotent cells could be 
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directly derived from explants of pre-implantation mouse embryos. These cells capture 
the developmental state of the ICM and are accordingly termed embryonic stem cells 
(ESCs) (Evans and Kaufman 1981; Martin 1981). ESCs show two remarkable features: 
the ability to self-renew indefinitely in culture, and – identical to the cells of the ICM in 
the embryo itself – pluripotency. This latter feature is highlighted by the ability of ESCs 
to form teratocarcinomas and to contribute to mouse chimeras when injected into 
blastocysts (Robertson et al. 1986). Most strikingly, tetraploid complementation assays – 
where ESCs are injected into a tetraploid embryo – have been used to demonstrate the 
ability of just one or two founder ESCs to generate the entire fetus (Nagy et al. 1990; 
Eggan et al. 2001). Successful propagation of ESCs in vitro requires media to be 
supplemented with two important additions, leukemia inhibitory factor (LIF) (Niwa et al. 
1998), and serum, the active ingredient of which is the transforming growth factor beta 
(TGF-β) member, bone morphogenetic protein 4 (BMP4) (Ying et al. 2003). As 
discussed later, these components are crucial activators of several cellular signalling 
pathways that converge on the activation of intrinsic factors to sustain self-renewal and 
prevent differentiation.  
 
In recent years, several other pluripotent cell lines aside from ESCs have been generated 
from cells taken at distinct stages during mouse development. Epiblast stem cells 
(EpiSCs) are notably the in vitro counterpart of the post-implantation epiblast (Figure 
1.1), and share similar self-renewal and differentiation capacities with ESCs as well as 
commonly expressing the core pluripotency factors Oct4, Sox2, and to some extent, 
Nanog. Despite this, they exhibit remarkable differences, such as a morphology that is 
more flattened than ESCs, a dependency upon basic fibroblast growth factor (FGF) and 
Activin signalling for their propagation and not LIF, and X-chromosome inactivation 
(Table 1.1) (Brons et al. 2007; Tesar et al. 2007). Pointing towards a more advanced 
developmental state is also the finding that EpiSCs cannot contribute efficiently to 
chimeras (Guo et al. 2009). Moreover, these cells cannot spontaneously revert back to an 
ICM-like state unless specifically reprogrammed (Hanna et al. 2009a; Guo and Smith 
2010). Interestingly, many of these features in EpiSCs, such as their morphology and 
growth factor requirements, are shared by human embryonic stem cells (hESCs), which 
has lead to the hypothesis that hESCs might arise from a later stage of embryonic 
development than their mouse counterparts (Brons et al. 2007). A third pluripotent cell 
type are embryonic germ (EG) cells. These cells are derived from the gonadal germ cells, 
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which themselves arise from a 5-day reprogramming process initiated in comitted 
primordial germ cells (PGCs) of the E7.25 embryo (Hayashi and Surani 2009). EG cells 
in contrast to EpiSCs closely resemble ESCs, exhibit X chromosome reactivation, and 
contribute fully to chimeras (Stewart et al. 1994) (Table 1.1).  
 
Table 1.1 Properties of embryo-derived cell lines 
Embryonic 
compartment 
Cell line Growth factors Pluripotency Chimera 
formation 
ICM ESCs LIF, BMPs + + 
Epiblast EpiSCs bFGF, Activin + - 
Germ cells EG cells bFGF, LIF* + + 
Trophectoderm TS cells FGF4, heparin - - 
Primitive endoderm XEN cells FGF4, heparin** - - 
*Maintenance only **Derivation only 
 
Aside from the pluripotent cell lines originating from the ICM/epiblast, two extra-
embryonic lines have also been successfully cultured, trophectoderm-derived TS cells 
(Tanaka et al. 1998) and primitive endoderm-derived XEN cells (Kunath et al. 2005). 
These, unlike their embryonic-derived equivalents, are more restricted in their 
developmental potency and only contribute to extra-embryonic lineages when returned 
back to the embryo (Yamanaka et al. 2006; Rossant 2008). In vitro, these cells similarly 
differentiate only into other trophoblast or primitive endoderm subtypes such as 
trophoblast giant cells, or visceral endoderm cells, respectively (Table 1.1). Together, 
both embryonic as well as extra-embryonic cell lines have provided the basis for detailed 
molecular and functional analysis into the signalling pathways and transcriptional 
networks that regulate each stage of development.  
 
1.3 The ESC transcription factor network 
1.3.1 The Oct4-Sox2-Nanog (OSN) pluripotency factor triad 
i Oct4 
Pluripotency depends on a unique transcriptional network focused around the core 
factors Oct4, Sox2, and Nanog. Oct4, a POU family transcription factor encoded by the 
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Pou5f1 allele, is restricted in its expression to the early embryo and germ cells in vivo, and 
correspondingly is highly expressed in ESCs, EpiSCs, and EG cells in vitro (Scholer 1991). 
In the embryo, Oct4 expression is strictly required for the development of the mouse 
ICM (Nichols et al. 1998), with similarly critical functions in ESCs, which remain acutely 
sensitive to the levels of Oct4 expression. Depletion of Oct4 in ESCs is sufficient to 
trigger differentiation towards a trophectodermal fate, a mechanism involving the direct 
derepression of TS cell-specific factor, Cdx2 (Niwa et al. 2000). Furthermore, addition of 
FGF4 to Oct4-depleted ESCs allows the successful derivation of TS cells in spite of the 
fact that ESCs do not normally differentiate towards this lineage. Thus, Oct4 seemingly 
acts as a barrier to guard against ES to TS cell differentiation (Niwa et al. 2000). 
Interestingly, increasing the levels of Oct4 in ESCs does not further stabilize the 
pluripotent state but instead triggers differentiation towards meso/endodermal lineages 
(Niwa et al. 2000). In agreement with this, an increase in Oct4 protein levels has been 
noted in the primitive endoderm of the developing embryo (Palmieri et al. 1994). 
Together, such findings point towards an ability of Oct4 to serve different roles 
dependent on cellular context, perhaps associating with distinct sets of cofactors to 
orchestrate cell-specific gene expression programmes.  
ii Sox2 
The SRY-related HMG-box transcription factor Sox2 is highly expressed in ESCs, 
EpiSCs, and germ cells, as well as in neural lineages. Embryos lacking Sox2 arrest at E6.5 
due to a failure to maintain the embryonic epiblast (Avilion et al. 2003). In ESCs, loss-of-
function studies also reveal a requirement for Sox2 to maintain ESC self-renewal and the 
undifferentiated state (Ivanova et al. 2006). In addition to binding to an enhancer 
sequence required for Oct4 expression in ESCs (Chew et al. 2005), Sox2 is arguably the 
most important Oct4-interaction partner. Both Oct4 and Sox2 bind together to adjacent 
motifs on DNA, accordingly termed the composite Oct-Sox element (Chew et al. 2005). 
Oct4/Sox2 binding to Oct-Sox cis-sites within Sox2 and Oct4 confers reciprocal 
activation of both these factors. Forced Oct4 expression is furthermore able to 
compensate for the loss of pluripotency of Sox2 null ESCs (Masui et al. 2007). These 
features, along with the discovery that Oct4 and Sox2 are both recruited to a high 
proportion of the genes required for ESC pluripotency (Chen et al. 2008), highlight their 
central role in ESC gene expression. Notably, Oct4 and Sox2 are two of the three 
initially-identified minimal factors capable of converting somatic cells back to a 
pluripotent state (Takahashi and Yamanaka 2006; Wernig et al. 2008). As discussed later, 
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the finding that only a handful of pluripotency factors is needed to re-wire entire somatic 
programmes of gene expression highlights the dominant nature of these molecules in 
both maintaining and inducing pluripotency. 
iii Nanog 
The third member of the core pluripotency factor triad is the Homeobox protein, 
Nanog. Named after the Celtic land of eternal youth, Tir nan Og, Nanog was identified 
as a molecule capable when overexpressed of conferring efficient ESC propagation in the 
absence of the cytokine LIF, as well as suppressing neuroectodermal differentiation 
(Chambers et al. 2003; Mitsui et al. 2003). Interestingly however, the relationship 
between the requirement for Nanog in the instigation of pluripotency versus its role in 
the maintenance of ESCs is more complex. As with Oct4 and Sox2, Nanog is expressed 
in ICM, epiblast, and germ cells, with Nanog null embryos dying at E5.5 due to a 
collapse of the ICM and its subsequent differentiation into primitive endoderm (Mitsui et 
al. 2003)(Messerschmidt and Kemler 2010; Frankenberg et al. 2011). Similarly, ESCs 
cannot be derived from Nanog null embryos (Mitsui et al. 2003; Silva et al. 2009). 
However, the remarkable discovery that within ESC culture, individual cells fluctuate 
dynamically between Nanog-positive and negative states lead to the finding that it is 
ultimately dispensable for ESC self-renewal (Chambers et al. 2007). Although acute 
shRNA-mediated depletion of Nanog triggers differentiation (Ivanova et al. 2006), 
targeted Nanog null ESCs may in fact be propagated stably in vitro, and additionally 
contribute to all somatic lineages save the germ cells (Chambers et al. 2007). Nanog has 
thus been proposed to be a molecule critical for the establishment of pluripotency in the 
ICM and germ cells, and similarly for the derivation of ESCs, but subsequently non-
essential once a stable pluripotent state is achieved. Rather, Nanog assists in guarding 
against premature lineage commitment towards all germ layers, a feature that is 
supported by the tendency of Nanog null cells to spontaneously differentiate. 
Conversely, transiting of ESCs to a Nanog-null state may be a general pre-requisite to 
allow a rapid exit from pluripotency (Osorno and Chambers 2011). The role for Nanog 
in maintaining the expression of downstream targets important for the ESC state is 
confirmed by genome-wide studies, which reveal extensive overlaps between Nanog, 
Oct4 and Sox2 binding patterns and transcriptional profiles in ESCs (Loh et al. 2006; 
Chen et al. 2008). Protein-protein interactions mediated by Nanog are also important for 
its role, highlighted by the large number of Nanog-interacting partners so far identified in 
ESCs (Wang et al. 2006a).  
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1.3.2 Other important ESC factors – Klf2, Klf4, & Klf5 
Aside from the core pluripotency factors Oct4, Sox2 and Nanog (OSN), several other 
molecules have been identified in recent years as playing similarly important roles in ESC 
maintenance. The Krüppel-like transcription factors Klf2, Klf4 and Klf5, are three 
members of the Klf family that comprises 17 proteins in total, with broad functions as 
activators or repressors of transcription in a variety of cell types. Indeed, Klf2, 4 and 5 
have important roles in the lung, gut, and intestine respectively, as well as being highly 
expressed in ESCs (Dang et al. 2000). These three factors share both distinct and 
overlapping functions in pluripotency; for example whilst Klf4 null embryos survive until 
perinatal development (Segre et al. 1999) and Klf2 null embryos until E12.5 (Kuo et al. 
1997), embryos lacking Klf5 die at implantation due to trophectodermal defects (Ema et 
al. 2008). Furthermore, although loss of any single Klf factor appears not to directly 
affect in vivo epiblast development as does OSN deletion, homozygous disruption of Klf5 
precludes ESC derivation from ICM cells, similar to Nanog (Ema et al. 2008). Such 
phenotypes may reflect the functional redundancy between these factors, supported by 
the observation that in ESCs, individual Klfs are dispensable for self-renewal and only 
triple Klf2,4,5 knockdown triggers differentiation (Nakatake et al. 2006; Jiang et al. 2008). 
Thus in vivo, a loss of any one Klf factor might be functionally compensated for by the 
other two members. Indeed, chromatin-immunoprecipitation (ChIP) analysis of Klf2,4,5 
occupancy on targets such as Nanog has shown that all three proteins bind together at 
enhancer elements driving ESC-specific expression (Jiang et al. 2008). Additionally, 
Klf2,4 and 5 have all been shown to support LIF-independent self-renewal (Ema et al. 
2008; Hall et al. 2009; Niwa et al. 2009), highlighting a key role for these factors in the 
regulation of the ESC transcriptional circuitry. More importantly, Klf4 – and with lower 
efficiency, Klf2 and Klf5 – together with Oct4 and Sox2 make up the minimal 
reprogramming cocktail capable of efficiently generating induced pluripotent stem cells 
(iPSCs) (Feng et al. 2009). 
 
1.3.3 Nuclear receptors in ESCs  
In addition to the master regulators Oct4, Sox2 and Nanog, recent years have marked the 
emergence of several nuclear receptors (NRs) as factors integral to the maintenance of 
pluripotency and ESC self-renewal.  This family of proteins, as discussed further in 1.6, 
has been extensively characterised in numerous somatic cell types including both normal 
and cancer cells. In ESCs, it is in contrast only in the past few years that NRs such as 
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Esrrb and Nr5a2 (LRH-1) have been discovered and characterised in maintaining or 
inducing pluripotency. These receptors, along with several others such as Rarg (RARγ) 
and Nr0b1 (Dax-1) are highly expressed in undifferentiated ESCs and rapidly 
downregulated upon the onset of differentiation (Figure 1.2).  
 
Figure 1.2 Expression dynamics of ESC-associated nuclear receptors 
Histograms showing the decrease in expression levels of nuclear receptors that are rapidly downregulated in 
the mouse ESC line, CMT1, upon ESC differentiation in embryoid bodies (EBs). Genes are referred to by to 
their standard MGI nomenclature; commonly known alternatives are in brackets. Graphs adapted from 
(Xie et al. 2009) 
 
Such dynamics suggest that these ESC-associated nuclear receptors are direct targets of 
one or more core pluripotency factors, which themselves are switched-off upon self-
renewal exit (Ivanova et al. 2006), and/or may even function upstream of OSN. The 
Nr0b1 gene, for example, is a direct downstream target of Oct4, and is downregulated 
within 10 hours of Oct4 depletion (Hall et al. 2009). On the other hand, Nr5a2 (also 
known as LRH-1 – liver receptor homolog-1), is essential to maintain the expression 
levels of Oct4 in the developing mouse epiblast and thus is an important upstream 
regulator of this gene in vivo (Gu et al. 2005). Further investigation has shown that Nr5a2 
upregulates levels of Tbx3 and Nanog in ESCs, acting as a key mediator of the Wnt/β-
catenin pathway that along with LIF/BMP is another signalling axis required for self-
renewal (Wagner et al. 2010). Whilst Nr5a2 is not absolutely essential for ESC 
maintenance as demonstrated by the successful derivation of Nr5a2 null ESC lines in vitro 
(Gu et al. 2005), it is also compellingly the only known ESC factor capable of 
substituting for Oct4 in somatic cell reprogramming (Heng et al. 2010). There is likely 
much more to be uncovered concerning the role for nuclear receptors in stem cell 
biology, which indeed may be both similar and distinct from the core pluripotency 
factors themselves.  
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1.3.4 The role of nuclear receptor Esrrb in ESCs 
Arguably the most important nuclear receptor to be characterised in ESCs and 
reprogramming to date is orphan nuclear receptor estrogen-related receptor beta (Esrrb), 
second member of the estrogen-related receptor (ERR) subfamily. Unlike the two other 
ERR isoforms, Esrra and Esrrg, Esrrb is highly expressed in ESCs and is required for 
embryonic development in vivo (Luo et al. 1997; Mitsunaga et al. 2004). In contrast, 
mutations in Esrra or Esrrg affect only postnatal physiology, such as adipose or cardiac 
physiology, respectively (Luo et al. 2003; Alaynick et al. 2007). Interestingly however, 
initial reports on Esrrb pointed more towards a predominantly extra-embryonic role in 
early development. Generation of Esrrb null embryos has revealed that its disruption is 
lethal at E10.5, occurring due to placental defects caused by the abnormal development 
of the trophoblast (Luo et al. 1997). The functional significance of Esrrb in the 
trophectoderm lineage was further highlighted in TS cells, where interfering with Esrrb 
function was found to trigger differentiation into polyploid giant cells (Tremblay et al. 
2001). In contrast, Esrrb is seemingly not required for the development of the ICM or 
epiblast itself, as embryonic arrest occurs several days after implantation and gastrulation 
(Luo et al. 1997). Tetraploid complementation experiments – where Esrrb null embryos 
are rescued by aggregation with wild-type (Wt) tetraploid embryos that then contribute 
exclusively to extra-embryonic lineages – were also used to dissect an epiblast-specific 
role for Esrrb. These demonstrated that Esrrb is indeed dispensable for maturation of 
the ICM/epiblast with development progressing normally (Mitsunaga et al. 2004). 
Interestingly, these mice suffer a significant reduction in PGCs, pointing towards a 
potential role for Esrrb in PGC reprogramming or proliferation (Mitsunaga et al. 2004), 
similar to Nanog (Chambers et al. 2007). Whether the derivation of Esrrb-/- ESCs from 
null embryos is possible, and whether functional complementation by another related 
factor could explain the mild phenotype seen in Esrrb null mice (as is the case for Klf4) 
still remains to be investigated.  
 
In contrast to the observations seen in embryonic development, altering the levels of 
Esrrb in ESCs has a significant effect upon both self-renewal and pluripotency. Two 
groups published simultaneous studies reporting an essential requirement for Esrrb 
expression for ESCs, showing that shRNA-mediated Esrrb knockdown rapidly triggers 
differentiation (Ivanova et al. 2006; Loh et al. 2006). Esrrb-depleted ESCs upregulate 
markers from all three embryonic germ layers: mesoderm, ectoderm and endoderm 
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(Ivanova et al. 2006), supporting a general role for Esrrb in guarding against 
differentiation towards all three lineages. Conversely, overexpression of Esrrb also has a 
potent suppressive effect upon differentiation.  Mirroring the effects of Nanog 
overexpression, sustained overexpression of Esrrb enhances ESC self-renewal and is 
sufficient to maintain cells in culture in the absence of LIF (Zhang et al. 2008). Embryoid 
body (EB)-mediated differentiation experiments performed with Esrrb-overexpressing 
ESCs also demonstrated that this factor effectively blocks both neuroectodermal and 
mesodermal differentiation (Ivanova et al. 2006). This, alongside several other 
transcriptomic and functional investigations, has firmly placed Esrrb as an integral part 
of the pluripotency network, with this molecule acting either upstream and/or parallel to 
factors such as Nanog, Oct4 and Klf2,4,5 (Figure 1.3). 
 
Figure 1.3 Crosstalk between Esrrb and other pluripotency factors 
Diagram illustrating transcriptional networks involving Esrrb. Notably, Esrrb was found to act either 
upstream or potentially in parallel to Nanog, whose overexpression can rescue shRNA-mediated Esrrb 
depletion (reference 3). Conversely, Esrrb may carry out the same function for members of the Klf family, as 
Esrrb can rescue ESC self-renewal after triple Klf2,4,5 knockdown (reference 6). Esrrb additionally binds to 
an enhancer within its own intron and so as with OSN and Klf4, participates in auto-regulation. Such a 
positive-feedback loop likely contributes to the maintenance of high Esrrb expression levels in ESCs as well 
as ensuring its swift downregulation upon cues to differentiate.  
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1.4 Regulation of ESC-specific gene expression 
1.4.1 Transcription factor clustering and the ESC ‘enhancesome’ 
The regulation of gene expression in pluripotent cells is necessarily complex because 
these cells must maintain high expression levels of self-renewal targets while transiently 
repressing lineage-specific genes required later in development. This is partly mediated by 
core pluripotency factors themselves, which may activate or repress transcription 
depending on the specific target gene and co-recruited factors present (Kim et al. 2008). 
As outlined in this section, regulatory mechanisms such as ESC-specific enhancesomes, 
co-ordination with external signalling pathways, and epigenetic modifications of DNA 
and histones all contribute to managing pluripotent gene expression. 
 
In the past half-decade, genome-wide studies have increasingly replaced candidate gene 
approaches to investigate transcriptional regulation in ESCs, greatly enhancing our 
understanding of whole networks controlling pluripotency. High throughput 
identification of global DNA binding sites for factors is a crucial step to understanding 
their direct targets, as transcriptome-based analyses alone do not distinguish between 
direct and indirect targets. Earlier methods to map genome-wide DNA binding sites 
combined ChIP with array technology (ChIP-chip); however these methods were limited 
by the sensitivity and coverage of the probes and chips utilized to analyse the DNA 
fragments (Kim and Ren 2006). Following on from this, a more recent genome-wide 
approach in ESCs utilized ChIP coupled with paired-end ditag (ChIP-PET) technology, 
where the isolated ChIP DNA fragments are cloned into a tagged library that can then be 
subjected to sequencing (Wei et al. 2006). This method was employed in the mapping of 
many binding sites for the core factors Oct4 and Nanog in mouse ESCs, for the first 
time revealing a large-scale picture of the direct targets of these factors (Loh et al. 2006). 
Combining their ChIP-PET approach with Oct4 and Nanog RNAi, the authors 
furthermore confirmed that Oct4 and Nanog indeed both directly activate and repress 
overlapping sets of genes in ESCs.  
 
The most recent, and most powerful technique, however, was developed in 2007, termed 
ChIP-sequencing (Johnson et al. 2007). This method, notably with higher sensitivity, 
cost-effectiveness, and requiring less work than ChIP-PET, uses massively parallel Solexa 
DNA sequencing to amplify and sequence the ChIP-enriched DNA fragments. 
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Consequently, low amounts of starting material can be used to generate accurate maps of 
the genome-wide locations of factors or even chromatin modifications to a resolution of 
50bp (Figure 1.4A). Pioneering work by Chen and colleagues utilized this technique in 
ESCs, mapping the binding sites for 13 transcription factors and 2 coregulators (Chen et 
al. 2008). Their findings remarkably revealed the presence of many sites throughout the 
ESC genome that contain several transcription factors all recruited to the same region of 
DNA, termed multi transcription factor-binding loci (MTL). These loci are not restricted 
to transcription start sites, but distributed between intergenic regions, within genes as 
well as at promoters, with over 80% of MTL containing more than 7 factors indeed not 
promoter-associated. These MTL are present in the vicinity of known pluripotency 
genes, such as Nanog (Figure 1.4B), as well as many previously uncharacterised targets. 
Importantly, these MTL demonstrate ESC-specific enhancer activity when cloned 
downstream of luciferase reporters (Figure 1.4C), implying an important role in 
regulating the expression of genes at these loci.  
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Figure 1.4 Outline of Chip-sequencing and example ESC enhancer loci 
(A) Diagram outlining the ChIP-sequencing (ChIP-seq) approach. A normal ChIP assay is performed to 
immunoprecipitate all DNA fragments bound to a particular protein of interest. The sonicated DNA 
fragments are purified and prepared for ChIP-seq, then subjected to high-throughput sequencing. The 
sequenced DNA fragments are then aligned with the relevant reference genome to identify DNA binding 
sites. Peaks of binding are generated based on the number of DNA sequences found for a particular locus, 
with the centre of each peak corresponding to the site of maximum binding. Diagram adapted from 
Illumina. (B) Example browser screenshot showing enrichment of the indicated factors at the Nanog locus 
in ESCs. Notice that enhancer loci can be identified based on co-binding of several factors at once. (C). 
Enhancer activity of DNA fragments identified via ChIP-seq based on the co-occupancy of multiple TFs. 
These fragments are cloned into reporter constructs downstream of luciferase, and confer a high level of 
ESC-specific activity. (B-C) taken from (Chen et al. 2008). 
 
What is not known, however, is the exact function of so many densely-bound factors at 
enhancer loci. In a separate study analyzing the expression of target promoters bound by 
up to nine different transcription factors (TFs) in mouse ESCs, it was described that 
higher TF occupancy correlates with gene activation, whereas the presence of only a few 
transcription factors is associated with repression (Kim et al. 2008). Such examples of 
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genes showing low promoter occupancy and are repressed in proliferating ESCs are the 
Wnt antagonist, Dkk1, or the trophectoderm marker genes, Cdx2 and Cldn4 (Loh et al. 
2006). Thus, it may be that only through the clustering of many pluripotency TFs that 
the apparatus required for active transcription is assembled. Chen et al also described the 
frequent recruitment of the histone acetyltransferase, p300, to transcription factor 
clusters containing OSN plus one or more other factors, with RNAi-mediated depletion 
of OSN reducing the enrichment of p300 at these sites (Chen et al. 2008). Given the 
known recruitment of p300 to active enhancer regions (Heintzman et al. 2007), these 
data further support the role of MTL in ESCs as enhancers, or ‘enhancesomes’, that 
promote high expression of actively transcribed ESC genes. A final important feature of 
such TF clustering is that dense binding is found at enhancers driving the expression of 
core pluripotency factors themselves. A clear example is Esrrb, which is bound by Esrrb 
as well as OSN at an intronic region that exhibits strong enhancer activity in ESCs (Feng 
et al. 2009). This finding highlights the importance for factors such as Esrrb and OSN of 
auto- as well as cross- regulation, conferring strong transcription of their own genes as 
well as relevant downstream targets. 
1.4.2 Co-ordination of pluripotency factors with external signalling pathways 
To maintain self-renewal and an undifferentiated state, ESCs in culture require external 
signalling to promote the expression of the intrinsic TFs that guard pluripotency. In 
typical culture conditions, the cytokine LIF must be added to ESC media, which activates 
two parallel signalling circuits, the Jak-Stat3 pathway and PI(3)K pathway (Niwa et al., 
2009) (Figure 1.5, centre). These pathways ultimately activate and maintain the 
expression of the OSN triad, which is otherwise downregulated upon LIF withdrawal. 
The importance of Stat3 and its downstream targets for LIF-mediated signalling is 
highlighted by the observation that Stat3, along with several of its downstream targets, 
can sustain ESC self-renewal in the absence of LIF when overexpressed (circled factors, 
Figure 1.5) (Matsuda et al. 1999). For example, through careful genetic and functional 
analysis, Klf4 and Tbx3 have also been placed upstream of OSN in these pathways. Klf4 
is directly activated by Stat3, and then upregulates Sox2 (Hall et al. 2009; Niwa et al. 
2009), whilst Tbx3 primarily upregulates Nanog (Figure 1.5, centre). Esrrb, which itself is 
known to target both Klf4 and Nanog, is also likely to be closely integrated with this 
network, though the upstream signalling pathways that regulate Esrrb expression or 
activity remain to be elucidated (Figure 1.5, dotted lines).  
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Figure 1.5 Co-ordination of external signalling pathways with the ESC network 
Summary of the main external signalling pathways and core pluripotency transcription factors upon which 
they converge in ESCs. The key targets of the LIF/Stat3 pathway are highlighted by their ability to support 
LIF-independent self-renewal when constitutively overexpressed (circled). Recently, dual inhibition of GSK3 
signalling (A) together with ERK inhibition (B) has been shown to support ground-state ESC self-renewal in 
the absence of any other exogenous stimuli such as LIF/serum (Ying et al. 2008).  
 
Though crucial for maintaining the expression of intrinsic TFs, LIF alone however is not 
sufficient to prevent differentiation. ESCs additionally require serum, the active 
component of which is BMP4. BMP4 signals through the TGF-β pathway, inducing the 
phosphorylation and activation of Smad1,5 and 8 transcription factors. These dimerize 
with Smad4, translocate to the nucleus and subsequently upregulate the expression of 
inhibitor-of-differentiation (Id) proteins, which themselves act as powerful negative 
regulators of neuroectodermal differentiation (Figure 1.5, left) (Ying et al. 2003). Forced 
expression of Ids negates the need for BMP/serum in ESC cultures, confirming that 
these factors are the key downstream targets of the BMP signalling pathway (Ying et al. 
2003).  
 
Interestingly, both LIF and BMP have been found to be dispensable for the maintenance 
of ESCs if a combination of two inhibitors (2i) is utilized, PD0325901, an inhibitor of 
MEK/ERK signalling, and CHIR99021, a GSK3β inhibitor (Ying et al. 2008). These two 
pathways normally negatively regulate the expression of pluripotency genes, with their 
inhibition proving sufficient to negate the need for LIF/Stat3 or BMP-dependent 
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signalling (Figure 1.5, right). Cells cultured in 2i/LIF are often referred to as being in 
“ground state” pluripotency, showing enhanced clonogenicity, with this cocktail also 
allowing ESC derivation from un-permissive strains (Batlle-Morera et al. 2008). In 
agreement with the positive effect upon self-renewal of GSK3 inhibition, overexpression 
of Wnt ligands, β-catenin, or ablation of the negative regulator of β-catenin signalling, 
Tcf3, have all been shown to enhance ESC self-renewal or reprogramming (Marson et al. 
2008; ten Berge et al. 2011; Wray et al. 2011; Yi et al. 2011). This is likely through both 
the β-catenin-mediated alleviation of Tcf3 repression on pluripotency genes, as well as 
activation of pluripotency targets by Tcf1/β-catenin complexes (Figure 1.5, right).  
Overall, these three axes of signalling pathways synergise and support the ESC 
transcriptional network. This confers a robust system to guard self-renewal that is also 
flexible and sensitive to signals to differentiate (such as addition of FGF4 or withdrawal 
of LIF).  
 
1.4.3 Epigenetic control of pluripotency 
As well as the recruitment of multiprotein complexes to activate genes, another key 
element in maintaining pluripotency-specific patterns of gene expression is the control of 
chromatin architecture. Chromatin in cells exists either in an open, transcriptionally-
permissive state (euchromatin), characterised for example by di- and tri- methylation of 
H3K4 (H3K4me2/3) and acetylation of H3K9 (H3K9ac), or as densely-coiled 
heterochromatin, which in turn is typified by histone deacetylation and H3K9 
methylation (H3K9me2/3) (Jenuwein and Allis 2001). The DNA of ESCs has been 
found to exist in a characteristically euchromatin-rich environment, showing generalized 
abundance of histone H3 and H4 acetylation and H3K4 di- and tri-methylation, which 
progressively becomes more densely compacted and heterochromatic during 
differentiation (Figure 1.6) (Arney and Fisher 2004). Supporting a direct link between the 
self-renewing/pluripotent state of ESCs and the presence of such active histone marks is 
the observation that ESC-induced T-cell reprogramming in nuclear fusion experiments 
involves a global increase in H3/H4 acetylation and H3K4 methylation as the somatic 
genome is remodelled into a pluripotent state (Kimura et al. 2004). Additionally, the use 
of the histone deacetylase (HDAC) inhibitor, Trichostatin A, inhibits ESC differentiation 
(Lee et al. 2004), implying that the acquisition of histone modifications that leads to 
chromatin condensation is a necessary step for ESCs to exit pluripotency. Conversely, 
shRNA-mediated depletion of the H3K9me2/3 demethylases, Jmjd2c and Jmjd1a, 
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downregulates pluripotency gene expression and induces differentiation (Loh et al. 2007). 
Such experiments demonstrate that altering the patterns of histone modifications can be 
both sufficient and necessary to modulate their differentiation status or lineage 
commitment of ESCs.  
 
Figure 1.6 Chromatin dynamics upon ESC differentiation 
Changes to nuclear organization and chromatin dynamics in undifferentiated vs. differentiated cells. DNA 
in undifferentiated ESCs (left) is typified by generally decondensed chromatin, with few heterochromatic 
foci, loosely associated chromatin proteins, and active histone marks such as H3K4me3. In differentiating 
ESCs (centre), chromatin structures gradually become more condensed, with more frequent foci of 
heterochromatin that contain repressive histone modifications (e.g. H3K9me3) and stably bound proteins 
such as HP1α. This can be visualised via immunofluorescence staining for HP1α or nuclear speckles 
(SF2/ASF staining), which become brighter and more numerous in differentiated cells (neural progenitor 
cells, NPCs) compared to ESCs. Scale bar, 5µm. Adapted from (Meshorer and Misteli 2006). 
 
Along with histone modifications, global DNA methylation is a covalent modification 
that is also dynamically altered in development, distinguishing between ESCs and 
differentiated cells. In vivo, early embryogenesis is accompanied by a progressive 
demethylation of both maternally- and paternally-inherited genomes, with methylation 
patterns later reinstated in the post-implantation blastocyst (Rougier et al. 1998; Borgel et 
al. 2010). Early-passage ESCs also exhibit global DNA hypomethylation, with a 
progressive increase in methylation with continued passaging (Nagy et al. 1993; Dean et 
al. 1998). At the level of specific genomic loci, the promoters of pluripotency factors are 
in general, hypomethylated, correlating with a high level of expression (Fouse et al. 2008). 
Conversely, exit from pluripotency is accompanied by increasing CpG methylation and 
consequent silencing of ESC-associated genes as cells differentiate (Li et al. 2007). 
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Somatic cells, such as MEFs, display CpG hypermethylation at promoters of genes 
including Nanog and Oct4, a modification that is reversed in the re-acquisition of 
pluripotency during reprogramming (Takahashi and Yamanaka 2006) Treatment with the 
DNA demethylating agent, 5-azacytidine, has been shown to reverse partially-
differentiated ESCs, demonstrating the importance of DNA hypomethylation, alongside 
active H3K4me2/3 marks at pluripotency genes, for ESC self-renewal (Tsuji-Takayama 
et al. 2004). Surprisingly, in contrast to highly transcribed genes that are marked mainly 
with active marks, several studies have demonstrated in recent years that many lineage-
specific genes are not simply marked with repressive histone modifications, but in fact 
contain both active and repressive histone marks, a phenomenon that has been termed 
chromatin bivalency (Bernstein et al. 2006). The presence of active H3K4me2/3 at these 
domains together with opposing H3K27me3 ‘anchors’ genes in a silent yet poised state, 
allowing for rapid induction by the removal of H3K27me3 as soon as signals to 
differentiate are initiated (Azuara et al. 2006). Such marks are deposited by the Polycomb 
complex, PRC2, which catalyzes the addition of H3K27me3 at these sites (Boyer et al. 
2006). Consistent with gene priming, bivalent genes assemble poised RNA Polymerase II 
complexes (RNApol2), preferentially methylated at Serine-5 of its CTD, an association 
that is further enforced by PRC1 (Stock et al. 2007; Brookes et al. 2012). These genes are 
thus not actively transcribed in ESCs, but exist in a transcriptionally primed, ready state, 
until their expression is induced upon differentiation and lineage specification. 
 
Interestingly, and with particular relevance to this thesis, is the finding that ESC 
enhancers, and not just promoters, also carry their own distinct chromatin modifications. 
The coactivator p300 – already mentioned earlier as an important component of ESC 
enhancesomes – is well-known for its histone acetyltransferase (HAT) activity, conferring 
p300 with the ability to enhance gene expression directly by remodelling chromatin 
architecture (Chan and La Thangue 2001). More specifically, recent genome-wide studies 
have identified key chromatin signatures that characterise enhancesomes, delineating 
between developmentally poised enhancers, and those that are actively transcribed 
(Creyghton et al. 2010). Here, it was observed that enhancers at genes that become active 
later in development are marked by H3K4me1 alone, whereas active enhancers have 
both H3K4me1 and additionally H3K27ac, a modification catalysed by CBP/p300 
(Wang et al. 2008). Several studies in human ESCs have also described the presence of 
similar histone codes, with poised enhancers additionally associated with the Polycomb-
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mediated mark, H3K27me3 (Heintzman et al. 2007; Rada-Iglesias et al. 2011; Taberlay et 
al. 2011). These findings suggest that a critical prerequisite for the function of active 
enhancers is the recruitment of p300 (Wang et al. 2008), as well as highlighting the 
existence not only of poised or bivalent promoters, but also poised enhancers (Figure 
1.7). 
 
Figure 1.7 Distinguishing between poised and active enhancers 
Diagram showing distinct subsets of enhancers in ESCs and progenitor cells. Inactive enhancers are 
characterised by the absence of both H3K4me1 and H3K27ac modifications, whereas poised enhancers 
that have the potential for later activation in a context- or cell type-specific fashion are marked by 
H3K4me1 alone. The acquisition of H3K27ac at these enhancers, potentially deposited by p300, marks 
their transformation from a poised to active state, and these enhancers would now be associated with 
active transcription. Diagram adapted from (Creyghton et al. 2010). 
1.4.4 Transcriptional cofactors and remodelling complexes 
As previously outlined in this section, extensive research in the past decade has dissected 
the necessary DNA-binding and epigenetic events that occur as cells acquire – or lose – 
pluripotency. In contrast, fewer investigations have focused on the function of individual 
TFs, and the mechanisms through which they participate in the ESC transcriptional 
network. For example, what is the exact role of Oct4/Sox2/Nanog at ESC promoters 
and enhancers? Why are so many molecules present within one individual MTL? It is 
only recently that some of these questions have begun to be addressed. An ESC-specific 
SWI/SNF complex – esBAF, for instance, is recruited to Oct4/Sox2 at many target 
genes, and is essential for self-renewal and pluripotency (Ho et al. 2009a; Ho et al. 
2009b). Another remodelling ATPase, Chd7, is similarly associated with Sox2 in neural 
stem cells and required for Sox2-dependent gene activation (Engelen et al. 2011). In 
ESCs, esBAF-dependent chromatin remodelling is furthermore required for Stat3 
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binding to target sites to mediate LIF-dependent signalling (Ho et al. 2011). As a 
chromatin remodelling complex, esBAF thus serves both to create an ‘open’, 
transcriptionally permissive environment, as well as to condition responsivity to external 
signalling pathways. Another large complex that is essential for ESCs and 
reprogramming, Trithorax/MLL (trxG), is also physically associated with both Esrrb and 
Oct4 in ESCs (van den Berg et al. 2010; Ang et al. 2011). Ang and colleagues found that 
depletion of the core trxG component, Wdr5, induces global reductions in H3K4me3 as 
well as compromising self-renewal and reprogramming. This work therefore highlighted 
the link between the deposition of H3K4me3 and maintaining transcription of ESC 
targets. Similarly, the presence of Nanog and H3K4me3 has been shown to be required 
for the full enrichment of Tip60-p400 at distinct sets of promoters (Fazzio et al. 2008), 
similar to the requirement for OSN to direct global p300 recruitment (Chen et al. 2008). 
Like p300, Tip60-p400 possesses its own HAT activity, and moreover is essential for the 
maintenance of proper ESC identity (Fazzio et al. 2008). Overall, these findings suggest 
that at least part of the role of OSN is the efficient organization of the epigenetic 
landscape surrounding target genes.  
 
Directly relating to transcription, one of first examples of an ESC-specific coactivator 
protein associated with a core TF was recently described. Here, a proteomics screen was 
conducted to identify the missing component needed for Oct4/Sox2-dependent 
activation of a Nanog reporter construct, which is active in ESCs but not in somatic cells 
(Fong et al. 2011). Their approach identified this stem cell-specific coactivator as XPC, a 
molecule already known in other contexts as the trimeric XPC-RAD23B-CETN2 
nucleotide excision repair complex. Whilst the mechanism through which XPC is 
required for gene activation was not identified, this study importantly highlighted that 
key ESC factors may critically require the presence of additional components in order to 
function as transcriptional activators.  
 
Finally, one link still not made in ESCs is that between pluripotency factors and the 
process of transcription itself. ESCs exhibit globally hyperactive transcription and 
express elevated levels of chromatin machinery and general transcription factors (Efroni 
et al. 2008). Furthermore, RNApol2-associated proteins such as TAFs are also important 
for ESC pluripotency and lineage specification (Kagey et al. 2010; Liu et al. 2011). Both 
these facts suggest that members of the general transcription machinery may have 
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particularly important roles in ESC biology. As will be discussed later in this thesis, many 
of these components were surprisingly recently associated with Esrrb (van den Berg et al. 
2010), suggesting a potentially unique role for this nuclear receptor that remains to be 
investigated. There are indeed several open questions regarding the control of ESC 
transcription, and the function of molecules such as Esrrb, Tbx3, Sall4, Klf2,4,5 and 
Nr5a2. For example, it is unclear whether all the TFs recruited to a particular enhancer 
are essential for its activity, or whether a degree of functional redundancy or flexibility 
exists. Furthermore, the individual role of each enhancer-bound factor is also unclear. 
Some of these TFs may simply act to stabilise OSN or other core molecules in ternary 
complexes at MTL. Other TFs may alternatively be responsible for the recruitment of 
their own specific cofactors to contribute to gene activation.  
 
1.5 Nuclear reprogramming 
1.5.1 Walking backwards: three routes back to pluripotency 
Nuclear reprogramming is a phenomenon that as well as holding great promise for 
regenerative medicine has also been used to improve our knowledge of the genetic and 
epigenetic requirements of pluripotency. The paradigm that cells proceed down a one-
way street during development was first challenged in the 1950s and 1960s. Here, 
seminal experiments in amphibians showed that somatic nuclei when transplanted into 
enucleated eggs were capable of producing live tadpoles (Briggs and King 1952; Gurdon 
1962). Later, experiments confirmed that this phenomenon is possible in mammals, 
highlighted in both scientific and non-scientific communities by the birth of ‘Dolly the 
sheep’, the first cloned mammal (Wilmut et al. 1997).  Most recently, fusion of a human 
adult nucleus with a non-enucleated oocyte was shown to support development of the 
resulting triploid cells to the blastocyst stage (Noggle et al. 2011). Nuclear transfer 
experiments can now be utilised to produce ESC lines derived from somatic cells from a 
variety of organisms (Figure 1.8A). In experiments complimentary to these somatic cell 
nuclear transfer (SCNT) assays, cell fusion experiments have confirmed that somatic 
nuclei contain all the genetic information required for reprogramming (Figure 1.8B). 
Heterokaryons, the product of fusing two cells together that retain separate nuclei, were 
first generated using a human muscle and non-muscle cell, which demonstrated that trans 
factors produced by the muscle cell could reprogram the gene expression of its non-
specialized partner (Blau et al. 1983). Later, factors this time from an EG cell were 
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shown to be capable of initiating global genomic reprogramming of a recipient 
lymphocyte when both cells were fused together (Tada et al. 1997). Fusion of adult nuclei 
with ESCs also confers rapid reprogramming (Pereira et al. 2008; Pereira et al. 2010), 
with re-activation of the Oct4 locus possible within as little as 48 hours (Tada et al. 2001). 
Such experiments have highlighted two things: firstly, that differentiation does not entail 
irreversible genetic changes that forever restrict a cell’s developmental potential, and 
secondly, that certain factors expressed highly in stem cells and eggs are capable of 
exerting a dominant effect over the somatic genome to rewire it back to a pluripotent 
state.  
 
It was over 50 years after the first SCNT experiments that scientists finally identified the 
specific transcription factors capable of converting somatic cells back to pluripotency, 
termed nuclear reprogramming. In groundbreaking work, Takahashi and Yamanaka 
screened ESC-enriched transcription factors for the ability to reprogram mouse 
embryonic fibroblasts (MEFs). For this, they utilized MEFs containing a G418 resistance 
cassette driven by ESC-specific gene, Fbx15, and monitored the emergence of G418-
resistant colonies after retroviral transduction with pools of factors. They indeed 
identified colonies of reprogrammed cells that were morphologically, genetically and 
epigenetically similar to ESCs, termed induced pluripotent stem cells (iPSCs) (Takahashi 
and Yamanaka 2006). Narrowing down, this group eventually identified four core factors 
that reproducibly reprogrammed MEFs, referred to as the Yamanaka factors: Oct4, Sox2, 
Klf4 and cMyc (OSKM) (Figure 1.8C).  
Chapter One                                                                                              Introduction 
 42 
 
Figure 1.8 Three approaches to reprogramming 
In (A) a somatic cell nucleus is transplanted into an enucleated oocyte. When activated, factors in the 
ooplasm override the somatic genome, remodelling its epigenetic status and gene expression profile to allow 
progression through embryonic development. (B) Cell fusion experiments demonstrate that an ES or EG cell 
following fusion with an adult cell can also reprogram the somatic genome, either in heterokaryons – where 
no nuclear fusion occurs – or in nuclear-fused hybrids containing multiple chromosome copies. (C) In the 
most recent reprogramming technique, forced overexpression of just four transcription factors is capable 
of directly converting somatic cells into induced Pluripotent Stem Cells (iPSCs). Diagram from (Yamanaka 
and Blau 2010). 
1.5.2 Optimal and alternative reprogramming factor combinations 
Within a year of this first discovery, two independent groups confirmed the regenerative 
potential of iPSCs by demonstrating that these cells could contribute efficiently to 
chimeras and show germline transmission, producing viable adult mice (Okita et al. 2007; 
Wernig et al. 2007). Reprogramming of human somatic cells was also soon achieved, 
though to date limitations still exist with the extent to which the developmental potency 
of hiPSCs can be evaluated (Takahashi et al. 2007). Eliminating one potential barrier to 
using iPSCs in the clinic, cMyc was shortly after shown to be dispensable for 
reprogramming in both human and mouse cells – albeit with reduced efficiency – 
redefining the minimal components as OSK (Nakagawa et al. 2008; Wernig et al. 2008). 
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Much research has since been conducted into defining alternative cocktails or reducing 
the number of factors required for nuclear reprogramming. For example, human and 
mouse neural stem cells, which express endogenous Sox2, Klf4, and cMyc, can be 
reprogrammed with Oct4 alone (Kim et al. 2009a; Kim et al. 2009b). Alternatively, 
factors or chemicals that either control key signalling pathways, contribute to epigenetic 
remodelling or upregulate endogenous pluripotency genes can also substitute for OSKM 
members. For example, TGF-β inhibition allows reprogramming in the absence of Sox2 
through upregulation of endogenous Nanog (Ichida et al. 2009), whilst Ding and 
colleagues have shown that a combination of chemical inhibitors and Oct4 alone is 
sufficient to reprogram human somatic cells (Zhu et al. 2010). Interestingly, Esrrb was 
one of the first TFs shown to replace a Yamanaka factor directly, substituting for Klf4 in 
the generation of iPSCs from MEFs (Feng et al. 2009). This is believed to be due to the 
ability of Esrrb to upregulate the expression of all three stem cell Klfs, Klf2,4,5, as well as 
its co-localisation with Klf4 at many target genes as defined by ChIP-seq. In agreement 
with its role in reprogramming, Esrrb can rescue ESC self-renewal upon triple Klf2,4,5 
knockdown (Feng et al. 2009). Another important ESC nuclear receptor, Nr5a2, and its 
close family member, Nr5a1, are to date the only transcription factors known to be able 
to substitute for Oct4 in reprogramming (Heng et al. 2010; Redmer et al. 2011). These 
findings point to an important role for nuclear receptors in the process of 
reprogramming.   
1.5.3 Roadblocks in the sequential acquisition of reprogramming 
Many sophisticated experiments have shown that nuclear reprogramming entails a 
progressive remodelling of the somatic genome, to acquire the gene expression patterns 
and both proteomic and epigenetic properties that define pluripotent stem cells. Thus, 
the parameters or factors that are essential in stably maintaining ESCs in culture may 
similarly be required in reprogramming. However, nuclear reprogramming is also a 
markedly slow, stochastic process, implying that many barriers exist to first achieving this 
stable ESC state.  
i Evading senescence 
A few years ago, several groups simultaneously identified a significant barrier to 
reprogramming as cellular senescence. In contrast to stem cells, somatic cells have only a 
limited cellular lifespan, undergoing progressive telomere shortening that eventually 
triggers p19ARF and p53-induced cell cycle arrest (Utikal et al. 2009).  This phenomenon is 
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relevant to reprogramming as donor cells are selected from primary cell populations with 
only limited culturing potential in vitro. Interestingly, forced expression of OSKM itself 
triggers significant senescence or apoptosis in MEFs, indicating that a substantial barrier 
to reprogramming is posed even by the overexpression itself of these reprogramming 
factors (Banito et al. 2009). In agreement, reprogramming of p53-/- MEFs or upon 
depletion of senescence effectors proves significantly more rapid and more efficient than 
using wild-type cells. Similarly, reprogramming efficiency has also been directly linked to 
proliferation rate, with p53 ablation increasing cell division and concomitantly enhancing 
reprogramming (Hanna et al. 2009b).  
ii Overcoming epigenetic barriers 
Reprogramming entails a drastic remodelling of the somatic genome in terms of both 
DNA and histone modifications, and has been shown to be a significant limiting factor 
in iPSC generation. Somatic cell reprogramming typically involves efficiencies of less 
than 1% and takes over 14 days. Indeed, reactivation of endogenous Oct4 and Nanog, 
which are hypermethylated in somatic cells, occurs only very late in this process 
(Stadtfeld et al. 2008; Theunissen and Silva 2011). The journey of specialisation 
undertaken by a zygote or ESC as it differentiates has been illustrated by Waddington’s 
landscape (Figure 1.9). Here, the totipotent cell is represented by a ball at the top of a 
slope, with its destiny as a committed unipotent cell at the base. Completing this journey 
involves progressive histone and DNA modifications that restrict alternative cell fates, 
also preventing regression back to an earlier stage of developmental potency. 
Reprogramming must thus achieve the thermodynamically-difficult task of going ‘uphill’, 
reversing epigenetic changes such as X inactivation and promoter hypermethylation of 
pluripotency genes, as well as instigating Polycomb-mediated repression of 
differentiation genes (Figure 1.8, right). 
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Figure 1.9 Waddington’s epigenetic landscape 
A modified Waddington’s landscape. Cellular developmental potential can be seen as an uneven, downward 
slope, with differentiating cells progressively gaining more and more epigenetic specialisation and 
restriction as they head towards the base. Cells thus become caught in valleys of stable epigenetic states, from 
which measures such as forced transcription factor expression (ie reprogramming) must be taken to push 
them ‘uphill’ to a higher state of pluripotency. Similar techniques can also be used to move cells from one 
valley to another, termed transdifferentiation. Diagram from (Hochedlinger and Plath 2009). 
 
Linked to these epigenetic requirements, the inappropriate expression or function of 
many components of the epigenetic machinery has been shown to limit reprogramming, 
highlighting the importance of establishing the correct epigenetic landscape when 
acquiring pluripotency. Incomplete DNA methylation of somatic genes contributes to a 
‘transcriptional memory’ in iPSCs (Ohi et al. 2011), with levels of DNA methylation 
often highly variable amongst different iPSC lines, a factor that also affects their 
differentiation potential (Bock et al. 2011). Indeed, PRC2 members including Eed were 
recently shown to be essential for reprogramming in heterokaryon-based experiments, 
despite Eed being dispensable in ESCs (Pereira et al. 2010). These results imply that 
either the activation of epigenetic machinery, or their function, may be sub-optimal in 
many cells during reprogramming, which may lead to incomplete repression of lineage-
specific genes or improper acquisition of bivalent chomatin marks. Conversely, de-
repression of pluripotency genes is also inefficient, as illustrated by the finding that 
knockdown of the methyltransferase Dot1l upregulates Nanog and improves 
reprogramming efficiency (Onder et al. 2012). Conversely, knockdown of Wdr5, a TrxG 
member associated with the deposition of ‘active’ H3K4me3 at pluripotency genes early 
in reprogramming, compromises iPSC generation (Ang et al. 2011; Koche et al. 2011).  
 
Chapter One                                                                                              Introduction 
 46 
Additional to specific gene activation or repression, one reason for the inefficiency of 
reprogramming may be that slow or incomplete epigenetic remodelling prevents strong 
OSKM binding to relevant target sites. Indeed, partially reprogrammed iPSCs were 
found to contain much lower OSK occupancy at ESC-associated genes than their fully 
reprogrammed counterparts, while targets bound by OSK plus cMyc early on in 
reprogramming remained the same (Sridharan et al. 2009). Relating this directly to DNA 
methylation, a separate study found that Oct4 binding to nucleosome-depleted regions 
(NDR) at the Oct4 and Nanog promoters is strictly dependent on prior DNA 
demethylation (You et al. 2011). This work also suggests that, as characterised in breast 
cancer, pioneer factors (proteins able to bind to heterochromatin), may have an 
important role to play early on in reprogramming (Gifford and Meissner 2012). Such 
proteins could first bind to nucleosomal DNA and remodel local chromatin, 
subsequently allowing OSKM to bind. Taken together, studies analysing the role of the 
epigenetic machinery in iPSC generation support the hypothesis that DNA and histone 
remodelling are key limiting factors in reaching the fully-reprogrammed state.  
iii Reactivation of endogenous factors and the ‘ground state’ iPSC 
Full reactivation of the endogenous pluripotency network is an essential step in 
reprogramming. One key determinant of reaching ground state pluripotency is the re-
expression of Nanog. Interestingly, Nanog was not one of the four Yamanaka factors 
discovered to be able to reprogram mouse somatic cells (Takahashi and Yamanaka 2006). 
Despite this, the reactivation of the Nanog allele during reprogramming is a reliable 
indicator that a colony consists of successfully-reprogrammed cells (Okita et al. 2007; 
Wernig et al. 2007). Moreover, Nanog is essential for reprogramming in cell fusion 
experiments, as well being crucial for the conversion of colonies from a partial to fully-
reprogrammed state (Silva et al. 2009).  Colonies formed in the absence of Nanog are 
proliferative and stain positive for alkaline phosphatase (AP) and SSEA-1, two markers 
for undifferentiated cells. However, these cells die upon transferral to 2i/LIF conditions 
– a treatment that normally induces conversion to full iPSCs (Silva et al. 2009). In 
contrast to fully-reprogrammed iPSCs, these pre-iPSCs retain an inactive X 
chromosome, rely on retroviral expression of reprogramming transgenes and cannot 
colonise chimeras (Silva et al. 2008), and thus have not reached the ground state. The 
exact role for Nanog in reprogramming still remains to be elucidated, though its 
colocalisation with OSKM at binding sites that are unoccupied in pre-iPSCs suggests that 
Nanog could be required for cooperative binding to these targets (Sridharan et al. 2009). 
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Apart from Oct4 however, which is essential for reprogramming in cell fusions (Pereira et 
al. 2008), it still remains to be investigated whether other endogenous components of the 
core pluripotency network are either essential or limiting factors in reprogramming. 
Interestingly, microarray data from a recent genome-wide investigation of 
reprogramming events reveal that like Nanog, Esrrb is highly upregulated in fully-
reprogrammed iPSCs (See Appendix I and (Mikkelsen et al. 2008)). This is in contrast to 
Klf4 and Nr5a2, which show significant expression in pre-iPSCs as well as their fully-
reprogrammed counterparts. Thus as well as enhancing reprogramming, it is possible that 
Esrrb plays a role either upstream or downstream of Nanog, in events required for pre-
iPSC acquisition of ground state pluripotency.  
1.5.4 Enhancing the reprogramming process 
An intense focus in iPSC research has predictably been the pursuit of factors, 
methodologies, or chemicals that can enhance reprogramming. Importantly, such efforts 
have also served to increase our knowledge of the molecular and transcriptional 
requirements of reprogramming. In agreement with the need for somatic gene 
hypermethylation and pluripotency gene demethylation (see 1.5.3.ii and Figure 1.9), the 
DNA de-methylating agent, 5-azacytidine, enhances reprogramming and can stimulate 
conversion of pre-iPSCs to fully reprogrammed cells (Mikkelsen et al. 2008). Similarly, 
Valproic acid (VPA), a histone deacetylase inhibitor, also improves reprogramming 
efficiency (Redmer et al. 2011). More recently, the surprising finding that Vitamin C 
addition enhances reprogramming was revealed to be due both to its suppressive effect 
upon senescence (Esteban et al. 2010), as well as its activation of two vitamin-C-
dependent H3K36 demethylases, Jhdm1a and Jhdm1b (Wang et al. 2011a). More 
intriguingly and in direct relation to transcription, fusing the individual OSKM 
reprogramming factors to the transcriptional activator VP16 (Sadowski et al. 1988) 
greatly enhances reprogramming, allowing the generation of germline-competent iPSCs 
using Oct4-VP16 alone (Wang et al. 2011b). This result highlights the possibility that the 
transcriptional activity of the reprogramming factors themselves, for example their ability 
to recruit cofactors to activate target genes – may also be limiting during reprogramming. 
Other molecules important in ESC-specific gene activation are also required for self-
renewal, such as the Oct4/Sox2 coactivator XPCC (Fong et al. 2011), as well as Mediator 
and TBP-associated factors (TAFs) (Kagey et al. 2010). It will be very interesting in 
future studies to determine whether these factors have similarly striking effects in 
enhancing somatic cell reprogramming. 
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1.6 Canonical mechanism of nuclear receptor action 
This chapter so far has outlined our current knowledge surrounding the acquisition and 
maintenance of pluripotency. Of particular importance is understanding the complex 
workings of the ESC/iPSC transcription factor network, and the mechanisms by which 
core factors orchestrate gene expression programmes in these cells. In this context, 
orphan nuclear receptor Esrrb is an ideal molecule to study, belonging to a superfamily 
of proteins whose DNA-binding and transcriptional activity have been extensively 
characterised ever since the first nuclear receptor was discovered in 1960. In this section, 
the canonical mechanism of orphan nuclear receptor function is explained, providing a 
foundation upon which to investigate Esrrb function in pluripotent cells. 
1.6.1 LBD-dependent gene activation 
The NR superfamily comprises 48 transcription factors that play an integral role in 
diverse and essential processes such as metabolism, fertility, development, nutrient 
assimilation and homeostasis. Unlike membrane-bound receptor proteins such as the 
receptor tyrosine kinase family, NRs are located inside the cell, either in the cytoplasm, 
complexed to heatshock protein chaperones (type I NR), or in the nucleus (type II NR). 
Stimulation of these NRs results in their translocation to the nucleus (type I), dissociation 
of complexed heatshock proteins or corepressors, followed by their direct recruitment to 
DNA. Here these proteins bind to cognate sites in the vicinity of target genes, triggering 
a cascade of events that alters the expression level of their targets.  
 
NRs consist of five regions (A/B, C-F). The DNA-binding domain (DBD) allows 
specific interaction with hormone response elements (HREs) located within target genes, 
whilst two transcriptional activation domains – the ligand-independent AF-1 activation 
domain and a ligand-binding domain (LBD) – confer transcriptional activity (Figure 
1.10). The LBD contains the AF-2 region, a structure responsible for the majority of 
transcriptional activation by NRs, and is thus key to their ligand-dependent function. 
 
Figure 1.10 Nuclear receptor (NR) domain structure 
Schematic illustrating the functionally-important NR domains. A/B: AF-1 region, C: DBD, D: hinge-region, 
E: LBD and F: C-terminal domain.  
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Endogenous ligands for the NRs are canonically hormones or other small lipophilic 
molecules, such as the soluble vitamins A and D, or steroid hormones such as estrogen 
and testosterone. These ligands enter the cell and bind specifically to the LBD, a three-
layer structure consisting of 12 alpha helices (H1-12) and one antiparallel beta sheet 
arranged in a helical ‘sandwich’, a structure that is highly conserved between various NRs 
(Figure 1.11A) (Bourguet et al. 1995). Analysis of the crystal structure of several NRs has 
revealed much about the basis of ligand-dependent activation, which involves a series of 
conformational changes within H1-12 of the LBD. Central to these adjustments is the 
rotation of H12 that occurs as a result of ligand binding, which creates a new surface 
within AF-2 that is subsequently able to bind coactivator proteins (Figure 1.11A-B) 
(Brzozowski et al. 1997). The interaction of liganded NRs with coactivators is crucial for 
their transcriptional activity on target genes. As discussed below, such coactivators 
recruit multiprotein complexes to remodel local chromatin structure, catalyse covalent 
histone modification, or bind members of the general transcription machinery, thus 
potentiating transcription. Conversely, certain antagonists stabilise AF-2 in an aberrant, 
inactive state, preventing adoption of the agonist position and furthermore recruiting NR 
corepressor complexes (Figure 1.11C) (Xu et al. 2002). Corepressors serve the opposite 
purpose as coactivators, recruiting HDACs and repressive chromatin remodelling 
complexes such as mSin3A to inhibit gene expression (Nagy et al. 1997).  
1.6.2 Regulation of ERR activity 
In contrast to most NRs, a subset of receptors called the orphan receptor subfamily do 
not appear to require or possess a cognate ligand for transcriptional activation. First to be 
discovered were the estrogen-related receptors (ERRs), referred to in Esrra, Esrrb, and 
Esrrg in mice. Esrra and Esrrb were initially identified in a screen for proteins that 
resemble estrogen receptor α (ERα) (Giguere et al. 1988). Unlike ERα however, these 
proteins do not bind estrogen, and appear to be transcriptionally active in the absence of 
ligand (Figure 1.11D-E).  
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Figure 1.11 Structure of the NR AF-2 region and mechanisms of NR activation 
(A) Ribbon diagram of a typical apo-NR LBD in the absence of ligand (inactive AF-2). (B) Agonist ligand 
bound LBD, in which H12 adopts an active position able to interact with coactivators (activator LxxLL 
peptide) (C) Antagonist ligands can stabilise the inactive NR conformation, preventing H12 rotation, and 
allowing docking of corepressors (repressor LxxLL peptide). Diagram from (Bain et al. 2007). (D) Ligand-
induced NR activation. In the absence of ligand, non-orphan NRs exist in an inactive conformation with 
the AF-2 region unable to bind coactivators. Ligand binding induces a shift in AF-2, allowing recruitment 
of coactivator proteins to stimulate transcription. (E) Orphan NRs such as the ERR family, for which no 
known endogenous ligand is known, may exist in an active conformation in the absence of ligands and are 
thus regulated by the availability of coactivator proteins, which as for (D) are necessary for transcription.  
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Supporting the hypothesis that ERR activity is not dependent on ligand binding, 
structural analysis has revealed that the LBD is indeed filled with bulky hydrophobic side 
chains, leaving a pocket of only 220Å in the case of Esrrg and an even smaller 100Å for 
Esrra. Such a cavity would only accommodate at most four to five carbon atoms (Kallen 
et al. 2004), making the LBD significantly smaller than typical NRs, and too small to 
accommodate a steroid hormone without a major LBD conformational change.  
Comparison of the unliganded, agonist and antagonist-bound conformations of orphan 
NRs such as Esrrg has provided an explanation for their constitutive activity. Such 
structures reveal that the apo-receptor in the absence of ligand already adopts a stable 
conformation with Helix 12 correctly positioned to interact with coactivators (Figure 
1.11E) (Greschik et al. 2002; Wang et al. 2006b). Only a few chemical agonists have been 
reported for Esrra, and these in agreement seem to work predominantly by further 
stabilising H12 in its active position (Suetsugi et al. 2003). The fact that ERRs are already 
stabilised in what mimics the ligand-bound state of typical NRs has lead to the theory 
that the regulation of ERR activity may be predominantly at the level of coactivator-
availability (reviewed in (Rosenfeld et al. 2006)).  
 
1.6.3 Regulation of NR activity by coactivators and repressors 
Critical for the activity of nuclear receptors, whether orphan or not, is their interaction 
with coactivator and corepressor proteins.  Mutations that disrupt the interaction of NRs 
with these cofactors abolish most, if not all of their LBD-dependent transcriptional 
activity (Heery et al. 1997), highlighting the essential nature of these proteins for receptor 
function. Over 200 coactivator proteins are now known to exist, many of which can be 
recruited by transcription factors as well as NRs.  
 
NR coregulator proteins comprise distinct domains, including a transactivation domain 
and a nuclear receptor interacting domain (RID), which contains one or more NR boxes 
with the consensus LxxLL motif that is crucial for receptor-interaction (Figure 1.12) 
(Heery et al. 1997). The conserved leucines within this motif have been shown to form 
the hydrophobic face of an alpha helix, which ‘docks’ onto H12, further stabilising the 
active NR conformation. Interestingly, as well as the ligand-dependent coactivators that 
will be discussed here, transcriptional repression may conversely be mediated by NRs 
utilizing ligand-dependent corepressors. Two such proteins are known, LCoR and 
RIP140, which both bind specifically to active conformations of the AF-2 region using 
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LxxLL motifs (Figure 1.12). These proteins subsequently recruit complexes such as 
HDACs and CtBP to catalyse transcriptional repression (Fernandes et al. 2003; Christian 
et al. 2004), which whilst not discussed further here, is nevertheless a large field of study 
in its own right. RIP140 for example, can act as a corepressor for many if not all NRs, 
where it has been shown to perform essential roles in adipocyte biology, skeletal muscle 
metabolism and even fertility (White et al. 2000; Leonardsson et al. 2004; Seth et al. 
2007).  
 
Figure 1.12 LxxLL motif organisation in coactivators and corepressors 
Diagram indicating the incidence of leucine/LxxLL motifs (black lines) that occur in coactivators 
(Ncoa1/SRC-1, p300 and CBP) as well as corepressors (RIP140) that bind nuclear receptors. Numbers 
indicate the amino-acid length of each protein.  
 
Unlike corepressor proteins, the complexes that are recruited by coactivators serve to 
create a local chromatin environment that facilitates gene activation. This is mediated 
both – in some cases – by catalytic activity contained within the coactivators themselves, 
as well as via their recruitment of ‘secondary-coactivators’. Such secondary coactivators 
include HATs, histone methyltransferases as well as multiprotein remodelling complexes, 
leading to the idea that coactivators are primarily ‘scaffolds’ upon which large 
transcriptional complexes are built. The proteins recruited by coactivators may 
furthermore include the general transcription machinery itself, thus bringing RNApol2, 
TAFs and Mediator to the promoter to initiate transcription.  
i Histone acetylation 
Of all the coactivator proteins, p300/CBP is best characterised for its intrinsic HAT 
activity (Ogryzko et al. 1996). Consisting of two closely related proteins, p300 and CREB 
binding protein (CBP), p300/CBP is responsible for H3 and H4 acetylation at promoters 
and enhancer regions, increasing the accessibility of the local DNA surrounding target 
genes. p300/CBP is also associated with p/CAF, a second coactivator with its own 
acetyltransferase activity (Yang et al. 1996). p300/CBP has been shown to interact 
RIP140 
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CBP 
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directly with NRs via its own LxxLL motifs (Figure 1.12) (Chakravarti et al. 1996), as well 
indirectly when recruited through its interaction with other NR-bound coactivators, such 
as the steroid receptor coactivator (Ncoa/p160/SRC1) family (Chen et al. 1997a). 
Interestingly, p300/CBP may also catalyse the acetylation of other proteins, for example 
p53, whose DNA binding affinity is activated following acetylation (Gu and Roeder 
1997).  
ii Coactivators as ‘transcriptional adaptors’ 
A key role of coactivators is to act as molecular scaffolds upon which other proteins and 
complexes may assemble (Figure 1.13). Two of the best characterised of these in 
mammalian cells is the Ncoa family, and the peroxisome proliferator-activated receptor 
gamma coactivator-1 (PGC-1) family of coactivators. Although some of these have been 
shown to possess HAT activity – for example Ncoa1 and Ncoa3 (Chen et al. 1997a; 
Spencer et al. 1997), this is significantly weaker than p300/CBP and so likely not their 
predominant mechanism of conferring NR transcriptional activity (Yan et al. 2006a). 
Instead, histone acetylation conferred by their recruitment of p300/CBP plays an 
important role in the ability of the Ncoa family to function as coactivators (Chen et al. 
1997a; Kalkhoven et al. 1998; Liu et al. 2001). The recruitment of scaffold coactivators to 
NRs importantly allows a variety of histone-modifying enzymes and chromatin 
remodellers to be brought into close proximity with the local chromatin structure, 
subsequently opening accessibility to the basal transcription machinery at target 
promoters.  In addition, the infinite combinations of coactivator proteins that can 
assemble on any one target gene undoubtedly serve to impart specificity to 
transcriptional regulation. Histone modifiers include HATs, as already discussed, as well 
as histone methyltransferases such as CARM-1 and PRMT1 (Koh et al. 2001), which may 
all be recruited to NRs via their associated coactivators. Secondly, many chromatin 
remodelling complexes are also recruited via coactivators to NRs, for example the 
BAF/Brg1 complex, which associates with ERα via Ncoa-mediated interactions with 
BAF57 (Belandia et al. 2002). Finally, NR coactivators serve as direct contacts to the 
general transcription machinery. The best characterised of these is the Mediator complex, 
also known as TRAP/DRIP (Meisterernst et al. 1991; Fondell et al. 1996). This 
multiprotein complex can be recruited to NRs directly via means of LxxLL motifs in 
individual MED subunits, for example in MED1 (Yuan et al. 1998). However, the 
                                                
1For clarity, Ncoa/p160/SRC family members will from hereon be referred to as Ncoa1, Ncoa2 and 
Ncoa3. 
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association of Mediator with NRs is also possible indirectly, via its binding to other 
coactivators. For example, a MED1 mutant lacking a functional LxxLL is still able to 
activate the NR, PPARγ (Ge et al. 2008). Other Mediator subunits are also known to 
bind p300 or members of the PGC-1 (Wallberg et al. 2003), or Ncoa families (Huang et 
al. 2003), which themselves are NR-associated (Figure 1.12). Scaffold coactivators may 
additionally bind RNApol2 (Wu et al. 2007), overall highlighting a combinatorial 
mechanism of linking NRs to the pre-initiation complex assembled at target gene 
promoters for transcription.  
 
Figure 1.13 Coactivator complexes recruited to NRs 
Diagram illustrating the many types of coactivators recruited by NRs to target genes, including ‘core’ 
coactivators that directly bind NRs (such as the Ncoa/p160 family), ATP-dependent remodelling complexes 
(BAF complex), HATs (p300/CBP and P/CAF) as well as those that contact the general transcription 
machinery (eg Mediator). Coactivators may be recruited to target genes via direct interaction with NRs, or 
additionally as ‘secondary coactivators’ – via their association with core coactivators. Diagram from 
(Rosenfeld et al. 2006). 
 
1.6.4 Roles of ERR coactivators in somatic cells 
In contrast with ESCs and pluripotent cells, the regulation of ERR activity by coactivator 
recruitment has been well defined in a number of somatic physiological contexts. Most 
studied is the PGC-1 family, comprising three proteins, PGC-1α, PGC-1β, and more 
recently, a third protein, PRC. PGC-1α was originally identified as a coactivator for 
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PPARγ in brown adipose tissue (BAT), where it is important for adaptive thermogenesis 
and energy metabolism (Puigserver et al. 1998). PGC-1β and PRC are similarly expressed 
at high levels in highly oxidative tissues, where they participate in upregulating genes 
involved in mitochondrial function and respiration (Andersson and Scarpulla 2001; Lin 
et al. 2002; Vercauteren et al. 2009). Both PGC-1α and PGC-1β bind with high affinity 
to ERR members and have been demonstrated to be crucial for the activity of these NRs 
in tissues such as heart and skeletal muscle (Huss et al. 2002; Kamei et al. 2003; Schreiber 
et al. 2003). PGC-1α levels are additionally highly sensitive to physiological stimuli, with 
conditions such as fasting, cold exposure or exercise all triggering a rapid increase in its 
expression (Puigserver et al. 1998; Cartoni et al. 2005). Such examples illustrate how ERR 
activity may be tightly regulated simply by the availability of its coactivator, with ERR 
target genes only being activated during conditions that upregulate PGC-1α. Additional 
to the PGC-1 family, the proline-rich nuclear receptor coregulatory protein 2 (PRNC2) 
also binds to ERRs (Zhou and Chen 2001). Interestingly, PRNC2 was shown to be able 
to interact with Esrrg via its AF-1 domain, highlighting the potential of ERRs to recruit 
some cofactors via AF-2 independent mechanisms (Hentschke and Borgmeyer 2003).  
 
Although there are currently no examples of cellular contexts where ERR-Ncoa 
interactions are important, Ncoa-family coactivators have been shown at least in vitro to 
enhance ERR activity. Esrrg was in fact identified in a screen for Ncoa2-interacting 
proteins, and was able to enhance Esrrg activity in transient transfection studies (Hong et 
al. 1999), also potentiating Esrra activity in lung cells (Liu et al. 2009). All three Ncoa 
members were also shown to bind and coactivate Esrra and Esrrb in in vitro transfection 
assays, though no physiological context was examined (Xie et al. 1999; Zhang and Teng 
2000). Indeed, while knockout mice models of Ncoa1, Ncoa2 and Ncoa3 have all been 
characterised, revealing various defects in specific NR-dependent signalling including ER, 
thyroid receptor (TR) and androgen receptor (AR) (Xu et al. 1998; Ghadessy et al. 1999; 
Weiss et al. 1999; Xu et al. 2000), no direct link to a defect in ERR signalling has yet been 
made. Interestingly, an interaction between endogenous human proteins, Esrra (ERRα) 
and Ncoa3, was recently reported in cancer cells, supporting clinical data that showed a 
significant correlation between the co-overexpression of these factors in primary breast 
carcinoma (Heck et al. 2009). Esrra is known to be a negative prognostic marker in 
breast cancer (Suzuki et al. 2004), whilst Ncoa3 (also known as Amplified In Breast 
cancer 1; AIB1) is frequently upregulated in various tumours (Yan et al. 2006a). Taken 
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together, these results suggest an important role for the interaction of Esrra and 
Ncoa3/AIB1 in breast cancer progression, which will be interesting as well as clinically 
relevant to investigate further in future studies.  
 
1.7 Aims and Hypothesis 
The orphan nuclear receptor Esrrb has been described in multiple studies as a critical 
component of ESC and induced pluripotency. Esrrb is also currently under further 
investigation by several independent groups, making it very likely that new roles will soon 
be described for this protein within the next year. In spite of this, no investigation has yet 
been carried out to examine the mechanism of Esrrb function in ESCs and iPSCs, in 
particular whether its activity is dependent on coactivator recruitment as is typically the 
case for most NRs. To gain a greater understanding of the roles of Esrrb in pluripotency, 
it is therefore crucial to obtain a mechanistic understanding of its transcriptional activity. 
Moreover, studying the regulation of Esrrb activity in ESCs may assist in furthering our 
understanding of how TFs assembled at ESC enhancers act together to orchestrate gene 
transcription.  
 
Based on the information presented in this introduction, two hypotheses are proposed 
for the mechanism of Esrrb action in pluripotent cells. One possibility is that being 
colocalised with multiple TFs at MTL, Esrrb may predominantly be required to stabilise 
factors such as OSN as part of a multi-protein complex. This could be mediated through 
one or several Esrrb domains, for example its DBD, AF-1 region or LBD, and may likely 
be coactivator independent. Alternatively, Esrrb may possess a more specialised role in 
ESCs and thus function as a canonical orphan nuclear receptor, as in somatic cells. In 
this case, Esrrb would be expected to possess an essential requirement for an intact LBD 
and AF-2 region in order to recruit a specific coactivator and activate transcription. The 
aim of this study is therefore firstly to distinguish between these two scenarios. Secondly, 
if Esrrb does indeed require a coactivator for its transcriptional activity in pluripotent 
cells, efforts will be focused upon identifying this protein and performing a detailed 
characterisation of its role in regulating Esrrb function and the ESC state, as well as upon 
reprogramming towards pluripotency.  
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All that I see 
Show me your ways 
Teach me to meet my desires 
With some grace 
 
Interpol, Lights 
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2.1 Materials 
2.1.1 Chemicals, Solvents and Reagents 
Chemicals and solvents were purchased from the suppliers listed below: 
 
Chemical Supplier 
Acetone Fisher Scientific 
Acrylamide/Bis Solution Biorad 
Agarose Bioline 
All Trans Retinoic Acid Sigma-Aldrich 
Ammonium Persulfate (APS) Sigma-Aldrich 
β-Mercaptoethanol Sigma-Aldrich 
Betaine Sigma-Aldrich 
Bovine Serum Albumin (BSA) Fluka 
Bromophenol Blue Sigma-Aldrich 
Coelenterazine Promega 
Complete Protease Inhibitor Tablets Roche 
DEPC-Treated Water Ambion 
Deoxynucleotide Triphosphate (dNTPs) 10mM Invitrogen 
Dimethyl Sulfoxide (DMSO) Sigma-Aldrich 
Electroporation Cuvettes 1mm Web Scientific 
Ethanol Fisher Scientific 
Ethidium Bromide Bio-Rad 
Formaldehyde Solution, 39% Sigma-Aldrich 
Fugene HD Transfection Reagent Roche 
Glycerol BDH 
Glycogen Invitrogen 
Glycine Sigma-Aldrich 
HEPES Sigma-Aldrich 
Hyperladder I-IV DNA Markers Bioline 
Isopropanol Fisher Scientific 
Laemmli Sample Buffer BioRad 
Lipofectamine 2000 Transfection Reagent Invitrogen 
Lithium Chloride (LiCl) Sigma-Aldrich 
Chapter Two                                                                              Materials and Methods 
 60 
Magnesium Sulphate (MgSO4) Novagen 
Methanol Fisher Scientific 
MOPS Running Buffer (20X) Invitrogen 
Nonidet P-40 (NP-40) Sigma-Aldrich 
Normal Goat Serum Sigma-Aldrich 
Novex Sharp Pre-Stained Protein Standards Invitrogen 
NuPage 4-12% (w/v) Bis Tris Polyacrylamide Gels Invitrogen 
Oligonucleotides Invitrogen 
Paraformaldehyde Sigma-Aldrich 
Phenol-Chloroform Sigma-Aldrich 
Phenylmethanesulphonylfluoride (PMSF) Sigma-Aldrich 
Phosphate-buffered Saline (PBS) Sigma-Aldrich 
Polyethylenimine Linear (PEI) MW 25.000 Polysciences 
Protein A-Sepharose Sigma-Aldrich 
PVDF Membrane GE Healthcare 
Random Hexamers Invitrogen 
Restriction Buffers 1,2,3,4 New England Biolabs 
Salmon Sperm DNA Invitrogen 
Skimmed Milk Powder  Fluka 
SDS-PAGE Resolving Buffer Biorad 
SDS-PAGE Stacking Buffer BioRad 
Sodium Deoxycholate (Na-deoxycholate) Sigma 
Sodium Dodecyl Sulfate (SDS) Solution 10% Fluka 
Sodium Fluoride Fluka 
Sodium Orthovanadate Sigma-Aldrich 
SYBR Green Sigma-Aldrich 
TEMED Sigma-Aldrich 
Transfer Buffer (20X) Invitrogen 
Tris-Acetate (TA) SDS Running Buffer (20X) Invitrogen 
Tris Base Sigma-Aldrich 
Triton X-100 Sigma-Aldrich 
Tween-20 BDH 
Vectashield with DAPI Vector Laboratories 
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2.1.2 Kits 
 
Kit Name Supplier 
Alkaline Phosphatase Staining Kit Sigma-Aldrich 
Amicon Ultra-4 Centrifugal Filter Units 10,000 NMWL Millipore 
Bicinchoninic acid (BCA) Protein Assay Pierce 
ECL Western Blotting Reagent Pierce 
ECL Plus Western Blotting Reagent GE Healthcare 
HiSpeed Plasmid Maxi Kit QIAGEN 
KOD HotStart DNA Amplification Kit Novagen 
QIAquick PCR Purification and Gel Extraction Kit QIAGEN 
QIAprep Spin Miniprep Kit QIAGEN 
QuikChange XL Site Directed Mutagenesis Kit Stratagene 
Quick Ligation Kit New England Biolabs 
RNeasy Mini Kit QIAGEN 
Steadylite Plus Dual Luciferase Kit Perkin Elmer 
Superscript II Reverse Transcription Kit Invitrogen 
  
2.1.3 Antibiotics 
 
Antibiotic Supplier 
Ampicillin Sigma-Aldrich 
Blasticidin Invitrogen 
Puromycin Sigma-Aldrich 
Zeocin Invitrogen 
 
2.1.4 Enzymes 
 
Enzyme Supplier 
Bacterial Alkaline Phosphatase (BAP) Invitrogen 
DNase I (RNase-free) QIAGEN 
KOD HotStart DNA Polymerase Novagen 
Proteinase K Invitrogen 
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Restriction Endonucleases (all) New England Biolabs 
RNase A (DNase-free) Invitrogen 
SuperScript II First Strand Synthesis Kit Invitrogen 
SYBR Green Taq JumpStart ReadyMix Sigma-Aldrich 
T4 PNK New England Biolabs 
 
2.1.5 Buffers, Solutions and Gels 
Buffers and solutions were made up to the following final specifications and stored at 
room temperature unless otherwise specified. Techniques carried out with commercial 
kits were performed utilizing manufacturer-supplied buffers and reagents. 
 
DNA Manipulation 
 
TBE 10X 900mM Tris Borate 
20mM EDTA pH 8.0 
 
Tris-EDTA (TE) Buffer 1mM EDTA 
10mM Tris pH 8.0 
 
DNA Loading Buffer 10x 0.2% (w/v) Bromophenol Blue  
40% (v/v) Glycerol  
100mM EDTA pH 8.0 
 
DNA Plasmid Transfection 
 
Polyethylenimine Linear (PEI) 1mg/ml 
 
Dissolve PEI in water heated at 80°C 
Cool and adjust to pH 7.0 
Sterile-filter (0.2µm) 
(Store at -20°C) 
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Chromatin Immunoprecipitation (ChIP) 
 
ChIP Swelling Buffer 25mM Hepes pH 7.9 
1.5 mM MgCl2 
10mM KCl 
0.1% NP-40  
(Store at 4°C) 
 
ChIP Sonication Buffer 50mM HEPES pH 7.9 
140mM NaCl 
1mM EDTA 
1% Triton X-100 
0.1% Na-deoxycholate 
0.1% SDS 
(Store at 4°C) 
 
ChIP Wash Buffer A As Sonication Buffer but with 500mM 
NaCl 
(Store at 4°C) 
 
ChIP Wash Buffer B 20mM Tris pH 8.0 
1mM EDTA 
250mM LiCl 
0.5% NP-40 
0.5% Na-deoxycholate 
(Store at 4°C) 
 
ChIP Elution Buffer 50mM Tris pH 8.0 
1mM EDTA 
1% (w/v) SDS 
(Make up fresh on day of use) 
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Protein Manipulation and Co-immunoprecipitation (Co-IP) 
 
Radioimmunoprecipitation assay (RIPA) 
Buffer 
50mM Tris pH 8.0 
1mM EDTA 
0.5mM EGTA 
1% Triton X-100 
0.1% Na-deoxycholate 
140mM NaCl 
(Aliquot and store at -20°C) 
 
TSE Buffer 20mM Tris pH 8.0 
2mM EDTA 
150mM NaCl 
1% Triton X-100 
(Store at 4°C) 
 
Sodium Fluoride (NaF) (200X) 5mM sodium fluoride in distilled water 
(Aliquot and store at -20°C) 
 
Sodium Orthovanadate (Na3VO4) (50X) 100mM sodium orthovanadate solution in 
distilled water, adjusted to pH 9.0 with 
HCl, boiled until colourless, then re-set to 
pH 9.0. Repeat until colourless and pH 9.0 
at room temperature. 
(Aliquot and store at -20°C) 
 
Polyacrylamide Gels (Resolving)  375mM Tris HCl pH 8.8 
7% (w/v) Acrylamide/Bis  
0.1% (w/v) SDS  
0.05% (w/v) Ammonium Persulfate  
0.005% (v/v) TEMED 
 
Polyacrylamide Gels (Stacking) 
 
125mM Tris HCl pH 8.8 
4% (w/v) Acrylamide/Bis  
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0.1% (w/v) SDS  
0.05% (w/v) Ammonium Persulfate  
0.01% (v/v) TEMED 
 
SDS Running Buffer 25mM Tris base 
190mM Glycine  
0.1% (w/v) SDS 
 
Transfer Buffer (1X) 3.03g Tris base 
14.4g Glycine 
0.01% SDS 
10% (v/v) methanol 
 
TBS-T 130mM NaCl  
20mM Tris pH 7.6  
0.1% (v/v) Tween-20 
 
Immunofluorescence (IF) 
 
4% Paraformaldehyde (PFA) 4% (w/v) PFA dissolved in PBS pre-heated 
to 40°C containing 2mM NaOH 
Sterile-filter (0.2µm) 
(Aliquot and store at -20°C) 
 
IF Blocking Buffer 10% (v/v) normal goat serum 
2.5% (w/v) BSA 
 
IF Permeabilization Buffer Blocking buffer plus 0.4% (v/v) triton X-
100 
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Miscellaneous Buffers 
 
Renilla Buffer 500mM HEPES pH7.8  
40mM EDTA 
10µg/mL Coelenterazine 
 
2.1.6 Plasmids 
The following constructs have been generated by myself for this thesis unless otherwise 
acknowledged under ‘Source’. See Appendix for shRNA sequences and vector maps. 
Plasmids were stored in sterile TE at 4°C.  
 
Plasmid Name Source 
pCDNA4/TO Invitrogen 
pCDNA4/TO-eGFP (Ariel Poliandri) 
pCDNA4/TO-Ncoa3  
pCI Stratagene 
pCMV-Renilla Promega 
pCMV-SPORT6-Ncoa3 Source BioScience, IMAGE 30104508 
pCMV-Δ8.91 (Anil Chandrashekran) 
pGL3-Oct4pp (Feng et al. 2009) 
pGL3-Esrrb-Luc (Feng et al. 2009) 
pGL3-Klf4-Luc (Feng et al. 2009) 
pGL3-Sox2-Luc (Feng et al. 2009) 
pMDG2-vsvg (Anil Chandrashekran) 
pNanog-Luc (Rodda et al. 2005) 
pPyCAG-IP (Chambers et al. 2003) 
pPyCAG-IP-Nanog (Chambers et al. 2003) 
pPyCAG-IP-Ncoa3  
pSG5 Stratagene 
pSG5-mEsrra (Mark Christian) 
pSG5-Flag-mEsrrb (Vanacker et al. 1999) 
pSG5-Flag-mEsrrb-Rescue  
pSG5-Flag-mEsrrb-ΔAF-1  
Chapter Two                                                                              Materials and Methods 
 67 
pSG5-Flag-mEsrrb-ΔLBD  
pSG5-Flag-mEsrrb-DBD mut  
pSG5-Flag-mEsrrb-AF-2 mut1  
pSG5-Flag-mEsrrb-AF-2 mut2  
pSV5-mEsrrg (Vanacker et al. 1999) 
pMXs-Oct4/Sox2/Klf4/cMyc Cell Biolabs Inc 
pMXs-Esrrb (Feng et al. 2009) 
pMXs-Ncoa3  
ERE-Luc (Belandia et al. 2005) 
ERRE-Luc Mark Christian 
  
shRNA Vector Name Source 
pSuper.puro-shGFP (Loh et al. 2006) 
pSuper.puro-shEsrrb (Loh et al. 2006) 
pLKO.1 shScrambled Sigma-Aldrich 
pLKO.1 shNcoa3-1 Sigma-Aldrich 
pLKO.1 shNcoa3-2 Sigma-Aldrich 
pLKO.1 shPRC Sigma-Aldrich 
pLKO.3G Addgene vector #14748 
 
2.1.7 siRNA 
All siRNAs were reconstituted in DEPC RNase/DNase-free water to a final 
concentration of 20µM and aliquots stored at -20°C. 
 
siRNA Supplier 
siGenome siControl #3 Dharmacon 
ON-TARGETplus siNcoa3 SMARTpool Dharmacon 
2.1.8 Chemical inhibitors 
Inhibitors were reconstituted in the appropriate solvent and aliquots stored at -80°C. 
 
Inhibitor Supplier 
Doxycycline (Dox) (H2O) Sigma-Aldrich 
Diethylstilbestrol (DES) (Ethanol) Sigma-Aldrich 
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4-hydroxytamoxifen (OHT) (Ethanol) Sigma-Aldrich 
 
2.1.9 Antibodies 
Antibodies used in this study are listed below, including the dilutions used for 
immunofluorescence (IF) and western blotting. The amount of primary antibody used in 
chromatin immunoprecipiration (ChIP: 8-10 µg) and co-immunoprecipitation (co-IP: 
2.5µg) remains the same for all antibodies. 
 
Primary 
Antibody 
Cat # Supplier Dilution (IF) Dilution  
(western 
blot) 
α-Tubulin T6074 Sigma-Aldrich NA 1:10,000 
BrdU ab6326 Abcam 1:1000 NA 
Caspase-3 9664S Cell signaling 1:150 NA 
Esrrb* H6705/7 R&D Systems 1:300 1:1000 
Flag M2 F1804 Sigma-Aldrich NA 1:1000 
Gapdh MAB374 Millipore NA 1:30000 
Klf4 AF3158 R&D Systems 1:250 NA 
Nanog RCAB0002P Cosmo 1:150 1:1000 
Ncoa3 sc-9119 SantaCruz 1:300 1:2500 
Ncoa3** #611105 BDBiosciences NA NA 
Oct4 sc-8629 SantaCruz 1:150 1:1000 
RNApol2 (tot) sc-899 SantaCruz NA 1:500 
 
Secondary Antibody (IF) Cat # Supplier Dilution  
Alexa488 Goat Anti-mouse IgG A11029 Invitrogen 1:500 
Alexa488 Goat Anti-rabbit IgG A11034 Invitrogen 1:500 
Alexa633 Goat Anti-mouse IgG A21050 Invitrogen 1:500 
Alexa633 Goat Anti-rabbit IgG A21070 Invitrogen 1:500 
 
 
   
                                                
* Esrrb clones H6705 and H6707 were mixed in a 1:1 ratio then 2.5µg used for co-IP 
** Used only for Ncoa3 Co-IP with Nanog IB in COS-1 cells (Chapter four) 
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Secondary Antibody (western blot) Cat # Supplier Dilution  
Donkey Anti-goat-HRP P016002 DAKO Cytomation 1:5000 
Goat Anti-mouse-HRP P044701 DAKO Cytomation 1:5000 
Goat Anti-rabbit-HRP P044801 DAKO Cytomation 1:5000 
 
Normal IgG control (for co-IP and 
ChIP) 
Cat # Supplier 
Normal Mouse IgG sc-2025 SantaCruz 
Normal Rabbit IgG sc-2027 SantaCruz 
 
2.1.10 Tissue Culture Components 
Fetal calf/bovine serum was stored long-term at -80°C, with working aliquots kept at -
20°C. Aliquots of L-Glutamine and Penicillin/Streptomycin were stored at -20°C. All 
other components were stored at 4°C for up to two months before discarding. 
 
Reagent Supplier 
Dublecco’s MEM (DMEM), High Glucose, no Glutamine Gibco 
Fetal Bovine Serum, Heat-inactivated (HI FBS) Gibco 
Fetal Calf Serum (FCS) Globepharm 
Gelatin Solution 2%, from Bovine Skin Sigma-Aldrich 
Glasgow BHK-21 Modified Eagle Medium (GMEM) Gibco 
KnockOut Serum Replacer (KSR) Gibco 
L-Glutamine 200mM (100X) Gibco 
Leukaemia Inhibitory Factor (LIF) Home-produced 
MEM Non-essential Amino Acids 10mM (NEAA) (100X) Gibco 
2-Mercaptoethanol 50mM (1000X) Gibco 
Penicillin/Streptomycin (100X) Gibco 
Sodium Bicarbonate Solution 7.5% Gibco 
Sodium Pyruvate 100mM (100X) Gibco 
Trypsin 0.25% 1X with phenol-red Gibco 
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2.1.11 Media 
 
Bacterial Media and Agar 
 
LB Agar 1% (w/v) Bactotryptone  
0.5% (w/v) Yeast Extract  
0.5% (w/v) NaCl  
0.1% (w/v) Glucose  
1.5% (w/v) Bactoagar 
(Store at 4°C) 
 
LB Broth 1% (w/v) Bactotryptone  
0.5% (w/v) Yeast Extract  
0.5% (w/v) NaCl  
0.1% (w/v) Glucose 
(Store at 4°C) 
 
Low-Salt 2X LB Broth 2% (w/v) LB-Broth-Lennox 
1% (w/v) Peptone 
0.5% (w/v) Yeast Extract 
(Store at 4°C) 
 
SOC Media (Invitrogen) 2% (w/v) Bactotryptone  
0.5% (w/v) Yeast Extract  
10mM NaCl  
2.5mM KCl 
10mM MgCl2  
10mM MgSO4  
20mM Glucose 
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Mammalian Tissue Culture Media 
All media was stored at 4°C 
 
293T and COS-1 Media DMEM high-glucose supplemented with: 
10% (v/v) HI-FBS 
2mM L-Glutamine 
50U/mL Penicillin 
50µg/mL Streptomycin 
 
Embryonic Stem Cell  
(ESC) Media 
GMEM supplemented with: 
10% (v/v) FCS 
2mM L-Glutamine 
25U/mL Penicillin 
25µg/mL Streptomycin 
1mM Sodium Pyruvate 
100µM NEAA 
50µM 2-Mercaptoethanol 
0.2475% (w/v) Sodium Bicarbonate 
LIF 1:250  
 
Induced Pluripotent Stem Cell 
(iPSC) Media 
DMEM high-glucose supplemented with: 
15% (v/v) KSR 
2mM L-Glutamine 
50U/mL Penicillin 
50µg/mL Streptomycin 
100µM NEAA 
90µM 2-Mercaptoethanol 
LIF 1:250  
 
Mouse Embryonic Fibroblast  
(MEF) Media 
As 293T/COS-1 media but 15% (v/v) 
HI-FBS 
 
Plat-E Media 293T media supplemented with: 
1µg/mL Puromycin 
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10µg/mL Blasticidin 
 
Viral Collection Media As 293T/COS-1 media but 5% (v/v) HI-
FBS 
 
2.1.12 Strains and Cell lines 
 
Bacteria Strains 
 
DH5α .  [F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA 
supE44 λ– thi-1 gyrA96 relA1]. Bacterial strain used to make electrocompetent cells for 
cloning.  
XL10-Gold. [Tetr ∆(mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 
gyrA96 relA1 lac Hte [F’ proAB lacIqZ∆M15 Tn10 (Tetr) Amy Camr]]. Stratagene-supplied 
ultracompetent bacterial strain, optimized for transformation with large plasmid 
constructs.  
 
Mammalian Cell Lines 
 
293T. Human embryonic kidney cell line immortalized with adenovirus type 5 DNA 
(Belandia et al. 2005).  
 
COS-1. African green monkey kidney cell line immortalised with SV40 (Livak and 
Schmittgen 2001). 
 
E14Tg2A. Feeder-independent Hprt-deficient mouse embryonic stem cell (ESC) line  
derived from Lesch-Nyhan embryos (Morita et al. 2000). 129/Ola genetic background. 
 
MEF-Oct4GFP. E13.5-derived mouse embryonic fibroblasts (MEFs), containing a 
GFP transgene under the control of the distal enhancer (DE) responsible for driving 
Oct4/Pou5f1 gene expression in ESCs and germ cells (Yeom et al. 1996). Mixed 
MF1/129/B6 genetic background. 
 
MEF p53-/-. MEFs homozygous null for the p53 gene. Mixed genetic background. 
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Plat-E. 293T-derived cell line stably expressing viral packaging genes gag-pol and env 
under control of the EF1α promoter (Morita et al. 2000). High expression of structural 
proteins is achieved by maintained selection for IRES-Puromycin and -Blasticidin 
resistance genes inserted downstream of each expression cassette.    
 
2.1.13 Resources and Websites 
 
Computer Software 
Adobe Creative Suite 5  
Endnote X5  
Inkscape  
Leica LAS AF Lite  
Microsoft Office 2007  
 
Online Tools 
BLAST http://blast.ncbi.nlm.nih.gov/ 
ClustalW http://www.ebi.ac.uk/Tools/msa/clustalw2/ 
NEBcutter V2.0 http://tools.neb.com/NEBcutter2/index.php 
Mutagenesis primer design http://www.genomics.agilent.com 
Primer 3 http://frodo.wi.mit.edu/ 
Pubmed http://www.ncbi.nlm.nih.gov/pubmed/ 
UCSC Genome Browser http://genome.ucsc.edu 
 
2.2 Methods 
2.2.1 Bacterial Techniques 
i Production of Electrocompetent Bacteria 
To produce bacteria suitable for electroporation, DH5α were cultured in sterile LB broth 
minus antibiotics in a total volume of 1L at 37°C. Bacteria were grown until in log phase 
as judged by OD600 of 0.5-0.8, then split into four, 250mL cultures. Bacterial pellets were 
collected by centrifugation at 4500xg, 15 min, followed by resuspension in 250mL cold, 
sterile, deionised H2O. Centrifugation and resuspension steps were repeated twice, each 
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time resuspending in half the previous total volume of H2O. Finally, 50mL cultures of 
bacteria were pelleted as before, then resuspended in 5mL cold H2O containing 10% 
(v/v) glycerol and pooled. Bacteria were centrifuged once more before resuspension in a 
total volume of 2mL 10% glycerol solution and aliquoted for storage at -80°C.  
ii Transformation of Bacteria via Electroporation 
Electroporation-mediated transformations were performed utilizing 50µL 
electrocompetent DH5α per reaction thawed on ice then pipetted into the central 
chamber of electroporation cuvettes, 1mm. 1-3µL DNA ligation, or approximately 10ng 
plasmid DNA, was then added to the bacteria, mixed gently, then cuvettes subjected to 
electroporation in a Rad gene pulser, at 1.67kV, 25 F and 200Ω. Cuvettes were placed on 
ice for 2 min then 200µL SOC media added. Transformed bacteria were incubated for 1 
hour at 37°C then streaked onto LB-agar plates containing 50µg/mL Ampicillin. Plates 
were incubated overnight and emergent colonies picked the next day for further analysis. 
iii Plasmid Amplification and Purification 
For small-scale DNA amplification, 5mL cultures of 2X-low salt LB-broth (pLKO.1 
plasmids) or LB-broth (all other plasmids) containing 50µg/mL Ampicillin were 
inoculated with a single colony picked from plates containing the relevant 
transformation. These were left to grow overnight at 37°C with agitation at 220rpm. The 
next day, bacteria were pelleted by centrifugation at 4500xg, 15 min, and DNA extracted 
and purified utilizing the QIAprep Spin Miniprep Kit, according to manufacturer’s 
guidelines. Purified DNA was eluted in 35µL Elution Buffer (QIAGEN) and stored at -
20°C. For high-scale, high quality plasmid DNA suitable for transfection experiments, 
each 5mL overnight culture was used to inoculate 250mL LB-broth plus Ampicillin, 
which was incubated overnight as before. Cultures were centrifuged at 4500xg, 15 min 
then the pellets processed using the HiSpeed Plasmid Maxi Kit. DNA was eluted in a 
final volume of 500-1000µL sterile TE buffer and stored at 4°C. The concentration of 
plasmid DNA was determined according to A260 readings using a NanoDrop 
spectrophotometer. 
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2.2.2 DNA Manipulation 
i Polymerase Chain Reaction (PCR) 
DNA fragments to be cloned into a target vector of interest were generated via PCR 
from oligonucleotide primers, which contained 20bp of the target sequence flanked by 
the relevant restriction endonuclease target site. Four bases were included at the 5’ end of 
each primer to allow efficient digestion by endonucleases. Amplification was carried out 
utilizing the KOD Hotstart DNA Polymerase Kit in a total volume of 50µL. Each 
reaction contained 1X KOD buffer, 1mM MgSO4, 0.2mM dNTP mix, 20% (v/v) 
Betaine, 0.3µM each primer, 1U KOD Hotstart Polymerase and 1-50ng template DNA. 
The following cycling conditions were followed, with step 2 repeated for 35 cycles: 
1. 95°C 2 min 
2. 95°C 20 sec 
58°C 10 sec 
70°C 15 sec/kb 
3. 70°C 10 min 
4. 4°C Hold 
To isolate the amplified fragment of the correct size, each reaction was subjected to 
separation via 1% (w/v) agarose gel electrophoresis containing 1µL 0.2 g/mL Ethidium 
Bromide per 50mL gel. Electrophoresis was carried out in 1X TBE buffer and run at 
100V for 1 hr, then DNA fragments excised and purified using the QIAquick PCR Gel 
Extraction Kit and eluted in 40µL H2O, ready for DNA digestion. Primer sequences are 
listed in the Appendix. 
ii DNA Digestion 
Insert and linearized vector DNA were obtained by restriction endonuclease digestion of 
the relevant plasmid or purified PCR product according to New England Biolabs (NEB) 
guidelines. Reactions were performed in a total volume of 20-50µL containing up to 10% 
(v/v) enzyme, typically 1-2 uL of each appropriate restriction endonuclease, in the 
specified NEB buffer and in the presence of 1X BSA where required. Either the total 
PCR product, or 2-3µg plasmid DNA was digested. Digestions were performed at 37°C 
for 2-3 hours followed by an inactivation step of 65°C, 20 min. Digested PCR products 
were purified using the QIAquick PCR Purification Kit. Fragments released from 
plasmid DNA digestion were subjected to gel electrophoresis, excised and purified as in 
(i).  
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iii DNA Ligation 
Ligations were performed using the NEB Quick Ligation Kit, according to 
manufacturer’s guidelines. 50ng linearized vector DNA was incubated with a 3-fold 
molar excess of insert DNA, 1X Quick Ligation Buffer and 1uL Quick T4 DNA Ligase 
in a total volume of 20µL. Reactions were performed for 5 min at room temperature 
(RT) then chilled on ice for 5 min. For transformation of the ligation product via 
electroporation, each reaction was first purified using the QIAquick PCR Purification kit 
to remove polyethylene glycol (PEG) and eluted in 25µL H2O. Transformations were 
then performed as in 2.2.1ii, using 3-5uL of the ligation. 
iv Site-directed Mutagenesis 
To generate up to a few base pair substitutions in the desired expression vector, 
mutagenesis primers were designed using online tools at www.genomics.agilent.com 
accompanying the Stratagene QuikChange XL Kit. Mutant strand synthesis was carried 
out according to manufacturer’s guidelines followed by DpnI digestion of methylated 
parent (non-mutagenised) plasmid DNA. Dpn1-digested DNA was transformed into 
XL10-Gold ultracompetent cells via the kit’s recommended heat-shock protocol. 
Following transformation and plating on LB-agar, colonies were picked next day. 
v Generation of Esrrb Constructs 
The vector, pSG5-Flag-mEsrrb, contains Esrrb cloned into BamHI and XbaI sites 
directly downstream of a Flag sequence, generating Esrrb tagged N-terminally with a 
single copy of the Flag epitope, and was kindly donated by J.Vanacker (Vanacker et al. 
1999). To make an RNAi-resistant version of this construct, site-directed mutagenesis 
(see section 2.2.2iv) was used to introduce three silent base substitutions into the region 
targeted by pSUPER.puro-shEsrrb, generating pSG5-Flag-mEsrrb-Rescue. This rescue 
vector was then used as a template to generate Flag-tagged Esrrb deletion mutants via 
PCR. Full-length Wt Esrrb was thus substituted for truncated versions (99-433aa; ΔAF-1 
or 1-203aa: ΔLBD), which were cloned into BamHI and XbaI sites downstream of the 
Flag-tag. All constructs generated via cloning or site-directed mutagenesis were verified 
via sequencing. Primer sequences are listed in the Appendix. 
vi Chromatin Immunoprecipitation (ChIP) 
Fixation 
ChIP experiments were carried out with chromatin prepared from ESCs as previously 
described (Stock et al. 2007). For all procedures, protease inhibitor cocktail, PMSF 
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(1:1000), NaF (1:200) and Na3VO4 (1:50) were added to swelling and sonication buffers 
to prevent protein degradation. ESCs cultured in 175cm2 flasks were first washed in PBS 
then fixed with 1% (v/v) formaldehyde at 37°C, 10 min. The reaction was quenched by 
addition of glycine to 1.25M final concentration and incubated at RT, 5 min. Fixed cells 
were washed three times in cold PBS then placed on ice with 5mL swelling buffer, 10 
min. Cells were scraped, homogenized in a douce homogenizer and centrifuged to pellet 
cells and the pellet resuspended in 2mL sonication buffer.  Sonication was carried out in 
a Bioruptor Sonicator at 4°C for 60 min total in pulses of 30 sec, generating DNA 
fragments of 400-1000bp. Sonicated DNA was centrifuged at 16000xg, 10 min to pellet 
insoluble material with the resultant supernatant then collected and used for 
immunoprecipitation (IP) or stored at -80°C for future use.  
Immunoprecipitation 
For subsequent IPs, DNA concentration was first measured by alkaline lysis, diluting 
chromatin samples 1:50 in 0.1M NaOH and measuring A260 readout in a 
spectrophotometer. 500-800µg chromatin was used per IP, which was first pre-cleared 
with 100µL Protein A-Sepharose beads that had been pre-blocked overnight in 
0.5mg/mL salmon sperm DNA and 1 mg/mL BSA, incubating samples with rotation at 
4°C, 2 hours. Samples were then centrifuged at 200g, 5 min and the pelleted beads 
containing non-specifically bound chromatin discarded. The pre-cleared supernatant was 
rotated overnight at 4°C with 8-10µg of the relevant primary antibody or isotype-specific 
IgG control per IP in the presence of 0.05mg/mL BSA. 50µL of pre-cleared chromatin 
was retained as the relevant input sample.  
Washes and Elution of Immune Complexes 
The following day, 100µL pre-cleared beads were added to each sample then incubated 
for a further 2 hours. The chromatin-bead complexes were washed once with sonication 
buffer, once with ChIP wash buffer A and buffer B, then twice with TE buffer. After the 
final wash, immune complexes were eluted from the beads by two rounds of incubation 
in 250µL ChIP Elution Buffer at 65°C, 5 min, followed by rotating for 15 min at RT. 
The eluates were combined and samples together with input subjected to reverse 
crosslinking via addition of 16µL 5M NaCl and 1µL 10mg/mL RNase A and incubation 
at 65°C overnight. 
DNA Purification 
To isolate purified DNA fragments, protein contamination was first removed via 
addition of 4µL EDTA and 1µL 10mg/mL Proteinase K and samples incubated at 45°C 
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for 2-4 hours. DNA was then recovered by standard phenol-chloroform extraction and 
ethanol precipitation. DNA was precipitated overnight in 1mL 100% ethanol and 2µL 
15mg/mL glycogen at -20°C. The next day, samples were centrifuged at 16000xg at 4°C, 
30 min to pellet precipitated DNA. Pellets were then washed once in 70% ethanol, then 
tubes left to air dry for 30 min. Finally, 22µL TE was added and tubes placed at 4°C for 
DNA to dissolve overnight. ChIP efficiency for each antibody and locus was determined 
via SYBR green quantitative RT-PCR (qPCR), as performed for gene expression analysis 
(2.2.3ii). 
vii Genome-wide ChIP Sequencing 
Genome-wide ChIP sequencing (ChIP-seq) experiments were performed at the Genome 
Institute of Singapore, in collaboration with Jia-Hui Ng and Professor Huck-Hui Ng 
(Genome Institute of Singapore). DNA was immunoprecipitated using anti-Ncoa3 
antibody as for ChIP by Jia-Hui Ng. ChIP-seq was performed on DNA fragments 
according to (Chen et al. 2008). ChIP-seq co-ordinates are available at the GEO database 
under accession number GSE37262.  
viii Chip-seq Data Analysis 
Bioinformatics for the Ncoa3 chIP-seq experiments, including analysis of Ncoa3 
binding-site overlap with Esrrb, generation of the spatial heatmap, meme de novo motif 
discovery and gene ontology, was performed in collaboration with Vibhor Kumar, 
supervised by Shyam Prabhakar (Genome Institute of Singapore). 
 
2.2.3 RNA Manipulation 
i RNA Extraction and cDNA Synthesis 
RNA was extracted from adherent cells using the QIAGEN RNeasy Mini Kit. Cells were 
washed once in PBS then lysed directly on ice, via addition of 300µL RLT lysis buffer. 
Lysed cells were scraped, collected and samples processed according to manufacturer’s 
guidelines. DNA contamination was eliminated via treatment on-column with RNase-
free DNase I. RNA was eluted in 30-50µL RNase-free H2O and quantified using a 
Nanodrop Spectrophotometer. The purity of RNA samples was verified via checking for 
A260/A280 and A260/A230 ratios over the value of 2.0. RNA was then used to generate 
cDNA using the Superscript II First Strand Synthesis Kit. Primers were first annealed to 
RNA in a total volume of 12µL containing 0.25µg random hexamers, 1µL 10mM dNTPs 
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and 1µg RNA by incubation at 70°C, 5 min. Samples were then brought up to 20µL via 
addition of 4µL 5X first-strand buffer, 2µL 0.1M DTT, 1µL RNaseOUT and 1µL 
Superscript II Reverse Transcriptase. Tubes were subjected to the following conditions 
to allow cDNA synthesis: 
1. 25°C 10 min 
2. 42°C 90 min 
3. 70°C 15 min 
4. 4°C Hold 
cDNA was diluted to 160-200µL in DEPC H2O and used immediately or stored at -
20°C. 
ii Quantitative Real-time PCR (qPCR) 
Quantitative PCR was carried out on a real time ABI StepOne or 7900HT machine using 
SYBR Green Master Mix (Sigma), with a final primer concentration of 300nM and 5µL 
cDNA template per reaction. Duplicate reactions were carried out for each primer and 
sample. Expression levels for genes were normalized to the housekeeping genes Actin 
and L19 or B2m, and the relative expression for each gene calculated according to the 
2ΔΔCt method (Livak and Schmittgen 2001) 
iii Ncoa3 Microarray Analysis 
Analysis of global gene expression changes following Ncoa3 knockdown was performed 
via DNA microarray. The knockdown experiment and RNA purification was performed 
by myself, samples were prepared for annealing to the microarray chip by Jia-Chi Yeo, 
and data was analyzed and compared to data from Esrrb knockdown from (Feng et al., 
2009) by Vibhor Kumar (both Genome Institute of Singapore). The following protocol 
describes how samples for the Ncoa3 microarray were treated, similar to the Esrrb 
microarray, except that for Ncoa3 analysis a more updated beadchip was used.  Briefly, 
mRNA was derived from ESCs transfected with shScrambled or shNcoa3 #5 and 
harvested 3 days after Puromycin selection, using three biological replicates per each 
condition. Samples were used to prepare biotinylated cRNA according to standard 
protocols (Illumina TotalPrep RNA Amplification Kit). cRNA was hybridized to an 
Illumina Mouse WG-6 v2.0 expression beadchip and analysed as described previously 
(Feng et al. 2009), using Bead Array suite software. Microarrays were normalised using 
rank invariant normalisation. Microarray data are available at the GEO database under 
accession GSE40193. 
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2.2.4 Protein Manipulation 
i Preparation of Protein from Whole Cell Extracts 
Samples for protein analysis were washed once in PBS then lysed in 50µL ice-cold 
RIPA/10cm2, containing protease inhibitor cocktail (Roche), PMSF (1:1000), NaF 
(1:200) and Na3VO4 (1:50). For co-IP experiments, cells were cultured in 100mm dishes 
and lysed in 500µL RIPA per plate. Samples were incubated with rotation at 4oC for 30 
min, then centrifuged at 13,000rpm in a benchtop centrifuge at 4oC for 30 min to pellet 
any cell debris. Supernatants containing proteins were collected and protein 
concentration determined according to the BCA Assay. Samples were processed 
immediately (co-IP) or stored at -80°C until further use.  
ii Western Blotting 
For analysis of protein levels in whole cell lysates, 30-50µg protein was heated at 100oC in 
1 x Laemmli buffer supplemented with 5% β-mercaptoethanol for 10 min. Samples were 
loaded onto pre-cast 4-12% SDS NuPage Bis Tris acrylamide gels and electrophoresed in 
1X MOPS buffer at 150V for 1.3-5 hours. Proteins were transferred onto a PVDF 
membrane (GE Healthcare) in 2X Transfer Buffer (Invitrogen) containing 10% 
methanol using a semi-dry transfer system at 40V, 2 hours. After transferring, 
membranes were blocked in 5% milk-TBST for 1 hour before incubation with the 
relevant primary antibody at 4oC overnight. The next day, membranes were washed for 3 
x 10 min in TBS-T then incubated with secondary antibodies for 1 hour at RT. Proteins 
were detected using ECL or ECL Plus Western Blotting Substrate. 
iii Co-immunoprecipitation (Co-IP) 
For Co-IP experiments performed with ectopically-expressed proteins, COS-1 cells in 
100mm dishes were first transfected with 3-5µg each expression vector using Fugene HD 
(Roche), according to the manufacturer’s guidelines. Cells were collected 48 hours later 
and lysed in RIPA plus protease inhibitors. Detection of endogenous interactions was 
performed using extracts similarly prepared from ESCs. For all co-IPs, 1mg of protein 
extract was added to 50µL protein A-Sepharose beads pre-blocked in 1mg/mL BSA, and 
pre-cleared at 4°C for 2 hours. Pre-cleared samples were then incubated overnight at 4°C 
with 2.5µg of the indicated primary antibody or IgG control. The next day, the same 
volume of Protein A beads was added for 2 hours, then washed once with RIPA and 
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twice with TSE buffer. All centrifugation steps to pellet beads were carried out at 4°C at 
a maximum of 200xg so as not to disrupt protein-protein interactions. To elute immune 
complexes, the washed beads containing bound proteins were boiled in 30µL Laemmli 
buffer containing 5% β-mercaptoethanol for 10 min. Samples were then loaded onto 7% 
SDS-Page acrylamide gels and electrophoresed as for western blotting analysis. In co-IP 
experiments analyzing interactions between large proteins however (RNA Polymerase II, 
Ncoa3), transfer was instead carried out onto PVDF membranes overnight at 20V, 4°C 
utilizing a wet transfer system (Biorad) in only 5% methanol. Subsequent steps were 
carried out as for western blotting. 
iv Immunofluorescence (IF) 
Cells were cultured for IF experiments on 1cm2 glass coverslips placed inside 6-well 
tissue culture dishes for at least 24 hours prior to fixation and staining. To fix, slides were 
washed in PBS then incubated in 4% paraformaldehyde at RT for 10 min. Formaldehyde 
was replaced with PBS for 2 min then slides blocked and permeabilised in one step by 
incubating in IF permeabilization buffer for 30 min at RT. Slides were washed twice in 
PBS then incubated at 4°C overnight in the relevant primary antibodies diluted in IF 
blocking buffer. The next day, slides were washed as before then incubated in secondary 
antibodies in IF blocking buffer for 45 min at RT, in the dark. Slides were again washed 
and mounted onto microscope slides in Vectashield plus DAPI, and left to rest for 30 
min before visualization using a Leica SP5 confocal microscope.  
v BrdU Incorporation and Staining 
To quantify MEF proliferation, 10µM BrdU was added to MEF culture media 16 hours 
prior to fixation and staining. For staining, cells were first treated with 4% 
paraformaldehyde as for standard IF protocols, then permeabilised with 0.2% Triton X-
100 in PBS, and blocked in 1% BSA solution supplemented with 0.4% fish gelatin for 30 
min. Slides were incubated with primary anti-BrdU antibodies and treated as per other 
immunofluorescence protocols, except that the BrdU primary antibody buffer consisted 
of blocking solution supplemented with 0.5U/µL DNAse I and 1mM MgCl2. Prior to 
visualization, slides were mounted in Vectashield containing DAPI and the number of 
BrdU-positive nuclei counted using a Leica SP5 confocal microscope. 
vi Alkaline Phosphatase (AP) Staining 
ESCs and iPSCs were stained for AP activity using the Sigma Alkaline Phosphatase Kit, 
which stains undifferentiated cells red. To fix, cells were washed in PBS and incubated 
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for 30 sec in citrate/acetone fixation buffer containing 3% formaldehyde. Staining was 
carried out according to the manufacturer’s guidelines, incubating samples with AP stain 
for 20 min in the dark at RT. Wells were then washed once in deionised H2O, the liquid 
removed, and plates left upside down to dry before imaging or quantification. 
 
2.2.5 Cell Culture Methods 
i Derivation of Mouse Embryonic Fibroblasts (MEFs) 
Oct4GFP MEFs were prepared from E13.5 embryos obtained from the intercross 
between MF1 wild-type (Wt) females and Oct4GFP males. Uteri were harvested from 
pregnant females and placed in PBS on ice for 15 min.  Embryos were then isolated, the 
head and visceral tissues removed, before incubating with trypsin at 37°C, 10 min. 
Embryos were then dissociated by passing through 18G needles 5 times then incubating 
for a further 5 min at 37°C. Trypsin was inactivated via addition of MEF media then 
embryos pooled and centrifuged at 200xg, 5 min. The pellet was resuspended in 10mL 
MEF media x the number of embryos originally dissected then plated onto 100mm 
dishes (10mL per plate) and incubated overnight at 37°C. Media containing unattached 
embryonic tissue was removed after 24 hours and the adherent fibroblasts that emerged 
were cultured until confluent, when they were then harvested and frozen in cryovials in 
media containing 50% FBS and 10% DMSO. All MEFs were used below passage 3 to 
avoid replicative senescence.   
ii Maintenance of Cell Lines 
All cell lines were cultured at 37°C and 5% CO2 in their respective media as described in 
2.1.11. 293T and COS-1 cells were passaged 1:5-1:10 every 4-5 days. MEFs were 
passaged 1:3 every 2-3 days. ESCs were cultured feeder-free on plates coated with 0.1% 
gelatin and passaged 1:7-1:10 every other day. ESC media was replenished every day. 
iPSC clones were cultured as for ESCs but maintained on irradiated MEFs (iMEFs), and 
passaged 1:10 every 2-3 days. 
iii ESC Differentiation Experiments 
Retinoic Acid Differentiation 
For all trans retinoic-acid (atRA) induced differentiation, ESCs were plated on gelatin-
coated glass 1cm2 slides placed in 6-well plates at a density of 5x104 cells per well 24 
hours prior to the experiment. For differentiation, medium was exchanged for ESC 
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media minus LIF supplemented with atRA at a final concentration of 1µM, and 
replenished every 24 hours. 
 LIF Withdrawal 
ESC differentiation was accomplished via LIF withdrawal according to the same 
procedure used for atRA treatment, except that 24 hours following plating cells were 
cultured in 4mL/well ESC media minus LIF. Media was replenished every 24 hours and 
cells harvested 96 hours later.  
 Embryoid Body (EB) Mediated Differentiation 
For EB-mediated differentiation, ESCs were trypsinized to single-cell suspension and 
1x105 cells plated per well in ESC media minus LIF on ultra low attachment 6-well plates 
(Corning). Cells were left to aggregate for the indicated number of days. Half the media 
was replenished every other day.  
iv Transient siRNA and shRNA Transfection 
For transient depletion experiments, ESCs were plated 16-18 hours prior to transfection 
at a density of 50,000 cells/cm2. For siRNA-mediated knockdown, ESCs were 
transfected with 3pmol/96-well (luciferase assays) or 600pmol/100mm dish (co-IPs) of 
siGenome control siRNA #3 or an OnTargetPlus anti-Ncoa3 siRNA pool (both 
Dharmacon). Transient shRNA-mediated depletion was performed with 30-40ng/96-
well or 5µg/100mm dish of the relevant control or gene-specific RNAi vector. 
Transfections were performed using Lipofectamine 2000 according to the manufacturer’s 
guidelines. Media was exchanged 16 hours following transfection for fresh ESC media 
and cells harvested 48 hours post-transfection.  
v Stable shRNA-mediated Knockdown and Overexpression 
To stably select for ESCs depleted of the indicated gene of interest, cells were plated at a 
density of 10,000 cells/cm2 and transfected the next day with 1.0µg/6-well linearized 
shRNA vector. Media was exchanged 16 hours post-transfection and at 24 hours post-
transfection Puromycin was added at a final concentration of 1.0µg/mL. Selection was 
carried out for the indicated number of days, changing media daily. This protocol was 
followed similarly in order to generate ESC lines stably expressing proteins from CAG or 
pCDNA4/TO vectors, except that Zeocin at 300µg/mL final concentration was used to 
select for the pCDNA4/TO vector. At day 8, plates containing stably transfected 
colonies were trypsinized and the pooled cells re-plated for use in subsequent 
experiments. 
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vi Production of Lentiviruses Containing Ncoa3 shRNA 
Lentiviral particles containing pLKO.1 vectors were packaged in 293T cells, which were 
first split 1:4 in 100mm plates to be 80% confluent the day of transfection. To transfect, 
15µg pLKO.1 vector, 10µg pCMV-Δ8.91 and 5µg pMDG2-vsvg per plate were mixed 
together in 1mL serum-free media with 75µL PEI transfection reagent and incubated for 
30 min, then added to each plate of 293T dropwise. The following day, the transfection 
mix was exchanged for 6.5mL/plate viral collection media. Supernatants were harvested 
at 24 hours and 48 hours after the first media change and stored at -80°C. To 
concentrate, supernatants from both time points were thawed, pooled and centrifuged at 
200xg, 5 min to pellet any cells. Viral supernatants were next concentrated to a final 
volume of 200µL/plate utilizing Amicon 10,000 NMWL centrifugal filter units, 
according to the manufacturer’s instructions, then aliquoted for storage at -80°C. Viral 
titer was calculated using serial dilutions of pLKO.3G GFP-expressing plasmid to infect 
293T and MEFs in 12-well plates in the presence of 8µg/mL Polybrene. GFP was 
analyzed 72 hours later by fluorescence activated cell sorting (FACS), and the minimum 
volume of virus (typically 5-10µL) required to give 90-100% GFP-positive MEFs then 
used in subsequent experiments, corresponding to an MOI of approximately 20. Viral 
titer was calculated according to the following formula: 
Transducing units/mL (TU/mL) = (% GFP-positive cells x No cells plated) 
                                                     mL virus added 
vii Production of Retroviruses Containing Reprogramming Factors 
Retroviral vectors used for reprogramming (pMXs-Oct4, Sox2, Klf4, cMyc and Esrrb) 
have been described previously (Feng et al., 2009). Retroviruses were produced in Plat-E 
cells, which stably express viral structural genes required to package pMXs vectors 
(Morita et al. 2000). Plat-E cells were seeded in 100mm dishes to be 80% confluent the 
following day, when separate plates were transfected with 30µg of each of the pMXs 
expression vectors, utilizing Lipofectamine 2000. The standard manufacturer’s protocol 
was followed except that 2.5µL lipid was used per 1µg DNA. Transfection mixes were 
added dropwise to each plate and cells incubated for 7-8 h, after which the media was 
exchanged for 6.5mL viral collection media. Media was left on cells for 48 h, after which 
the supernatants were collected, concentrated and stored as described in vi. mCherry-
expressing retrovirus was also produced alongside reprogramming factors to monitor for 
infection efficiency in subsequent experiments.  
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2.2.6 Functional Assays 
i Luciferase Reporter Assays 
ESCs were plated 5 hours prior to transfection at a density of 2x104 cells per well in 
gelatin-coated 96-well plates. COS-1 cells were plated the day before at a density of 1x104 
cells/well. ESCs and COS-1 were transfected similarly, except that Fugene HD (Roche) 
was utilized for COS-1 instead of Lipofectamine 2000. Amounts of plasmids were 
20ng/well luciferase vector, 10ng Renilla or GFP (used to normalize for transfection 
efficiency in each well) and 20-40ng expression vector. RNAi constructs, where added, 
were at 30-40ng/well (shRNA) or 2.5-3pmol/well (siRNA). Transfection mix was 
removed from cells 16 hours post-transfection and exchanged for normal media, or 
media supplemented with ligand or inhibitors where indicated. Cells were harvested 48 
hours post-transfection to assay for Firefly luciferase activity using the Steadylite Plus Kit 
(PerkinElmer), according to manufacturer’s guidelines. If used, GFP fluorescence was 
read prior to lysis in Steadylite Buffer. Alternatively, normalization via Renilla expression 
was carried out after assaying for Firefly luciferase by addition of 25µL/well Renilla 
buffer, incubating for 20 min, then reading the plate again. GFP and luciferase were both 
read on a Wallac Victor microplate reader. 
ii Reprogramming Experiments 
For retroviral infection, MEFs were seeded in the morning in 24-well plates at a density 
of 3x104 cells/well. 5 hours later, media was exchanged for 300µL/well MEF media 
supplemented with 8µg/mL Polybrene. To infect, retroviral cocktail containing 10uL of 
each of the four (OSKM) or three (OSK) reprogramming factors was added to each well. 
20µL mCherry was also added to a separate well to monitor quantify infection efficiency.  
48 hours post-infection MEFs were trypsinized and resuspended in iPSC media, and the 
contents of each well seeded onto iMEF feeders in 6-well plates. Thereafter, cells were 
replenished each day with fresh iPSC media, and emerging iPSC colonies were monitored 
until day 12-14 when cells were harvested or individual colonies picked for further 
analysis. 
iii Self-renewal Assays 
To test ESC self-renewal capacity, cells were plated onto gelatin-coated 6-well plates in 
normal ESC media plus LIF at clonal density, equating to 5000 cells/well. The following 
day, media was exchanged for 2mL or 4mL ESC media plus or minus LIF, respectively. 
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Cells were cultured with daily media changes for 5 days, then ESC colonies fixed and 
stained for AP activity.  
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Chapter Three: Results 
 
 
3 Characterisation of Esrrb Functional Domains in Somatic 
Cells and ESCs 
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And I cannot guess what we'll discover 
When we turn the dirt 
With our palms cupped like shovels 
 
Death Cab for Cutie, Soul meets body 
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3.1 Introduction 
Studies of the structure-function relationship of members of the Estrogen-Related 
Receptors (ERRs) have established that these orphan receptors are not ligand-dependent. 
Nevertheless, they still require an intact AF-2 portion of their ligand-binding domain 
(LBD) for their transcriptional activity (Tremblay et al. 2001; Greschik et al. 2002). 
Information concerning ERR member Esrrb in embryonic stem cells (ESCs), however, is 
limited to the mapping of its DNA-binding sites, which consist for the main part, of 
enhancer loci densely occupied by groups of pluripotency factors (Chen et al. 2008). The 
function of Esrrb at these sites, and indeed that of other factors at these loci, is 
unknown. One possibility is that Esrrb serves simply to stabilise other pluripotency 
factors as part of a complex. Alternatively, as in somatic cells, protein-protein 
interactions mediated by its LBD may play a crucial part in activating transcription.  
 
To assess the function of Esrrb in the transcription of ESC genes, experiments in this 
chapter were therefore performed to determine the molecular basis of Esrrb activity. For 
this, Esrrb deletion and point mutants were generated in order to examine the function 
of specific domains within Esrrb. These were tested both in COS-1 cells using a somatic 
reporter, as well as in ESC-specific luciferase assays performed in ESCs. Relating to this, 
the transcriptional activity of the other two ERR isoforms, Esrra and Esrrg, was also 
investigated in ESCs, which show differing LBD sequence conservation as well as 
differences in their reprogramming abilities compared to Esrrb (Feng et al. 2009). Finally 
and most importantly, a link was made between the transcriptional activity of Esrrb and 
its function in ESCs, by inactivating the AF-2 region and investigating how this impacts 
upon the ability of Esrrb to sustain ESC self-renewal. 
 
3.2 Results 
3.2.1 The LBD is essential for Esrrb transcriptional activity 
As with other nuclear receptors, the ERRs consist of a modular structure including two 
activation domains – the AF-1 domain and LBD – that are known to be important for 
transcription. Whilst the study of ERR members in somatic cells has shown that the 
LBD is essential for activating transcription (Hong et al. 1999; Xie et al. 1999), the basis 
of Esrrb activity in ESCs is unknown. To extend previous knowledge of ERRs in 
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somatic cells, and uncover new insights in ESCs, a combination of mutagenesis and 
luciferase reporter assays was therefore used. For this, Flag-tagged Esrrb deletion 
mutants that lack either the AF-1 domain or the LBD were first generated via PCR and 
cloned into the same vector used to express wild-type (Wt) Flag-Esrrb (Figure 3.1A). 
Before examining their activity in ESCs, these constructs were tested in somatic cells in 
order to confirm whether the activity of mouse Esrrb is similarly LBD-dependent, as 
previously shown for human ERRs (Xie et al. 1999) and mouse Esrrg (Hong et al. 1999). 
For this, a luciferase reporter construct driven by the Pparα promoter containing two 
ERR response elements (ERREs) was used, accordingly referred to as ERRE-Luc 
(Figure 3.1B). Pparα was previously identified as an ERR target gene in metabolic cells, 
where it is strongly activated by Esrra in the presence of the ERR coactivator, PGC-1α  
(Mark Christian and Malcolm Parker, unpublished data). The expression of these 
proteins was first verified in COS-1 cells (Figure 3.1C) then the ability of Wt or mutant 
Esrrb to activate ERRE-Luc together with PGC-1α was tested. Luciferase assays 
performed in COS-1 with Wt Esrrb demonstrated a strong activation of ERRE-Luc in 
the presence of PGC-1α. In contrast, ΔLBD Esrrb was unable to activate this reporter, 
confirming that the LBD, as expected, is necessary for Esrrb activity (Figure 3.1D). 
Deleting the AF-1 domain also inhibited Esrrb activity approximately 50%, implying that 
although less important than the LBD, this domain may still contribute to PGC-1α 
stimulated Esrrb activity on targets such as Pparα. For example, residues in AF-1 could 
assist in stabilising the LBD-PGC-1α interaction (Kallen et al. 2004), which would thus 
be disrupted in AF-1 deletion mutants. 
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Figure 3.1 Transcriptional activity of Esrrb deletion mutants in COS-1 cells 
(A) Diagram indicated Flag-tagged wild-type (Wt) and Esrrb deletion mutants lacking either the LBD 
(ΔLBD) or AF-1 (ΔAF-1) region. “F” denotes the Flag-tag. (B) Schematic of the somatic luciferase reporter, 
ERRE-Luc, utilized in COS-1 cells as shown in (D). The vector consists of luciferase downstream of the 
mouse Pparα promoter sequence, containing two ERR-response elements (ERREs) driving its expression 
(Mark Christian and Malcolm Parker, unpublished data). (C) Expression of Esrrb constructs in transiently 
transfected COS-1 cells.  (D) ERRE-Luc reporter assay in COS-1 cells. Cells were transiently transfected with 
ERRE-Luc along with the ERR coactivator, PGC-1α, and the indicated Esrrb expression vectors. Reporter 
assay minus Esrrb was set as 1. Data are shown as mean +/- SEM of three transfections. Three experiments 
were performed with similar results. 
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Following the validation of Esrrb’s LBD requirement in somatic cells, Esrrb activity was 
next investigated in ESCs. For this, previously-described luciferase reporters were 
utilized that contain an Oct4 proximal promoter along with an ERRE-containing 
regulatory element found in the vicinity of one of the key Esrrb targets, Esrrb, Klf4 or 
Sox2 (Figure 3.2A). These enhancers, originally identified from Esrrb ChIP-seq data 
(Chen et al. 2008), have already been shown to be dependent on endogenous Esrrb for 
their activity in ESCs (Feng et al. 2009). As a fourth assay, a reporter derived from 
another important Esrrb target, Nanog, was additionally used. This construct consists of 
luciferase driven by the Nanog promoter and has similarly been verified as Esrrb-
dependent (Rodda et al. 2005; van den Berg et al. 2008). Following confirmation that Wt 
and all three Esrrb constructs were expressed at similar levels in ESCs (Figure 3.2B), 
their relative transcriptional activities on ESC targets were next examined. For this, it was 
tested whether Wt or Esrrb deletion mutants could rescue Enhancer-Luc reporter 
activity following knockdown of endogenous Esrrb. Importantly, this had been made 
possible by engineering all Esrrb constructs used in ESC and COS-1 assays (i.e. also 
Figure 3.1) to contain silent point mutations that make them resistant to the shRNA 
targeting endogenous Esrrb (Feng et al. 2009). When co-expressed with shEsrrb, Wt 
Esrrb was effectively able to rescue reporter activity from Esrrb, Klf4, Nanog and Sox2 
reporters (Figure 3.2C). In contrast, ΔLBD Esrrb was unable to rescue luciferase activity 
from any reporter, indicating that the LBD is absolutely required for Esrrb 
transcriptional activity. In contrast to its reduced activity on ERRE-Luc (Figure 3.1D), 
ΔAF-1 Esrrb interestingly showed no loss in function in ESC reporter assays, restoring 
luciferase activity to the same if not a higher level than control ESCs. This indicates that 
in contrast to some somatic contexts, where AF-1 is required to activate transcription 
(Zhou and Chen 2001), in ESCs the LBD is the sole activation domain required for 
Esrrb activity.  
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Figure 3.2 Transcriptional activity of Esrrb deletion mutants in ESCs 
(A) Schematic of Esrrb, Klf4 and Sox2 reporters used in embryonic stem cell (ESC) luciferase assays. 
Enhancer fragments containing ERREs from the indicated genes are inserted downstream of luciferase, 
which also contains an Oct4 promoter that drives basal expression in ESCs (Feng et al. 2009). An 
additional Nanog-Luc reporter was also used, as described in (Rodda et al. 2005). (B) Expression of Flag-
tagged Wt Esrrb and deletion mutants in ESCs. (C) Luciferase assays for Esrrb-bound targets. ESCs were 
transfected with the indicated ERRE-containing reporter plus either a control shRNA (shScrambled) or 
shRNA targeting endogenous Esrrb (shEsrrb), with and without RNAi resistant Esrrb rescue constructs as 
depicted in (B). Dotted lines indicate reporter activity following endogenous Esrrb depletion. Data are the 
mean +/- SEM of three transfections; shown is a representative assay of three independent experiments. 
 
3.2.2 ERR isoforms exhibit distinct transcriptional activities on ESC targets 
Additional to an important role in maintaining the ESC state, Feng and colleagues 
recently showed that Esrrb is capable of substituting for Klf4 in reprogramming somatic 
cells to pluripotency alongside Oct4, Sox2 and cMyc (Feng et al. 2009). This same study 
additionally examined the potential of the other two ERR isoforms, Esrra and Esrrg, to 
generate iPSCs, and interestingly found that Esrrg was also capable of reprogramming 
whereas Esrra could not. However, no mechanism behind the inability of Esrra to 
function in reprogramming was proposed. It was therefore next investigated whether 
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variation in the reprogramming ability of ERR isoforms might be due to differences in 
their transcriptional activity. For this, ESCs were co-transfected with Esrrb, Klf4 or Sox2 
Enhancer-Luc reporters along with shEsrrb to deplete endogenous Esrrb, with or 
without simultaneous Esrra, Esrrb or Esrrg overexpression. Like Wt Esrrb, Esrrg 
rescued the knockdown of endogenous Esrrb fully, whereas in contrast, Esrra showed 
little or no transcriptional activity (Figure 3.3A).  These results corroborate the ability of 
Esrrg, and not Esrra, to substitute for Esrrb in reprogramming, suggesting that Esrra 
may not be able to activate ESC target genes. The difference in the activity of different 
ERRs was furthermore specific to ESC reporters, as all three ERR isoforms were capable 
of activating the somatic ERRE-Luc reporter in COS-1 cells when co-transfected with 
PGC-1α (Figure 3.3B).  
 
Given the importance of the Esrrb LBD in activating transcription (Figure 3.2C) the 
degree of sequence conservation between Esrrb and the other two ERR members was 
next calculated. This revealed that the primary sequence homology between the LBD of 
Esrra and Esrrb was indeed low (55%), with the Esrrg LBD much more similar to Esrrb 
(73.1%) (Figure 3.3C). In contrast, all three ERRs showed highly conserved DBDs, in 
agreement with the ability of these isoforms to bind the same consensus ERRE motif 
(Dufour et al. 2007; Chen et al. 2008).  Taken together, these results strongly suggest that 
the inability of Esrra to activate ESC-based reporters could be due to structural 
differences specifically in its LBD, for although the AF-1 domain is also poorly 
conserved (Figure 3.3C), it was already shown here to be dispensable for Esrrb activity 
(Figure 3.2C). Mechanistically, these data support the published findings that only Esrrb 
and Esrrg can successfully reprogram MEFs (Feng et al. 2009). Thus, protein-protein 
interactions mediated by the Esrrb/g LBD in ESCs, but perhaps not Esrra, could be key 
to activating transcription of ESC target genes, further underpinning the importance of 
this specific domain in ESCs. 
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Figure 3.3 Differing activity of ERR isoforms in ESCs 
(A) ESC reporter assays using the indicated luciferase vectors following depletion of endogenous Esrrb, with 
or without co-transfection of Esrra, Esrrb, or Esrrg rescue constructs. Dotted lines show reporter activity 
following Esrrb depletion. The identity of each ERR isoform used in the reporter assays is indicated by its 
colour as shown in (C). (B) Luciferase assay in COS-1 demonstrating that all three ERR isoforms together 
with a coactivator (PGC-1α) are able to activate the somatic ERRE-Luc reporter. Luciferase assays in (A-
B) are the mean +/- SEM of three transfections; assays are representative of at least two independent 
experiments. (C) Diagram indicating the primary sequence (amino acid; a.a) conservation between the key 
functional domains of Esrrb and Esrra or Esrrg.  
 
3.2.3 The AF-2 region is essential for Esrrb transcriptional activity 
Having demonstrated a key requirement for the Esrrb LBD on both somatic and ESC-
relevant gene targets, attention was next focused on analysing the specific function of 
this domain, using Esrrb point mutants and luciferase assays. Unlike non-orphan nuclear 
receptors, ERR activity is not dependent on ligand binding, with mutations that reduce 
the volume of the ligand pocket having no effect upon receptor function (Greschik et al. 
2002).  Nevertheless, activity is thought to be regulated at the level of coactivator 
recruitment via the LBD AF-2 region, a structure of 12 helices highly conserved between 
nuclear receptors that form a unique protein-binding surface (Wurtz et al. 1996). In 
agreement with the key function of the AF-2 region, mutations that disrupt the AF-2 of 
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nuclear receptors such as ERα abolish their transcriptional activity effectively, thus 
highlighting a requirement for this region to recruit coactivators and stimulate 
transcription (Danielian et al. 1992). Therefore, it was next investigated whether Esrrb 
requires a functional AF-2 region to activate transcription in ESCs. First, residues whose 
mutation would likely disrupt the Esrrb AF-2 region were selected. For this, the primary 
sequence of Esrrb was aligned with that for ERα, in order to determine whether 
essential AF-2 residues that have been identified in ERα are also conserved in Esrrb 
(Figure 3.4). Alignment of the relevant ERα regions with Esrrb as well as with other 
mouse or human ERR isoforms showed that previously-mutated ERα AF-2 residues are 
indeed conserved (K366A in ERα Helix 3, and L543A/L544A in Helix 12 (Danielian et 
al. 1992; Henttu et al. 1997)). These data implied that analogous mutations generated in 
Esrrb would also be likely to inactivate its own AF-2 region. Based on this, the same 
amino acid substitutions that had been introduced into ERα were therefore generated in 
Flag-Esrrb in order to disrupt the Esrrb AF-2 region: K259A and L424A/F425A (Figure 
3.4). Additionally, an Esrrb DBD mutant was generated as a control for these 
experiments, containing cysteine to alanine substitutions in the first zinc finger (the ‘P-
Box’) of the Esrrb DBD (C120G/C123G). This analogous mutation was previously 
shown to abolish the binding of Esrra to the ERRE consensus (Barry et al. 2006) (Figure 
3.4) and would therefore inhibit Esrrb transcriptional activity in either COS-1 or ESC 
reporter assays. 
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First, it was examined whether these point mutations indeed abolish Esrrb activity, which 
was tested in COS-1 cells using the ERRE-Luc reporter. Western blot analysis 
demonstrated that all three mutants were expressed at similar levels to Wt (Figure 3.5A). 
When co-transfected with PGC-1α in somatic reporter assays, all three mutants behaved 
identically, showing little or no transcriptional activity in contrast to Wt Esrrb on ERRE-
Luc (Figure 3.5B). These results validated that mutating these residues in Esrrb has the 
same inhibitory effect as demonstrated for ERα. The inability of either AF-2 mutant to 
activate ERRE-Luc furthermore demonstrated that the AF-2 region of the LBD is 
indeed critical for the activation of a somatic reporter by Esrrb and its coactivator PGC-
1α.  
 
 
Figure 3.5 Transcriptional activity of Esrrb point mutants in COS-1 cells 
(A) Expression of Wt and mutant Esrrb in COS-1 cells. (B) Ability of Esrrb Wt or point mutants to activate 
the ERRE-Luc reporter in COS-1 cells when co-transfected with PGC-1α.. Data are mean +/- SEM of three 
transfections, a representative experiment of two is shown.   
 
What is the specific function of the Esrrb LBD in ESCs? In contrast to ERR LBD-PGC-
1α interactions, which are known to be AF-2 dependent (Kallen et al. 2004)(Figure 
3.5B), the requirement for a functional AF-2 in ESCs remained to be investigated. 
Indeed, given the transcription factor clustering that occurs at MTL, it is conceivable that 
a different portion of the Esrrb LBD and not AF-2 could be essential to stabilise 
neighbouring pluripotency factors bound to these enhancers. Therefore, following 
confirmation that the AF-2 mutations are effective, the activity of Esrrb point-mutants 
was next investigated in ESC-specific luciferase assays, as previously performed in Figure 
3.2. Analysis of Wt and Esrrb point-mutants revealed that, despite equal expression in 
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ESCs (Figure 3.6A), neither the DBD mutant nor either AF-2 mutant was able to restore 
Esrrb, Klf4, Nanog and Sox2 Enhancer-Luc activity following Esrrb depletion (Figure 
3.6B). Thus, the AF-2 region is indeed the specific LBD region required in ESCs. 
Interestingly, overexpressing Esrrb point-mutants furthermore caused a reduction in 
Esrrb and Sox2 Enhancer-Luc reporters below levels in Esrrb-depleted cells, suggesting 
they might act as dominant-negative proteins, potentially by competing with any 
remaining endogenous Wt Esrrb on these reporters. Taken together, these results 
demonstrate unequivocally that Esrrb function in ESCs critically requires its LBD 
domain, and specifically an active AF-2 region, in order to bring about transcription. 
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Figure 3.6 Transcriptional activity of Esrrb point mutants in ESCs 
(A) Expression of Wt and mutant Esrrb in ESCs. (B) Ability of Esrrb Wt or point mutants to rescue ESC 
Enhancer-Luc reporter activity following depletion of endogenous Esrrb. Dotted lines indicate luciferase 
activity following endogenous Esrrb depletion. Data are mean +/- SEM of three transfections, shown is a 
representative experiment of three. 
3.2.4 AF-2 region inactivation abrogates Esrrb function in ESCs 
Having shown a strict requirement for a functional LBD/AF-2 domain for Esrrb 
transcriptional activity, the functional consequences in ESCs of inhibiting this important 
region were next examined. Stable overexpression of Esrrb in ESCs is known to confer a 
strong resistance to differentiation, promoting robust self-renewal and negating the need 
for LIF to prevent differentiation (Zhang et al. 2008). To determine whether the AF-2 
dependence of Esrrb activity is linked to its role in ESCs, the ability of Wt Esrrb or AF-2 
point-mutants to enhance self-renewal was compared. For this, Flag-Esrrb cDNAs were 
first cloned into the pPyCAGIP vector, which may be used to generate ESC lines stably 
overexpressing a protein of interest under selection from a downstream IRES-pac 
(Puromycin resistance) cassette (Chambers et al. 2003). Stable ESC lines were 
subsequently generated from these vectors by transfection and selection for Puromycin 
resistance. Once selected, resultant colonies from each plate were pooled and via western 
blot were shown to express mutant or Wt Flag-tagged Esrrb at similar levels (Figure 
3.7A). Next, to test the properties of these cell lines, ESCs were plated at low density 
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then cultured for 5 days in the absence of LIF. On day 6, plates were then fixed and 
assayed for alkaline phosphatase (AP), which stains undifferentiated cells red. From this, 
the numbers of undifferentiated, mixed and differentiated colonies were scored (Figure 
3.7B). Following 5 days of LIF withdrawal, the majority of control ESCs expressing 
empty vector alone displayed a flattened, AP-negative morphology, with over 70% 
scoring as differentiated and no undifferentiated colonies remaining (Figure 3.7C top left, 
Figure 3.7D). In contrast, 80% of colonies from Wt Esrrb-overexpressing cells were 
either completely or partially undifferentiated, confirming that wild-type Esrrb has a 
strong positive effect on LIF-independence (Figure 3.7C top right, Figure3.7D). 
Strikingly however, both cell lines overexpressing AF-2 point mutants closely resembled 
control ESCs, with only 0-1% undifferentiated colonies and overall 60-80% colonies 
completely AP-negative (Figure 3.7C bottom, Figure3.7D). Thus, similar to its effect on 
Esrrb transcriptional activity, abrogating AF-2 function strongly inhibits the ability of 
Esrrb to enhance self-renewal.  
 
Chapter Three                                                                                                  Results 
 102 
 
Figure 3.7 Esrrb point mutants cannot support LIF-independence 
(A) Levels of CAG-Flag-Esrrb construct expression in ESCs. Stable lines expressing empty vector, Wt, or 
mutant constructs were generated following transfection and selection with Puromycin for 8 days, then 
pooled and used in assays. (B) Indicated morphology and alkaline phosphatase (AP) staining for colonies 
scored in self-renewal assays, categorized as undifferentiated (>85% AP-positive), mixed (15-85% AP-
positive) or differentiated (<15% AP-positive). (C-D) Ability of Wt or Esrrb point-mutants to confer LIF-
independence in stably transfected ESCs. Each cell line was plated at low density in normal ESC media and 
the following day cultured minus LIF for 5 days. Colonies were fixed and stained for AP and scored 
according to (B). Data are mean +/- SEM of three independent experiments. Scale bars, 100µm. 
 
As with several core pluripotency factors such as Oct4, Sox2 and Nanog, acute depletion 
of endogenous Esrrb inhibits ESC self-renewal and triggers multi-lineage differentiation 
(Ivanova et al. 2006; Loh et al. 2006). To investigate further the relevance of the AF-2 
region for Esrrb function, it was therefore next determined whether disrupting AF-2 also 
negatively affects ESC self-renewal. For this, a previously-described ERR antagonist, 
diethylstilbestrol (DES), was utilized. This compound was originally discovered in a 
screen for ligands able to disrupt ERR-coactivator interactions, where it was 
demonstrated that DES specifically inhibits all three ERR isoforms but not other 
unrelated nuclear receptors such as PPARγ (Tremblay et al. 2001). Subsequent 
crystallographic analysis of the Esrrg LBD complexed with DES revealed that binding of 
this antagonist forces conformational changes within the AF-2 region, ultimately shifting 
Helix 12 out of its normally stabilised agonist position (Figure 3.8A). This would in turn 
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preclude coactivator recruitment by the AF-2 region, thus inhibiting ERR activity 
(Greschik et al. 2004). In these experiments, reporter assays were first used to 
demonstrate an inhibitory effect of DES upon Esrrb activity. ESCs that were transfected 
with Esrrb, Klf4, Nanog and Sox2 Enhancer-Luc vectors and treated with DES for 24 h all 
showed a dose-dependent loss in activity (Figure 3.8B). The IC50 of DES was 6-8µM, 
similar to studies in trophoblast stem cells where the DES-ERR relationship was 
previously examined (Tremblay et al. 2001). Having confirmed the ability of DES to 
inhibit Esrrb activity, the effect of inactivating AF-2 upon ESC self-renewal was next 
assessed. ESCs were plated at low density as previously performed in Figure 3.7, then 
maintained plus LIF supplemented with DES for 4 days. Treatment of ESCs with DES 
efficiently induced differentiation in a dose-dependent fashion (Figure 3.8C-D). This 
further supports evidence to show that the AF-2 region is key to Esrrb function in ESCs, 
which is in turn critical for maintenance of the embryonic stem cell state. 
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Figure 3.8 The AF-2 antagonist, DES, inhibits ESC self-renewal 
(A) Structural basis for diethylstilbestrol (DES)-induced ERR inactivation. Crystal structure of the Esrrg 
(ERRγ) LBD complexed with DES (green), superimposed upon the apoLBD (yellow). Note the rotation in 
Helix 11, which in turn prevents Helix 12 adopting its active, agonist position. Adapted with permission 
from (Greschik et al. 2004). (B) The activity of Esrrb, Klf4, Nanog and Sox2 luciferase reporters was 
measured in ESCs following 24 h treatment with increasing doses of DES. Data are mean +/- SEM of three 
experiments, representative of two independent experiments. The dotted line represents the average 
luciferase activity following shRNA-mediated Esrrb depletion in previous experiments, shown for 
reference. (C-D) AP staining of ESCs following treatment with DES for 4 days. Colonies were quantified as 
in Figure 3.7. Cells cultured minus LIF for this period were included as a control for ESC differentiation. 
Data are mean +/- SEM of three independent experiments. Scale bars, 100µm. 
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3.3 Summary and Conclusions 
Here, it was investigated how Esrrb mechanistically functions in ESCs, which was 
discovered in the past five years to be a key component of the pluripotency transcription 
factor network. It was first found that – as in somatic cells – Esrrb transcriptional activity 
in ESCs is absolutely dependent upon an intact LBD. Esrrb deletion mutants lacking the 
entire LBD cannot activate ESC-specific Enhancer-Luc reporters, showing that this 
domain is essential for Esrrb transcriptional activity. In contrast, the AF-1 region is 
dispensable for Esrrb function in ESCs. Further pointing to the importance of the LBD 
in ESCs, Esrra shows much greater LBD sequence divergence from Esrrb and Esrrg and 
accordingly possesses no transcriptional activity on ESC-based reporter genes. Next, the 
role of the LBD AF-2 region was examined, the C-terminal portion of nuclear receptors 
known to be responsible for recruiting coactivators. Point mutations inserted into AF-2 
in order to disrupt this region effectively abrogate Esrrb transcriptional activity, 
demonstrating that protein-protein interactions mediated by this specific region are 
indeed essential. Finally, to link the transcriptional activity of the Esrrb LBD and AF-2 
region with its function in ESCs, it was shown that both the ability of Esrrb to enhance 
self-renewal and also prevent differentiation is absolutely dependent on an intact AF-2 
region. Taken together, these results show that DNA-binding alone is not sufficient for 
Esrrb activity and function in ESCs. Moreover, these data strongly implicate the presence 
of a cognate coactivator that must be recruited to the Esrrb AF-2 region in order to 
potentiate its role in ESC self-renewal.  
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Chapter Four: Results 
 
 
4          Identification of an Esrrb Coactivator in ESCs 
 
Chapter Four                                                                                                   Results 
 107 
 
 
 
 
 
 
 
 
 
 
 
I am a marathon runner 
And my legs are sore 
And I am anxious to see 
What I am running for 
… 
I will run until I know what to believe 
 
Yellow Ostrich, Marathon runner 
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4.1 Introduction 
The experiments performed in Chapter three revealed that Esrrb requires an intact AF-2 
region within its LBD for it to function in ESCs. This was found to be essential both in 
terms of Esrrb transcriptional activity as well as its ability to enhance self-renewal. These 
findings clearly pointed towards there being key protein-protein interactions mediated by 
the AF-2 region, i.e. the recruitment of a specific coactivator required for Esrrb activity. 
In somatic cells, the best-characterised ERR coactivators are the PGC-1 family, with 
PGC-1α and PGC-1β co-operating with Esrra or Esrrg to activate pathways of energy 
expenditure, inflammation, and fat metabolism as ERR ‘protein ligands’ (reviewed in 
(Giguere 2008)). In this chapter, it was first examined whether a member of the PGC-1 
family of coactivators could be performing a similarly essential role in potentiating Esrrb 
activity in ESCs. Following the finding that PGC-1 members do not seem to act as Esrrb 
coactivators in these cells, the expression and function of the p160 family of nuclear 
receptor coactivators was investigated, the only other family of proteins that have been 
previously cited as potential ERR coactivators (Xie et al. 1999). In particular, efforts were 
focused upon Ncoa3 (also known as SRC-3/AIB1), a p160 member that was recently 
identified as an Esrrb-associated protein in ESCs via mass spectrometry (van den Berg et 
al. 2010), and discovered here to be highly expressed in undifferentiated ESCs. Further 
experiments were consequently aimed at determining whether Ncoa3 could be a specific 
coactivator important for Esrrb function in ESCs. 
 
4.2 Results 
4.2.1 The PGC-1 family do not act as Esrrb coactivators in ESCs 
The PGC-1 family of coactivators comprise three members: PGC-1α, PGC-1β and more 
recently a third member, PRC, which was discovered to be a regulator of NRF-1 and 
mitochondrial function (Vercauteren et al. 2009). Given the importance of PGC-1α/β in 
acting as coactivators for ERRs in somatic and metabolic cell contexts, it was first 
determined whether this might also be the case in ESCs. To investigate this, gene 
expression profiling was carried out on PGC-1α, β and PRC in ESCs via qRT-PCR, 
alongside template generated from an immortalized brown adipose tissue cell line 
(IMBAT) as a positive control (a kind gift from Eleni Daniel). This revealed that in 
contrast to IMBAT cells, the known ERR coactivators PGC-1α/β were not expressed in 
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ESCs, precluding a role in these cells as Esrrb coactivator (Figure 4.1A). Interestingly, 
PRC transcripts were detected in ESCs as well as IMBAT cells, and experiments were 
therefore undertaken to determine if this member could be functioning as Esrrb 
coactivator. The requirement for PRC to potentiate Esrrb transcriptional activity was 
first examined using Enhancer-Luc reporter assays in PRC-depleted cells (Figure 4.1B). 
Unlike Esrrb depletion itself, the reporter activity of Esrrb, Klf4 or Sox2 vectors was not 
affected by PRC knockdown, suggesting that PRC is not required for Esrrb activity 
(Figure 4.1C). To further support this, the effect of stable PRC depletion upon ESC self-
renewal was also tested. ESCs were transfected with shScrambled, shPRC or shEsrrb 
vectors and selected with Puromycin for 6 days. Whilst Esrrb depletion efficiently 
induced a loss of AP staining and morphological changes indicative of differentiation as 
expected (Figure 4.1D-E) (Ivanova et al. 2006; Loh et al. 2006), in contrast no negative 
effect upon PRC knockdown was apparent (Figure 4.1D-E). Scoring carried out of the 
types of colonies produced in knockdown experiments also illustrated that shPRC-
transfected cells closely resemble control ESCs, whereas in contrast over 80% of Esrrb 
knockdown ESCs were differentiated (Figure 4.1E). Interestingly, a decrease in average 
colony size upon PRC depletion was evident compared to control ESCs (Figure 4.1D), 
which may be due to a degree of growth inhibition potentially owing to the role of PRC 
in mitochondrial function (Vercauteren et al. 2009). Further arguing against a role for 
PRC as a specific Esrrb coactivator however, only PGC-1α and PGC-1β, and not PRC, 
were able to enhance ERR activity in ERRE-Luciferase assays performed in COS-1 cells 
(data not shown). Taken together these results indicated that PRC is not an Esrrb 
coactivator in ESCs, implying that another unknown protein must be fulfilling this role. 
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Figure 4.1 Analysis of PRC function in ESCs 
(A) Expression of members of the PGC-1 family in ESCs, assessed by qRT-PCR and normalized to two 
housekeeping genes. Expression levels in a brown adipose tissue cell line (IMBAT) are shown alongside as a 
control. (B) shRNA-mediated depletion of PRC in ESCs 48 hours after transfection. Data for all qRT-PCR 
is expressed as the mean +/- SEM of three biological replicates. (C) Activity of Enhancer-Luc reporters in 
ESCs following co-transfection with control shRNA (shScrambled), Esrrb shRNA (shEsrrb) or PRC shRNA 
(shPRC). Shown is the mean +/- SEM of three independent experiments. (D) AP staining of ESCs following 
transfection with shScrambled, shEsrrb or shPRC and selection with Puromycin for 6 days in the presence 
of LIF. Scale bars, 100µm. (E) Quantification of the number of undifferentiated, mixed, and differentiated 
colonies produced in (D). Data are the mean +/- SEM of three independent experiments. 
4.2.2 Ncoa3 is highly expressed in undifferentiated ESCs 
Having ruled out the PGC-1 family as Esrrb coactivators, it was next asked which 
factor(s) might instead perform this function in ESCs. From published data, the only 
other nuclear receptor coactivators known to be capable of interacting with ERRs is the 
Ncoa/p160/SRC family (Xie et al. 1999). Using human proteins, all three SRC isoforms 
were shown to be capable of binding to ERR1 and ERR2 in vitro and enhancing their 
transcriptional activity. More interestingly, out of the Ncoa/p160/SRC family in mice 
(denoted Ncoa1/2/3), Ncoa3 was recently identified in a mass-spectrometry analysis of 
the Esrrb interactome in ESCs (van den Berg et al. 2010). Based on this, Ncoa1, 2 and 3 
were next examined in ESCs. As performed for the PGC-1 family, qRT-PCR was utilized 
Chapter Four                                                                                                   Results 
 111 
to profile the expression of all three isoforms, revealing very high levels of Ncoa3 in 
ESCs, whereas in contrast Ncoa1/2 were not expressed (Figure 4.2A). To determine 
whether Ncoa3 expression is linked to the undifferentiated/self-renewing state of ESCs, 
experiments were performed to analyse changes to its expression upon differentiation. 
Treatment of ESCs with 1µM all trans retinoic acid (atRA) for 96 hours effectively 
induced the loss of both Ncoa3 and Esrrb proteins (Figure 4.2B). To rule out a retinoid-
specific effect, ESCs were also induced to differentiate by withdrawal of LIF for 96 
hours, a method that leads to pluripotency factor downregulation and consequently 
triggers multi-lineage differentiation. Ncoa3 protein levels were decreased 96 hours after 
LIF-withdrawal, along with Esrrb, Nanog and Oct4, showing that Ncoa3 downregulation 
is not a specific response to retinoic acid treatment but potentially a general feature of 
differentiation (Figure 4.2C). To support this, the expression of Ncoa3 was also profiled 
during embryoid body (EB)-mediated differentiation. This method involves the culture 
of ESCs in suspension minus LIF over several days, during which spherical EBs are 
formed from ESC aggregates (Figure 4.2D), which mimic the emergence of cells derived 
from all three germ layers in vivo during mouse embryonic development. qRT-PCR 
analysis over a 6 day period of EB formation revealed that Ncoa3 was rapidly 
downregulated upon differentiation along with Esrrb and other key pluripotency factors 
(Figure 4.2E). Overall, these results reveal Ncoa3 to be an ESC-associated protein that is 
highly expressed in self-renewing ESCs and downregulated alongside Esrrb and other 
pluripotency factors upon differentiation. 
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Figure 4.2 Ncoa3 is expressed in undifferentiated ESCs 
(A) Expression of Ncoa1, Ncoa2 and Ncoa3 transcripts in ESCs assessed by qRT-PCR, and normalized to 
two housekeeping genes. Expression levels in IMBAT cells are shown as a control. Data are the mean +/- 
SEM of three biological replicates. (B) Immunofluorescence (IF) staining of ESCs maintained in 
proliferative conditions (+LIF) or induced to differentiate by removal of LIF and addition of 1µM retinoic 
acid (atRA) for 96 hours. Scale bars, 50µm. (C) Western blotting showing downregulation of Ncoa3 
alongside other ESC-associated proteins after differentiation induced by LIF withdrawal for 96 hours. (D) 
Typical morphology of embryoid bodies (EBs) formed from ESCs at the indicated time points. (E) Relative 
levels of Ncoa3 alongside other pluripotency factors downregulated during EB-mediated differentiation. 
Data are mean +/- SEM of three independent experiments, expressed relative to EB day 0. Experiment (E) 
was performed in collaboration with Fabrice Lavial. 
4.2.3 Ncoa3 interacts with Esrrb in ESCs via its AF-2 domain 
The high levels of Ncoa3 in ESCs and its similar pattern of expression to Esrrb 
suggested that Ncoa3 could be a potential candidate coactivator for Esrrb. To investigate 
this, experiments were first performed to determine if Ncoa3 and Esrrb interact. Co-
immunoprecipitation assays (Co-IPs) were initially performed with extracts from COS-1 
cells that had been transiently transfected with both Ncoa3 and Flag-Esrrb expression 
vectors. For this, extracts were incubated with anti-Ncoa3 or anti-Flag antibodies, then 
immunoprecipitated complexes visualised by western blotting, probing with the indicated 
antibodies. The level of unspecific enrichment was simultaneously examined for each 
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experiment in separate incubations with normal mouse or rabbit IgGs. These assays 
demonstrated that Ncoa3 and Esrrb are indeed associated when ectopically co-expressed 
(Figure 4.3A), as has been previously described for human ERRs and Ncoa3 (Xie et al. 
1999). Next, the important question was addressed of whether these endogenous 
proteins interact, as opposed to an effect only seen when Ncoa3 and Esrrb are over-
expressed. To test this, Co-IPs were performed with ESCs, using extracts incubated with 
anti-Esrrb or anti-Ncoa3 antibodies to enrich for each protein. Probing for Ncoa3 (top) 
or Esrrb (bottom) demonstrated that these factors at their endogenous levels do indeed 
bind each other, and are thus co-associated in ESCs (Figure 4.3B).  
 
Figure 4.3 Ncoa3 and Esrrb proteins interact in v i tro 
(A) Co-immunoprecipitation experiments (Co-IPs) performed in COS-1 cells cotransfected with Flag-Esrrb 
and Ncoa3. Proteins were immunoprecipitated using anti-Flag or anti-Ncoa3 antibodies and 
immunoblotted for the indicated protein. The relevant normal anti-mouse or anti-rabbit IgG was used as a 
negative control (anti-IgG). Loaded alongside for each experiment is 1-5% pre-cleared cell lysate as the 
input.  (B) Co-IPs performed with ESC extracts demonstrating an interaction between endogenous Esrrb 
and Ncoa3; experiments in (B) were performed in collaboration with Fabrice Lavial. Co-IPs shown are 
representative of at least two independent experiments. 
 
Following this, it was next investigated whether Ncoa3 is recruited to the Esrrb AF-2 
region.  Wt or AF-2 mutated Flag-Esrrb point mutants (as utilized in Figure 3.5-6) were 
introduced into COS-1 cells along with Ncoa3, and Co-IPs performed to determine the 
ability of these mutants to bind Esrrb. In contrast to Wt Esrrb, the AF-2 point mutants 
showed a strong reduction in their ability to interact with Ncoa3 (Figure 4.4A). 
Interestingly, the Esrrb DBD point mutant showed an increased affinity for Ncoa3 over 
wild-type, which could potentially be due to an enhanced immunoprecipitation effect 
when Esrrb is not bound to DNA. Supporting these results in COS-1, treatment of ESCs 
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for 24 hours with the AF-2 antagonist, DES, which was used previously to inhibit Esrrb 
activity (Figure 3.8), also efficiently abrogated the interaction between endogenous 
Ncoa3 and Esrrb (Figure 4.4B). These results therefore confirmed that Ncoa3 is 
recruited to the Esrrb AF-2 region in ESCs. Furthermore, they suggest that the inhibitory 
effect of DES upon ESC self-renewal could be via disruption of the Esrrb AF-2-Ncoa3 
interaction. 
 
Figure 4.4 The Esrrb-Ncoa3 interaction is AF-2 dependent 
(A) Co-IPs performed in COS-1 cells transfected with Ncoa3 and either Wt or point-mutant Flag-Esrrb 
expression vectors. The Esrrb-Ncoa3 interaction is lost or strongly reduced in AF-2 mutants. (B) Co-IP in 
extracts from ESCs treated for 24 hours with Ethanol or DES, immunoprecipitated for endogenous Esrrb 
and then immunoblotted for Ncoa3 (left-hand panels). The efficiency of the Esrrb-IP itself was not affected 
(right-hand panels), performed in collaboration with Fabrice Lavial. 
 
The experiments so far demonstrated that Esrrb and Ncoa3 do interact in ESCs, an 
association mediated specifically by the LBD AF-2 region. However, it was unclear 
whether these associations take place as part of a complex where Ncoa3 could also bind 
proteins such as Oct4 and Nanog, or whether Ncoa3 is specifically recruited by Esrrb. 
Although first discovered as a coactivator of nuclear receptors, Ncoa3 was also found to 
bind other transcription factors, such as E2F1 and Sp1 (Louie et al. 2004; Mussi et al. 
2006). Co-IP experiments were therefore performed to determine whether interactions 
could be detected between Ncoa3 and Oct4/Nanog, which themselves are known to 
bind to Esrrb (van den Berg et al. 2008; Zhang et al. 2008). Whilst Esrrb and Oct4 were 
confirmed to interact in ESCs, Ncoa3 was not detected in Oct4-immunoprecipitated 
complexes (Figure 4.5A, left). Conversely, Co-IPs with anti-Ncoa3 antibodies did not 
pull down Oct4, in contrast to Esrrb (Figure 4.5A, right). Similarly, ESC and COS-1 
samples immunoprecipitated with anti-Nanog or anti-Ncoa3 antibodies, respectively, 
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showed no evidence of an interaction between Ncoa3 and Nanog (Figure 4.5B). 
Additionally, it was verified that in DES-treated ESC extracts where the Ncoa3/Esrrb 
interaction was inhibited (Figure 4.4B), the ability of Esrrb to bind Oct4 was still 
maintained, suggesting that the binding of Esrrb to Ncoa3 is fully independent from its 
interaction with Oct4 (Figure 4.5C). These experiments together provided strong 
evidence that Ncoa3 interacts with Esrrb in ESCs, and that an interaction with 
Oct4/Nanog is either absent, or too weak to be detected. 
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Figure 4.5 Ncoa3 does not interact with Oct4 and Nanog  
(A) Co-IP in ESCs to determine if Ncoa3 and Oct4 interact. Left – samples were immunoprecipitated with 
anti-Oct4 antibodies and then immunoblotted for either Esrrb (top; positive control) or Ncoa3 (bottom). 
Right – the same was performed, this time immunoprecipitating with anti-Ncoa3 antibodies and probing 
for Esrrb (top; positive control), or Oct4 (bottom). (B) Co-IP in ESCs investigating if Nanog and Ncoa3 
interact. Left – ESCs were immunoprecipitated using anti-Nanog antibodies then probed for Oct4 (top; 
positive control) or Ncoa3 (bottom). Right – for the reverse orientation, Nanog immunoblotting could not 
be performed after Ncoa3 IP due to cross-reactivity, as both IP and IB antibodies are raised in rabbit. 
Therefore, the Ncoa3 IP was performed in COS-1 cells using mouse anti-Ncoa3 antibodies (BDBiosciences 
#611105). COS-1 cells were transiently transfected with Ncoa3 and Flag-Esrrb (top) or Ncoa3 and Nanog 
(bottom) and extracts immunoprecipitated with anti-Ncoa3 antibodies, then probed for Flag (top, positive 
control), or Nanog (bottom). (C) Ethanol or DES-treated ESCs were immunoprecipitated with anti-Esrrb 
antibodies then probed for Oct4. Blots are representative of two independent experiments. See also Figure 
4.4B. Experiments in (A&C) were performed in collaboration with Fabrice Lavial.  
4.2.4 Ncoa3 is recruited to Esrrb-bound loci in ESCs 
Genome-wide chromatin immunoprecipitation (ChIP)-sequencing (ChIP-seq) has 
demonstrated that Esrrb, along with many other ESC-associated factors such as Oct4, 
Sox2, Nanog and Klf4, maps to densely-bound enhancers at key targets in ESCs (Chen et 
al. 2008). To investigate the functional importance of an Esrrb-Ncoa3 interaction in 
ESCs, ChIP-qPCR assays were first performed to determine if Ncoa3 is co-recruited to 
Esrrb target genes. Locus-specific primers were designed to amplify ERRE-containing 
regions found in the vicinity of Esrrb, Klf4, Nanog and Sox2 genes (Figure 4.6A), as these 
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four regions were previously studied in luciferase assays (see Chapter three). ChIP 
experiments carried out on chromatin prepared from ESCs confirmed that Esrrb was 
recruited to all these loci, in contrast to a control intergenic region, which showed only 
background levels of enrichment similar to that immunoprecipitated by control IgGs 
(Figure 4.6B). Simultaneous analysis of Ncoa3 recruitment to these sites strikingly 
revealed a high level of enrichment at all four Esrrb-bound loci, showing Ncoa3 is 
indeed co-recruited to these ERREs (Figure 4.6B). Interestingly, both Esrrb and Ncoa3 
exhibited a 5-10 fold higher enrichment at Esrrb and Klf4 loci than Nanog and Sox2. The 
reason for this is unknown; it could perhaps suggest that Esrrb/Ncoa3 are recruited with 
a higher efficiency or further stabilized at Esrrb and Klf4 in ESCs.  
 
Although these ChIP experiments demonstrated that Ncoa3 is present with Esrrb at the 
candidate loci tested, they do not prove that Esrrb is directly responsible for recruiting 
Ncoa3 to its targets. In order to determine whether this is the case, the effect of 
depleting Esrrb upon Ncoa3 recruitment was tested. ESCs were transiently transfected 
with a control (shGFP) or Esrrb (shEsrrb) shRNA vector and 48 hours later the cells 
harvested. At this time point Esrrb protein was reduced as expected, whilst importantly, 
neither Ncoa3 nor Oct4 proteins were decreased, ruling out the possibility that any loss 
in enrichment might be due to the onset of differentiation (Figure 4.6C). ChIP assays 
were carried out upon control or Esrrb-depleted extracts and showed a decrease in 
Ncoa3 enrichment that mimicked the reduction in Esrrb binding itself (Figure 4.6D). In 
contrast, the control intergenic region was again very similar to background in both cell 
populations. These findings strongly suggest that Esrrb is required to recruit Ncoa3 to 
Esrrb, Klf4, Nanog and Sox2 loci in ESCs. 
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Figure 4.6 Ncoa3 is recruited to ERREs via Esrrb  
(A) Schematic illustrating the position of primers used to detect Esrrb and Ncoa3 enrichment at ERREs 
within the ESC enhancers where Esrrb has been previously detected (Chen et al. 2008). Pink triangles 
indicate the position of the ERRE-containing fragments present in Enhancer-Luc luciferase reporters. 
Included below each primer is the distance (Kb) of each ERRE from the transcription start site. (B) 
Chromatin-immunoprecipitation (ChIP) experiments assessing the recruitment of Esrrb and Ncoa3 to 
Esrrb, Klf4, Nanog and Sox2 loci as indicated in (A), expressed relative to input. Enrichment at an 
intergenic control region (Inter.) is shown as a negative control. Dotted lines for (B) and (D) indicate 
background enrichment by control IgGs. Data for ChIP experiments are mean +/- SD of at least two 
independent experiments. (C) Western blotting showing specific Esrrb protein depletion 48 hours after 
transfection with shGFP (control) or shEsrrb. 1µg/mL Puromycin was added 24 hours after transfection to 
select for successfully transfected cells. (D) ChIP performed in ESCs knocked down for Esrrb as in (C). 
Enrichment in shGFP-transfected cells is set to 100% for each experiment and expressed relative to input.  
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4.2.5 Ncoa3 is required for Esrrb transcriptional activity 
Having shown using Co-IP assays that Ncoa3 interacts with Esrrb via its AF-2 region, 
and that Ncoa3 is recruited in an Esrrb-dependent fashion to its target genes, it was 
finally investigated whether Ncoa3 is the coactivator required for Esrrb transcriptional 
activity in ESCs. To address this, ESCs were transiently depleted of Ncoa3 using a pool 
of ON-TARGETplus siRNA oligos (Figure 4.7A), and the effect upon Esrrb Enhancer-
Luc reporter assays determined. Co-transfection of siNcoa3 with Esrrb, Klf4, Nanog or 
Sox2-Luc reduced the activity of all four reporters, which importantly closely 
phenocopied the effect of Esrrb depletion itself using shEsrrb (Figure 4.7B). 
Furthermore, the ability of Wt RNAi-resistant Esrrb to rescue reporter activity following 
depletion of endogenous Esrrb was strictly dependent on Ncoa3, as simultaneous 
siNcoa3 transfection abolished the restoration of luciferase activity in all four reporters 
(Figure 4.7C). Interestingly, the overall reduction in reporter activity by shEsrrb was less 
in these experiments than observed in Figure 4.7B, potentially due to saturation of the 
RNA-induced silencing (RISC) machinery when simultaneously transfecting both 
shRNA and siRNA. Overall, these experiments together demonstrate that the activity of 
Esrrb is dependent upon Ncoa3 expression at these candidate targets. They additionally 
mirror previous experiments that demonstrate a similar loss in reporter activity when 
Esrrb AF-2 mutants – that cannot bind Ncoa3 – are utilized.  
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Figure 4.7 Esrrb transcriptional activity depends on Ncoa3  
(A) Western blotting showing Ncoa3 levels in ESCs 48 hours after transfection with control siRNA 
(siControl) or ON-TARGETplus siRNA SMARTpool targeting Ncoa3 (siNcoa3). (B) Loss of ESC 
Enhancer-Luc luciferase activity as assessed 48 hours after Esrrb or Ncoa3 depletion. (C) Ability of Wt 
Esrrb to rescue reporter activity after Esrrb depletion with or without simultaneous Ncoa3 knockdown. 
Data are the mean +/- SEM of three transfections, shown is one representative experiment of three. The 
dotted reference lines indicate the level of reporter activity in Esrrb depleted cells. 
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4.3 Summary and Conclusions 
Following Chapter three, which pointed to the requirement of Esrrb for a cognate 
coactivator, attention was turned here to identifying this protein in ESCs.  The PGC-1 
family was first investigated, a key set of nuclear receptor coactivators that includes 
PGC-1α and PGC-1β, whose importance in potentiating ERR activity in various 
physiological contexts is well-established (Huss et al. 2002; Kamei et al. 2003; Charest-
Marcotte et al. 2010). Interestingly however, neither PGC-1α nor PGC-1β transcripts 
were detected in ESCs, and only PRC – a relatively uncharacterized third PGC-1 family 
member – was found to be expressed in ESCs. Despite this however, experiments to 
assess the role of PRC as Esrrb coactivator could not provide supportive evidence that it 
is required either for Esrrb function or ESC self-renewal. Thus PRC may be important 
for another role in these cells, such as a previously documented function in controlling 
mitochondrial function in somatic cells via NRF-1 (Vercauteren et al. 2009).  
 
Having ruled out PGC-1 members, experiments were next performed to profile the 
expression of the Ncoa/p160/SRC family of nuclear receptor coactivators, Ncoa1, Ncoa2 
and Ncoa3. Building on the recent identification of Ncoa3 as an Esrrb-associated protein 
in a study of the Esrrb-interactome in ESCs (van den Berg et al. 2010), Ncoa3 was here 
found to be highly expressed in ESCs and downregulated at the mRNA and protein level 
alongside Esrrb upon differentiation. Ncoa3 interacts specifically with Esrrb via its AF-2 
region, whereas in contrast no interaction could be detected between Ncoa3 and 
Oct4/Nanog in endogenous ESC extracts or when overexpressed in COS-1 cells. 
Furthermore, treatment with DES inhibited only the interaction of Esrrb with Ncoa3 
and not with Oct4, highlighting the specificity of the AF-2-mediated Esrrb-Ncoa3 
association. Finally, it was demonstrated that Esrrb recruits Ncoa3 to ERREs found in 
the vicinity of Esrrb, Klf4, Nanog and Sox2 genes, and importantly, that Ncoa3 expression 
is required for the activity of Esrrb-dependent reporter assays. Overall, these findings 
point towards the proposed model, depicted below, whereby Esrrb is present at ERRE-
containing enhancers in the vicinity of target genes such as Esrrb, Klf4, Nanog and Sox2, 
and interacts with co-bound Oct4 and Nanog at these sites. Ncoa3 is recruited to Esrrb 
at ERREs via its AF-2 region, and furthermore is required for the activation of these 
ESC-specific enhancers by Esrrb (Figure 4.8). Interestingly, it is also notable that Esrrb 
depletion never fully abolishes Enhancer-Luc reporter activity, only reducing levels to 35-
45% compared to shScrambled-transfected cells. It is therefore likely that Esrrb-
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associated proteins such as Oct4/Sox2 or Nanog could themselves also contribute to the 
full activity of these reporters (Chen et al. 2008). Overall these findings reveal Ncoa3 to 
be an important coactivator for Esrrb in ESCs, and – together with previous results 
showing AF-2 inhibition negatively impacts upon ESC self renewal – point towards a 
crucial role for this cofactor in maintaining the ESC state.  
 
Figure 4.8 Model of transcription factor and cofactor organization at ERREs 
Esrrb binds to ERRE elements within enhancer regions at target genes in ESCs, along with Oct4 and Nanog, 
with which Esrrb physically interacts. Ncoa3 is recruited to Esrrb at these targets specifically via the LBD 
AF-2 region. This interaction is abrogated by the AF-2 antagonist, DES, or in Esrrb AF-2 point mutants. 
Ncoa3 is essential for the full activation of target genes by Esrrb such as Esrrb, Klf4, Nanog and Sox2, as 
indicated by luciferase reporter assays.  
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5 Analysis of Ncoa3 Function in ESCs and Reprogramming 
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You tell me its just growing pains  
Oh I make mistakes 
And yes I know its growing pains 
 
La Roux, Growing pains 
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5.1 Introduction 
Ncoa3 was identified here as an important ESC coactivator for Esrrb. Experiments 
demonstrated that Ncoa3 is essential for the transcriptional activity of Esrrb as well as 
being recruited to ERRE-containing enhancers in the vicinity of Esrrb target genes, 
Esrrb, Klf4, Nanog and Sox2. These results suggested an important role for Ncoa3 within 
the ESC transcriptional network, potentially through controlling Esrrb function. Many 
factors that participate in the ESC transcriptional circuitry and cluster together at such 
enhancers must have maintained levels of high expression to prevent precocious 
differentiation. For example, acute depletion of either Oct4 (Niwa et al. 2000), Klf2,4,5 
(Feng et al. 2009), Nanog (Ivanova et al. 2006), or Esrrb itself (Ivanova et al. 2006; Loh 
et al. 2006) causes a loss of ESC pluripotency. Conversely, it has been shown for a select 
number of pluripotency factors – including Esrrb and Nanog – that their overexpression 
in ESCs is sufficient to partially inhibit differentiation induced either by LIF-withdrawal 
or in embryoid bodies (Chambers et al. 2003; Ivanova et al. 2006; Zhang et al. 2008). 
Furthermore, Esrrb was also recently shown to be capable of reprogramming MEFs to 
pluripotency, substituting for Klf4 in the Yamanaka OSKM reprogramming cocktail 
(Feng et al. 2009). Given these important roles of Esrrb in self-renewal and 
reprogramming, it was therefore next investigated whether Ncoa3, like Esrrb, might 
possess similar functions in regulating the ESC state. 
 
In this chapter, experiments were therefore carried out to assess the importance of 
Ncoa3 in both the maintenance and induction of the pluripotent state. Firstly, shRNA-
mediated knockdown experiments were performed to determine if, as with Esrrb, the 
absence of Ncoa3 impacts upon ESC self-renewal. Next, the ability of Ncoa3 to enhance 
Esrrb-mediated LIF-independence and resistance to differentiation was also tested, using 
ESC cell lines overexpressing Esrrb with Ncoa3, as well as Ncoa3 alone.  Having studied 
the importance of Ncoa3 in ESCs, experiments were carried out in order to determine 
whether Ncoa3 is required in somatic cell reprogramming, a process during which 
pluripotency factors such as Esrrb are highly upregulated. Additionally, it was recently 
found that Esrrb can replace Klf4 in reprogramming MEFs when overexpressed with 
Oct4 and Sox2; however this was less efficient than with Klf4. Thus, the ability of Ncoa3 
to enhance Esrrb-mediated reprogramming was examined. 
Chapter Five                                                                                                   Results 
 126 
5.2 Results 
5.2.1 Ncoa3 is essential for the ESC state 
In order to study the importance of Ncoa3 in ESCs, the impact of its depletion via 
pLKO.1-based shRNAs was first investigated. For this, cells were transfected with either 
a scrambled Puromycin-selectable shRNA vector or one of five different constructs 
targeting Ncoa3 mRNA, and the levels of Ncoa3 assessed 48 hours after transfection 
(Figure 5.1A). Of these vectors, two constructs gave the best knockdown, shNcoa3 #1 
and #5, and were chosen for use in further experiments. These shRNAs were both 
confirmed to reduce Ncoa3 messenger levels specifically (Figure 5.1B). A slight increase 
in Ncoa2 was apparent, potentially as a compensatory response to the reduction in Ncoa3. 
Additionally, each shRNA effectively reduced Ncoa3 protein levels 48 hours following 
transfection (Figure 5.1C).    
 
Figure 5.1 shRNA-mediated Ncoa3 depletion 
(A) qRT-PCR analysis of Ncoa3 expression in ESCs transfected with pLKO.1 shScrambled or one of 5 
different shNcoa3 vectors (#1-5). Cells were harvested 48 h after transfection. shRNAs #1 and #5 (in red) 
gave the highest knockdown efficiency and were used in subsequent experiments. Data are the mean +/- 
SEM of 3 replicates, normalised to shScrambled in each replicate. (B) Expression profiling of Ncoa1/2/3 
following transfection with shNcoa3 #1 or #5. Data are the mean +/- SD of at least two independent 
experiments. (C) Analysis of Ncoa3 protein levels 48 hours after Ncoa3 knockdown. Gapdh is shown as a 
loading control. 
 
To test the importance of Ncoa3, the effect of its depletion upon the undifferentiated 
state of ESCs was investigated. For this, ESCs were transfected with shRNA vectors and 
stably knocked-down cells selected using Puromycin for 4 days. As a positive control, it 
was first verified that depletion of Esrrb induced differentiation in these conditions 
(Figure 5.2A). Strikingly, ESCs targeted with each independent Ncoa3 shRNA also 
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displayed a similarly altered morphology, rapidly losing the tightly packed colony 
organisation characteristic to ESCs. Importantly, Ncoa3-knockdown cells exhibited a 
flattened shape and stained negative for AP, in contrast to shScrambled ESCs, indicative 
of a loss of the undifferentiated state (Figure 5.2B). Additionally, no stable Ncoa3-
knockdown cells could be maintained. To confirm that Ncoa3 depletion was inducing 
differentiation in these cells, changes to the expression levels of key self-renewal and 
differentiation-association genes were assessed following 4 days of Puromycin selection. 
Depletion of Ncoa3 caused a reduction in self-renewal gene expression by both shRNAs, 
including Esrrb targets such as Esrrb, Klf4 and Sox2 (Figure 5.2C), as well as a 
derepression of early lineage-specific markers (Figure 5.2D). These results indicated that 
the expression of Ncoa3  - like Esrrb – is essential in ESCs for the maintenance of the 
pluripotent state, and that its depletion triggers an exit from self-renewal and the onset of 
differentiation.                         
 
Figure 5.2 Ncoa3 knockdown induces differentiation 
(A-B) Analysis of ESCs following shRNA-mediated knockdown of Ncoa3 and Esrrb. Cells were transfected 
with a panel of shRNA vectors, and 24 hours later 1.0µg/mL Puromycin added to select for successful 
transfectants. Puromycin was maintained for 4 days then cells fixed and stained for AP, an indicator of 
undifferentiated ESCs. Scale bars, 100µm. (C-D) Quantitative expression analysis of self-renewal genes and 
differentiation-associated genes following knockdown of Ncoa3 in ESCs. Expression for each gene is shown 
relative to shScrambled-transfected cells. Data are the mean +/- SD of at least two independent 
experiments. 
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5.2.2 Ncoa3 overexpression enhances LIF-independence 
Whilst many important ESC-associated factors are now known to be necessary for the 
undifferentiated state, only a subset of these when overexpressed are sufficient to sustain 
ESC self-renewal in conditions where differentiation is normally induced, as shown for 
Esrrb in the absene of LIF (Zhang et al. 2008) (Figure 3.7). Moreover, Esrrb 
overexpression was found to inhibit differentiation into meso- and neuro- ectodermal 
lineages in embryoid bodies (Ivanova et al. 2006). In other cell types where ERRs play 
important roles such as in oxidative metabolism, the expression level of their cognate 
coactivator is a key influence upon receptor activity. This is exemplified by the PGC-1 
family of coactivators whose expression level dictates the activation of select ERR target 
genes (Huss et al. 2002; Kamei et al. 2003). Thus, it was next asked whether stably 
overexpressing Ncoa3 might enhance the activity of Esrrb in ESCs and its ability to 
prevent differentiation and sustain self-renewal. For this, a series of stable ESC lines was 
generated, either overexpressing control empty vector (ESCControl) Esrrb alone (ESCEsrrb), 
Ncoa3 alone (ESCNcoa3), or both factors together (ESCEsrrb + Ncoa3), through two rounds of 
transfection and selection, as outlined in Figure 5.3A. When the self-renewal capacity of 
these cell lines was tested in the absence of LIF, the three overexpressing cell lines all 
showed a substantial increase in the number of mixed and undifferentiated colonies 
relative to ESCControl cells (Figure 5.3B-C). An increase in the number of partially or fully 
undifferentiated colonies was seen in ESCEsrrb + Ncoa3cells compared to ESCEsrrb, indicating 
that stable overexpression of Ncoa3 can indeed synergise with Esrrb and potentiate its 
ability to enhance self-renewal (Figure 5.3B). Remarkably, an approximate twofold 
increase in the number of mixed colonies was also apparent in cells expressing Ncoa3 
alone (ESCNcoa3) compared to control ESCs, with over 60-70% of colonies scoring as 
partially or fully undifferentiated, suggesting that overexpression of Ncoa3 alone could 
also enhance resistance to differentiation even in the absence of ectopic expression of 
Esrrb.  
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Figure 5.3 Ncoa3 and Esrrb sustain ESC self-renewal  
(A) Schematic indicating the method used to derive stable ESC cell lines overexpressing combinations of 
Esrrb and Ncoa3. First, ESCs were transfected with linearized CAG-Control or CAG-Esrrb vectors and 
transfectants selected with Puromycin. Pooled clones for each stable cell line were passaged 1-2 times then 
transfected with linearized control vector (pCDNA4/TO-GFP) or pCDNA4/TO-Ncoa3, and overexpressing 
cells selected using Zeocin. (B) ESC lines generated in (A) were plated at low density, and cultured for 5 days 
without LIF to assess their self-renewal ability, as performed in Figure 3.7. Colonies were fixed and stained 
for AP and scored as undifferentiated, mixed or differentiated. Each three bars represent three 
independent experiments. (C) Representative colony morphology for each cell line from (B). Scale bars, 
50µm. 
 
To explore further the interesting observation that Ncoa3 overexpression can partly 
enhance ESC self-renewal, Ncoa3 was cloned into the pPyCAGIP expression vector. 
Unlike selection cassettes driven by a second promoter as is commonly the case in 
mammalian expression vectors, the pPyCAGIP vector harbours an IRES-pac Puromycin 
resistance cassette directly downstream of the inserted cDNA to ensure enhanced and 
stable overexpression in ESCs. Utilizing this vector, an ESC line overexpressing Ncoa3 
was next generated alongside CAG-Nanog ESCs as a positive control, as constitutive 
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Nanog expression at high levels has been previously shown to confer resistance to 
differentiation (Chambers et al. 2003). To compare the properties of these cells, self-
renewal assays were repeated both in the presence and absence of LIF. CAG-Ncoa3 cells 
showed an increase in fully undifferentiated colonies compared to CAG-Control ESCs 
when plated at low density plus LIF, similar to CAG-Nanog (Figure 5.4A, left). More 
strikingly, the ESC CAG-Ncoa3 line displayed an increase in both undifferentiated and 
mixed colonies in the absence of LIF, with slightly lower efficiency than the CAG-Nanog 
line (Figure 5.4A, right). In contrast, colonies formed from CAG-Control cells minus 
LIF were over 80% differentiated. These findings thus support previous results from 
Figure 5.3 and demonstrate that Ncoa3-overexpressing ESCs exhibit an increased 
resistance to differentiation induced by LIF withdrawal. To explore this further, gene 
expression analysis was carried out on stable ESC lines in the presence of LIF via qRT-
PCR. This revealed elevated levels of several pluripotency factors in the ESC CAG-
Ncoa3 line, most notably the Esrrb targets Esrrb and Klf4, along with a small increase in 
Nanog (Figure 5.4B), a result that could additionally be confirmed for Esrrb and Nanog 
by western blot analysis of protein extracts taken from each line (Figure 5.4C). The 
increased expression of Esrrb and Klf4 in CAG-Ncoa3 ESCs corroborates the strong 
Esrrb and Ncoa3 enrichment found at these targets by ChIP assays (Figure 4.6). 
Interestingly, Klf4 was not highly upregulated in CAG-Nanog ESCs, highlighting two 
potentially distinct pathways of sustaining self-renewal by Esrrb/Ncoa3 and Nanog. 
Esrrb mRNA and protein levels, but not Ncoa3, were also increased in CAG-Nanog 
ESCs, suggesting Esrrb may be a novel downstream target of Nanog (Figure 5.4B-C). 
Finally, to test whether Ncoa3 could enhance the expression of Esrrb targets directly, the 
effect of its overexpression upon Esrrb, Klf4, Nanog and Sox2 Enhancer-Luc reporters 
was determined. Cotransfection of ESCs with these vectors and Ncoa3 plasmid modestly 
enhanced the activity of Esrrb, Nanog and Sox2-Luc, with a much stronger increase 
conferred upon Klf4-Luc (Figure 5.4D). Taken together these results indicated that Ncoa3 
overexpression is able to enhance self-renewal in normal ESC conditions as well as 
resistance to differentiation upon LIF withdrawal, associated with increased expression 
of the endogenous levels of key Esrrb targets such as Esrrb, Klf4 and Nanog.  
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Figure 5.4 Ncoa3 overexpression alone can partly confer LIF independence 
(A) Self-renewal assays of stable ESC lines overexpressing Ncoa3, Nanog, or control empty pPyCAGIP 
vector. Lines were generated via transfection with the indicated linearized pPyCAGIP construct and 
selection with Puromycin for 8-9 days. Clones we pooled, passaged 1-2 times and then plated at low density 
in ESC media with or without LIF as indicated. Colonies were allowed to grow for 5 days then cells fixed 
and stained for AP and quantified as undifferentiated, mixed or differentiated. Data are the mean +/- 
SEM of three independent experiments. (B) Analysis of the expression levels of a panel of pluripotency 
factors in stable ESCs. Each gene is normalised to the level in CAG-Control ESCs. Data are mean +/- SEM 
of three independent experiments. (C) Western blotting of the indicated proteins in stable ESC lines under 
normal ESC conditions. (D) Effect of Ncoa3 overexpression upon ESC enhancer-Luc vectors, measured 48 
hours after cotransfection of ESCs with the indicated reporter and 30ng pCDNA/4TO empty vector or 
Ncoa3.  
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Although it was found that Ncoa3 overexpression sustained LIF independence in self-
renewal assays similar to Nanog, it was not clear whether this would be sufficient to 
confer long-term resistance to differentiation. The overexpression of Esrrb itself has 
been shown to partially inhibit differentiation in EBs, preventing pluripotency factor 
downregulation and suppressing the emergence of neuroectodermal and mesodermal 
lineages, but allowing endodermal differentiation (Ivanova et al. 2006). To therefore 
investigate whether Ncoa3 overexpression similarly inhibits differentiation, Control or 
CAG-Ncoa3 ESCs were plated in suspension and allowed to form EBs, then samples 
taken at the indicated time points during EB formation to assess whether differentiation 
could successfully occur. Both cell lines upon inspection formed similar EBs in terms of 
shape and number. Moreover, gene expression analysis of CAG-Ncoa3 ESCs indicated 
that although elevated Ncoa3 levels were maintained during differentiation, the initially 
high expression of Esrrb was rapidly lost upon EB culture, as with control cells (Figure 
5.5A, top). These results suggested that Ncoa3 overexpression is not able to prevent Esrrb 
downregulation and subsequent differentiation in these assays. In support of this, 
analysis of two early lineage-specific markers known to be upregulated upon EB 
formation showed that induction of these genes was not inhibited in the ESC CAG-
Ncoa3 line (Figure 5.5A, bottom). In agreement, western blot analysis of CAG-Ncoa3 
ESCs cultured with or without LIF also showed that though clearly increased compared 
to CAG-Control ESCs, endogenous Esrrb, Nanog and Oct4 proteins were still 
downregulated in CAG-Ncoa3 upon LIF withdrawal (Figure 5.5B). Unexpectedly, this 
was also true for CAG-Nanog overexpressing cells, which in spite of maintained Nanog 
overexpression, showed a similar decrease in Esrrb protein levels, and an even greater 
loss in Oct4 protein compared to ESC CAG-Ncoa3 (Figure 5.5B). The ability of Nanog 
to upregulate targets such as Esrrb may therefore co-operatively rely on the LIF/Stat3 
signalling pathway. Overall, these results imply that, consistent with its role as a 
coactivator and not a transcription factor, Ncoa3 alone cannot maintain Esrrb expression 
in the absence of LIF. Thus, another signalling pathway that induces Esrrb 
downregulation is likely to be dominant in differentiation, eventually causing the loss of 
Esrrb protein and subsequent exit from self-renewal.   
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Figure 5.5 CAG-Ncoa3 ESCs cannot maintain resistance to differentiation 
(A) Expression analysis of Ncoa3 and Esrrb during embryoid-body (EB)-mediated differentiation, along 
with two early lineage markers (Fgf5 and Brachyury) as positive controls for EB differentiation. (B) 
Western blot analysis of the indicated proteins from ESCs cultured either in the presence or absence of LIF 
for 5 days, as performed in self-renewal assays in Figure 5.4. Tubulin is shown as a loading control.  
 
5.2.3 Ncoa3 is required for somatic cell reprogramming 
In groundbreaking work in 2006, Shinya Yamanaka and colleagues discovered that MEFs 
can be converted back into a pluripotent state by overexpressing just four ESC 
transcription factors, Oct4, Sox2, Klf4 and cMyc (OSKM), in a process termed 
reprogramming. Since then, several molecules have been identified that can replace one 
or more members of the OSKM cocktail, along with much investigation into which 
factors and signalling pathways are either required or able to enhance the reprogramming 
process. Intriguingly, Esrrb was one of the first transcription factors found able to 
replace an OSKM member, where it was shown to substitute for Klf4 and produce bone 
fide iPSCs that are germline competent (Feng et al. 2009). This was associated with the 
ability of Esrrb to co-bind many Klf4 target sites, to upregulate Klf4 expression, as well as 
its ability to rescue triple Klf2,4,5 knockdown (Feng et al. 2009). Given the discovery here 
that Ncoa3 plays an important role in the potentiation of Esrrb-dependent transcription 
and subsequent involvement in ESC self-renewal, indeed associated with Klf4 as a key 
target gene, it was therefore next explored whether this coactivator might also be 
important for reprogramming. 
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First, it was investigated whether levels of Ncoa3 are altered during the reprogramming 
process, which could be indicative of a potential role in iPSC generation. For this, 
published microarrays were initially taken advantage of containing data collected in 
MEFs, at several time points during reprogramming, as well as in partially and 
successfully-reprogrammed cell lines (Mikkelsen et al. 2008). As expected, endogenous 
Esrrb and Nanog were both highly upregulated in iPSCs along with other factors such as 
Oct4 and Klf4, supporting a role for these molecules in inducing as well as maintaining 
pluripotency (Figure 5.6A). Profiling of the Ncoa family revealed that similar to ESCs, 
only Ncoa3 was upregulated in reprogrammed cells, with levels of Ncoa1 and Ncoa2 
remaining at a low and/or constant level across time points and cell lines (Figure 5.6A). 
Following this, it was next examined whether Ncoa3, as an important mediator of Esrrb 
activity and the undifferentiated state, might also be involved in the generation of iPSCs. 
To study the reprogramming process, MEFs were used that contain a GFP transgene 
driven by the distal enhancer (DE) element of Oct4/Pou5f1. These cells are termed ΔPE-
Oct4GFP MEFs, as the transgene lacks the Oct4 proximal enhancer (PE) that is active in 
partially-reprogrammed cells and EpiSCs. Therefore, GFP expression is only initiated in 
ESCs, successfully reprogrammed iPSCs, and germ cells (Figure 5.6B) (Yeom et al. 1996). 
MEFs derived from such embryos are GFP-negative, with GFP expression only initiated 
in emergent iPSC colonies. Using the traditional OSKM cocktail, iPSCs were successfully 
generated and stable iPSC lines were picked and expanded, which express high levels of 
GFP (Figure 5.6C). Next, the levels of Ncoa3 in these iPSCs were examined. 
Immunofluorescence staining of iPSC colonies revealed high levels of ESC-associated 
proteins such as Esrrb and Nanog as expected, with a similarly high expression of Ncoa3 
(Figure 5.6D). To compare an increase in Ncoa3 protein relative to MEFs, western 
blotting was also performed on two independent iPSC clones, showing that like Esrrb, 
Nanog and Oct4, Ncoa3 is highly upregulated in successfully reprogrammed iPS cells 
(Figure 5.6E).  These results confirmed that Ncoa3 is indeed increased in iPSCs 
generated from somatic cells, mirroring the high expression seen in pluripotent ESCs. 
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Figure 5.6 Ncoa3 is highly upregulated in iPSCs 
(A) Microarray expression data adapted from (Mikkelsen et al. 2008) showing the upregulation of Ncoa3 
along with key pluripotency factors during somatic cell reprogramming. Data in each histogram shows the 
level of the endogenous factor in MEFs (red), in samples from three time points during reprogramming 
initiated by doxycycline-inducible OSKM reprogramming factors (blue), a partially-reprogrammed iPSC 
line (orange), two fully reprogrammed iPSC lines, and in ESCs as a positive control (all green). (B) Structure 
and organisation of the ΔPE-Oct4GFP transgene in Oct4GFP MEFs. (C) Low-magnification micrograph 
of Oct4GFP iPSC clone 1. Bars, 200µm. (D) Immunofluorescence staining for the indicated proteins or 
GFP in iPSC clone 1. Bars, 50µm. (E) Western blotting showing high levels of Ncoa3 protein along with 
Esrrb and other pluripotency factors in two independently generated iPSC clones. Protein levels are shown 
alongside samples from uninfected proliferative MEFs. 
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The striking upregulation of Ncoa3 in iPSCs compared to MEFs opened the question as 
to whether its increased expression might be necessary during the reprogramming 
process. To address this, the effect of knocking down Ncoa3 in MEFs prior to 
reprogramming was examined. In order to deplete Ncoa3 in MEFs successfully - which 
are known to be very difficult to transfect – lentiviruses harbouring Scrambled or Ncoa3-
targeting shRNA were therefore used. These viruses were produced using the pLKO.1-
based vectors previously used in earlier experiments on ESCs (Figure 5.1), which as well 
as being useful for transfection also contain viral elements that allow them to be 
packaged into lentiviral particles (Moffat et al. 2006). Infection of Oct4GFP MEFs with 
shNcoa3 lentiviruses efficiently reduced the expression of Ncoa3 and not Ncoa1 or Ncoa2, 
showing that specific lentiviral-mediated silencing of Ncoa3 was possible in these cells 
(Figure 5.7A). Next, the ability of Ncoa3-depleted MEFs to undergo reprogramming was 
investigated. For this, Oct4GFP MEFs were infected with shScrambled or shNcoa3-
containing lentiviruses and 3 d later cells then re-seeded and equal numbers of cells 
infected with the OSKM reprogramming cocktail (Figure 5.7B). Whilst shScrambled- and 
shNcoa3-infected MEFs were transduced with retroviral particles with equal efficiency 
(Figure 5.7C), a striking decrease in the reprogramming efficiency of Ncoa3 knockdown 
MEFs was apparent, as assessed by the number of GFP-positive colonies scored 12-14 
days after reprogramming (Figure 5.7D). In agreement, a great reduction in the number 
of AP-positive colonies was also apparent in Ncoa3-knockdown MEFs (Figure 5.7E). 
Together these results demonstrate that as well as an essential role in ESC self-renewal, 
Ncoa3 is required for the efficient generation of iPSCs.  
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Figure 5.7 Ncoa3 is essential for somatic cell reprogramming 
(A) Expression of the Ncoa family in Oct4GFP MEFs 3 days after infection with shNcoa3 #5 lentiviruses, 
normalised to two housekeeping genes. Note that the expression of Ncoa3 is still over 10-fold lower than its 
level in ESCs, as shown in Figure 4.2A. (B) Schematic illustrating the protocol used to analyse the 
requirement for Ncoa3 in somatic cell reprogramming. (C) Equal infection of shScrambled and shNcoa3-
knockdown Oct4GFP MEFs with retroviral mCherry 3 days after retroviral infection. Scale bars, 20µm. 
(D) Reduction in the efficiency of somatic cell reprogramming upon Ncoa3 knockdown in Oct4GFP MEFs, 
as assessed by the number of GFP-positive colonies on day 12-14 post-OSKM infection. The number of 
colonies generated from shScrambled MEFs is set at 1 for each experiment; shown is three experiments. 
(A&D) (*) Denotes P<0.05, (**) P<0.01, (***) P<0.001, Student’s t-test comparing shScrambled and 
shNcoa3-infected MEFs. (E) AP staining of iPSC colonies 14 days after OSKM infection. 
 
One significant barrier to reprogramming was recently identified as cellular senescence, 
with the activation of ARF-p53 signalling pathways strongly inhibiting the generation of 
iPSCs (Banito et al. 2009; Kawamura et al. 2009; Utikal et al. 2009). Similarly, MEF 
proliferation rate has been positively linked to reprogramming efficiency, with p53 
ablation enhancing cellular growth rate and subsequent generation of iPSCs (Hanna et al. 
2009b). It was therefore next investigated whether inhibition of reprogramming by Ncoa3 
depletion was simply because of increased senescence or apoptosis. To look at cell death, 
shScrambled or shNcoa3-infected Oct4GFP MEFs were stained for active caspase-3, a 
marker of apoptosis, three days after lentiviral transduction. However, no difference was 
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seen in the number of caspase-3-positive cells from shScrambled or shNcoa3-infected 
MEFs, with both groups showing over a seven-fold lower incidence of apoptosis than 
MEFs treated with the apoptosis-inducing drug, Staurosporine (Figure 5.8A). In addition, 
no decrease in proliferation was seen as assessed by BrdU incorporation three days after 
lentiviral infection (Figure 4.8B). Finally, to rule out if Ncoa3 depletion was inducing 
senescence and consequently inhibiting iPSC generation, RNAi-reprogramming 
experiments were repeated in p53 null MEFs. These MEFs, as previously reported, may 
be propagated for extensive periods of time in culture without undergoing replicative 
senescence and are reprogrammed with enhanced efficiency even in the absence of cMyc 
(OSK) (Marion et al. 2009). Reprogramming experiments performed on shScrambled 
p53-/- MEFs with the OSK reprogramming cocktail produced high numbers of AP-
positive colonies as expected. In contrast, reprogramming of shNcoa3-infected MEFs 
was again severely inhibited (Figure 5.8C). Taken together, these results demonstrate a 
requirement for Ncoa3 in the induction of pluripotency in reprogramming, even in 
MEFs immune to p53-mediated senescence. 
 
Figure 5.8 Ncoa3 requirement is independent of p53-mediated senescence 
(A) Quantification of MEF apoptosis three days after lentiviral infections, expressed as the number of 
caspase-3 positive cells per 500 cells counted. MEFs treated for 16 hours with 10-100nM Staurosporine 
were included as a positive control. (B) Percentage of BrdU-positive nuclei from shScrambled or shNcoa3 
MEFs assessed three days after lentiviral infection. (A-B) Data are the mean +/- SEM of three infections (C) 
AP staining of p53-/- MEFs 14 days after infection with OSK retroviruses. 
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5.2.4 Overexpression of Ncoa3 does not enhance reprogramming 
Remarkably, Esrrb was recently discovered to be able to reprogram MEFs in place of 
Klf4, both in combination with cMyc (OSEM) as well as with Oct4 and Sox2 alone 
(OSE) (Feng et al. 2009). Although producing chimeras that show germline transmission 
when injected into blastocysts, the “gold standard” of iPSC quality, use of Esrrb in 
reprogramming was however found to be two to three-fold less efficient than Klf4, 
suggesting that there could be a limiting factor in the generation of iPSCs by Esrrb. 
Indeed, enhancing the activity of OSKM themselves by fusing each factor to the 
transcriptional activator, VP16, has been shown enhance reprogramming significantly 
(Wang et al. 2011b).  As Ncoa3 is critical for Esrrb function in ESCs, and itself is 
required for the reprogramming process, it was next therefore investigated whether 
overexpression of Ncoa3 could enhance reprogramming via Esrrb.  
 
To determine the impact of Ncoa3 overexpression in reprogramming, it was first verified 
that Esrrb was able to reprogram Oct4GFP MEFs. Initial experiments using OSEM to 
produce GFP-positive colonies were however unsuccessful, which was not due to a 
general low efficiency of reprogramming as OSKM-mediated reprogramming performed 
simultaneously yielded many GFP and AP-positive iPSCs as expected (Figure 5.9A). The 
reason for a lack of success with OSEM-mediated reprogramming was not clear, though 
one obstacle was suggested to be a lower titre of the Esrrb retrovirus (Feng Bo, personal 
communication). Thus, the transfection of packaging cells used to produce all 
reprogramming factors was next optimized, using Lipofectamine 2000 instead of PEI, as 
normally performed by Feng Bo and colleagues (Feng et al. 2009). Under these 
conditions, whilst no overt difference in reprogramming efficiency was apparent using 
OSKM, it was possible on two occasions to obtain approximately 1-70 GFP-positive 
iPSCs by OSEM (Figure 5.9B). However, this result was highly variable and many times 
no colonies were obtained at all, highlighting that reprogramming utilizing Esrrb 
retrovirus was still sub-optimal, even when two to three-fold more pMXs-Esrrb virus 
was used (data not shown). Furthermore, the low frequency of iPSC colonies did not 
seem to be due to a limiting level of Ncoa3 during reprogramming, as MEFs infected 
with OSEM along with retroviruses expressing Ncoa3 showed no rescue in the low 
efficiency of reprogramming (Figure 5.9B). This did not appear to be due to an inability 
to overexpress Ncoa3, as MEFs infected with the pMXs-Ncoa3 vector generated for this 
study expressed high levels of Ncoa3 protein (Figure 5.9C). Additionally, no reproducible 
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enhancement was seen when Oct4GFP MEFs were co-infected with OSKM and Ncoa3 
retroviruses (Figure 5.9D). Overall therefore, while results suggest that Ncoa3 does not 
enhance reprogramming by OSKM, the low frequency of success utilizing OSEM 
precludes a reliable analysis of the potential enhancing effect of Ncoa3 upon Esrrb-
mediated reprogramming. Further optimization of OSEM reprogramming to improve 
efficiency will therefore be required in future. Then, experiments could be repeated with 
or without Ncoa3 virus, to determine its role in enhancing this process. 
 
Figure 5.9 Ncoa3 does not enhance the efficiency of reprogramming 
(A) Typical AP staining in initial experiments to compare the efficiency of reprogramming using OSKM 
or OSEM (substituting Esrrb for Klf4) retroviral cocktail in Oct4GFP MEFs. (B) Two independent 
experiments (of six in total) to analyse the effect upon reprogramming efficiency of overexpressing Ncoa3 
along with OSEM reprogramming cocktails in Oct4GFP MEFs. GFP-positive colonies were counted 14 
days after retroviral infection. (C) Validation of Ncoa3 overexpression in MEFs transduced with retroviral 
pMXs-Ncoa3, harvested three days after infection. Tubulin is shown as a loading control. (D) Experiments 
performed simultaneously with (B), assessing the effect of Ncoa3 overexpression upon OSKM-mediated 
reprogramming. 
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5.3 Summary and Conclusions 
The importance of Esrrb in maintaining undifferentiated ESCs and its ability to sustain 
self-renewal has been previously well documented. Here, a detailed analysis of the Esrrb 
coactivator Ncoa3 and its roles in ESC and iPSC pluripotency was carried out. Firstly, 
RNAi experiments to assess the requirement for Ncoa3 in ESCs were performed, which 
revealed that shRNA-mediated depletion of Ncoa3 mirrors the effect of knocking down 
Esrrb itself, with ESCs losing the typical morphology and AP-staining characteristic of 
the self-renewing, undifferentiated state. Furthermore, important Esrrb-targets such as 
Klf4, Nanog and Sox2 were downregulated upon Ncoa3 knockdown, whilst Oct4 at this 
time remained unchanged, highlighting the similarity between Ncoa3 and Esrrb gene 
regulation, as would be expected. Expression profiling of early lineage-specific markers 
also showed an upregulation of these genes following Ncoa3 knockdown, confirming 
that these cells are indeed entering differentiation. Next, as a coactivator for Esrrb, the 
ability of Ncoa3 to enhance Esrrb activity was explored. It was found that 
overexpression of Ncoa3, either with or without exogenous Esrrb, sustained ESC self-
renewal in the absence of LIF and conferred short-term resistance to differentiation, an 
effect notably associated with the increased expression of endogenous levels of Klf4 and 
Esrrb itself. Interestingly, ESCs overexpressing Ncoa3 eventually lost their ability to 
sustain self-renewal in the absence of LIF, likely due to the downregulation of Esrrb in 
these cells, which would thus be epistatic to the activity of its coactivator, Ncoa3. It 
would be interesting to determine the exact nature of the early events responsible for the 
rapid downregulation of Esrrb upon differentiation, an effect that is delayed but not fully 
inhibited by Ncoa3 overexpression.  
 
Next, the requirement for Ncoa3 in a recent technique of inducing pluripotency – 
somatic cell reprogramming – was investigated. An increasing number of factors that are 
not part of the minimal reprogramming cocktail have nevertheless been found to be 
essential for the establishment of ESC-like transcriptional networks that is required for 
iPSC generation. One such example is Nanog, whose absence precludes the successful 
derivation of fully reprogrammed iPSCs from neural stem (NS) cells (Silva et al. 2009). It 
was found here that Ncoa3 was highly expressed in iPSCs and furthermore via RNAi 
experiments was shown to be crucial for reprogramming. This requirement was 
independent of cellular senescence, as even the reprogramming efficiency of P53 null 
MEFs – which show enhanced speed and efficiency of reprogramming – was greatly 
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reduced upon Ncoa3 knockdown. Thus Ncoa3 is required not only to maintain 
pluripotent ESCs in culture, but also for the process via which pluripotency is gained by 
somatic cells in reprogramming. Finally, the potential for Ncoa3 to enhance the 
reprogramming process by Esrrb in combination with Oct4, Sox2 and cMyc was tested. 
However, although substituting Esrrb for Klf4 was only originally reported to confer a 
two-fold reduction in reprogramming efficiency (Feng et al. 2009), experiments 
performed here showed OSEM-mediated reprogramming is highly inefficient and often 
unsuccessful entirely. Thus, any effect of Ncoa3 overexpression would likely be masked 
by whichever unknown variable is limiting reprogramming. Future efforts to elucidate 
this barrier to reprogramming are thus critical before a proper understanding of the 
effect of Ncoa3 overexpression can be obtained. Overall, these results highlight the 
importance of Ncoa3 in the biology of ESCs and iPSCs, which furthermore represents 
the first detailed characterisation of a nuclear receptor coactivator in pluripotent stem 
cells.  
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6 Genome-wide Assessment of the Esrrb-Ncoa3      
Partnership 
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Over and over and over and over and over  
Like a monkey with a miniature cymbal  
The joy of repetition really is in you  
 
Hot Chip, Over and over 
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6.1 Introduction 
Through a series of functional experiments described in previous chapters, the 
coactivator Ncoa3 has been shown to be an essential molecule in ESCs and in 
reprogramming. Linked to the requirement for the Esrrb-Ncoa3 partnership in ESC self-
renewal, it was demonstrated that both these proteins are needed for Esrrb-dependent 
activation of four candidate genes, Esrrb, Klf4, Nanog and Sox2. In recent years, genome-
wide analysis of Esrrb binding sites has revealed that the targets of this nuclear receptor 
are not just limited to a few select genes, but that Esrrb in fact colocalizes extensively 
with many other members of the ESC transcription factor network at a large number of 
sites (Chen et al. 2008). In order to understand better the function of Ncoa3 in ESCs, it 
was therefore next investigated whether Ncoa3 association with Esrrb occurs at other 
pluripotency targets aside from the candidates tested, and whether Ncoa3 is necessary for 
their expression. To gain understanding of the role of the Esrrb-Ncoa3 partnership 
therefore, the powerful technique of ChIP-sequencing (ChIP-seq) was here taken 
advantage of. This was used to map all Ncoa3 DNA binding sites in ESCs and compare 
Ncoa3 enrichment with Esrrb itself as well as with other members of the pluripotency 
factor network. This allowed the analysis of different types of multi transcription factor-
binding loci (MTL) according to the combinations of other transcription factors present 
at Ncoa3-bound peaks. Following this, the importance of Ncoa3 and Esrrb for the 
expression of target genes in the vicinity of Esrrb-Ncoa3 peaks was investigated by 
microarray and qRT-PCR analysis.  
 
Secondly, a mechanistic analysis of the role of Ncoa3 in Esrrb-dependent gene 
expression was undertaken, whose function at ESC enhancers is still unknown. 
Interestingly, a recent mass spectrometry investigation in ESCs found that Esrrb was 
uniquely associated with RNApol2, Mediator and TFIID complexes (van den Berg et al. 
2010), overall suggesting a close partnership with the basal transcription machinery. 
These observations were not investigated further, raising the question of how Esrrb is 
associated with RNApol2 complexes in ESCs and the functional significance of such an 
interaction. As further mechanistic insight into the requirement for Esrrb and Ncoa3 in 
the pluripotent state, experiments were therefore performed here to investigate a 
potential interaction between endogenous Esrrb and RNApol2 in ESCs, and to 
determine if Ncoa3 could be a key limiting factor mediating the association between 
these proteins. 
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6.2 Results 
6.2.1 Ncoa3 ChIP-sequencing reveals genome-wide overlap with Esrrb 
ChIP-sequencing (ChIP-seq) has become a valuable tool to examine in an unbiased 
manner the genome-wide localisation of proteins or chromatin modifications. Moreover, 
it lead to the discovery of the ESC ‘enhancesome’, sites shown to contain up to nine 
transcription factors (TFs) simultaneously bound at one enhancer fragment (Chen et al. 
2008). Loci containing Oct4-Sox2-Nanog (OSN) along with several other TFs were 
strongly associated with p300 recruitment and active transcription, whilst classes of MTL 
with fewer factors, or containing Polycomb member Suz12, showed lower expression 
(Chen et al. 2008). To gain a better idea of the genome-wide role of Ncoa3, its sites were 
next mapped in ESCs via ChIP-seq, and compared to Esrrb as well as OSN peaks. This 
revealed similar binding profiles at the candidate enhancer loci tested previously, Esrrb, 
Klf4, Nanog and Sox2, thus confirming the quality of the ChIP-seq data and corroborating 
previous ChIP results for these genes (Figure 6.1). 
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Figure 6.1 Genome browser shots of Ncoa3 ChIP-sequencing 
(A) Genome browser shots showing peaks of Ncoa3 binding along with the indicated factors to select 
genomic loci. Pink triangles indicate the location of DNA fragments used in the relevant Enhancer-Luc 
reporters in Chapters three and four. ChIP-sequencing and all subsequent ChIP-seq analysis in this chapter 
was performed at the GIS in collaboration with Jia-Hui Ng and Vibhor Kumar. 
 
Focusing first on ESC-related genes and Esrrb-Ncoa3 recruitment, the overlap in peaks 
generated by these factors was next assessed. As performed previously to compare Esrrb 
and Klf4 overlap (Feng et al. 2009), pluripotency-relevant loci were first selected based 
on the additional presence of Oct4-Sox2, then the colocalization of Ncoa3 and Esrrb 
calculated at these sites. Comparing Esrrb and Ncoa3 peaks within 200bp revealed a 
highly significant overlap between these factors (P-value=1.11e-16). In contrast, a control 
factor, CTCF, did not show any significant colocalization with Esrrb-Oct4-Sox2 (P-
value=0.84) (Figure 6.2A). A MEME de novo motif discovery algorithm (Heng et al. 2010) 
was next utilized to identify significantly overrepresented sequences associated with the 
top 500 Ncoa3 peaks. This revealed a canonical ERRE motif enriched at Ncoa3-bound 
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sites, further highlighting its recruitment to targets in an Esrrb-dependent manner 
(Figure 6.2B).  An Oct-Sox motif was additionally identified, reflecting the frequent 
colocalization of Esrrb-Ncoa3 with Oct4 and Sox2 alongside other pluripotency factors 
at MTL (Figure 6.2B).  
 
Next, the types of targets associated with all Ncoa3-Esrrb peaks were examined, to 
investigate the general role of these factors in ESCs. For this, GREAT Gene Ontology 
(GO) analysis was performed, a tool commonly used to identify groups of genes 
involved in similar pathways, processes and phenotypes. GO analysis of Esrrb-Ncoa3 co-
bound sites showed significant enrichment of phenotypes relating to embryonic 
development, consistent with a key role for these factors in regulating targets important 
for the ESC state (Figure 6.2C). Additionally, fertility-related genes were also significantly 
bound by Esrrb-Ncoa3, agreeing with published knock out studies of Esrrb and Ncoa3 
that have described germ cell or fertility defects in these animals (Xu et al. 2000; 
Mitsunaga et al. 2004; Chen et al. 2010). A third set of GO phenotypes was related to 
organogenesis (Figure 6.2C). Although no morphological defects have been reported for 
Esrrb null mice, which can be successfully generated after aggregation with Wt embryos 
(Mitsunaga et al. 2004), Ncoa3 deletion has indeed been previously reported to affect 
growth and organ size (Xu et al. 2000). This suggested that a set of targets might relate to 
functions of Ncoa3 in later development. 
Chapter Six                                                                                                     Results 
 149 
 
Figure 6.2 Genome-wide analysis of Ncoa3 and Esrrb targets 
(A) Analysis of the overlap of Ncoa3 and Esrrb peaks within 200bp at Oct4-Sox2 co-bound sites. The 
intersection with the factor CTCF is shown in comparison. (B) Top two significantly-enriched DNA motifs 
as identified by MEME de novo discovery analysis. Motifs were generated from the top 500 Ncoa3-bound 
peaks. MEME provides an E-value of the found motif, which is a product of P-values. (C) GREAT 
(Genomic Regions Enrichment of Annotations Tool) gene ontology (GO) analysis of phenotypes associated 
with Esrrb-Ncoa3 co-bound sites.  
6.2.2 Ncoa3 is a key component of ESC enhancesomes 
The ChIP-seq results so far highlighted a strong degree of similarity between Esrrb and 
Ncoa3 binding profiles in ESCs, and furthermore confirmed that many of these targets 
are relevant to early development. Interestingly, browser screenshots in Figure 6.1 also 
illustrated the fact that multiple peaks for any one factor are present in the vicinity of a 
particular target gene, often in combination with different TFs. For example at Sox2, a 
second group of peaks could be seen immediately distal to the 3’ end of this gene 
displaying strong enrichment for Ncoa3 together with OSN, but with little or no Esrrb 
(Figure 6.1). Assuming that these do not represent false peaks, this observation raised 
two things: firstly, the question of whether all peaks bound by Ncoa3 contain enhancer 
activity and are thus functionally relevant, and secondly whether Ncoa3 might associate 
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with other transcription factors independently from Esrrb. Therefore to compare Ncoa3 
colocalization with many ESC-associated factors simultaneously, as well as with marks 
that delineate enhancers, spatial heatmap analysis was carried out. This technique allows 
visualisation of the degree of overlap of a particular molecule across all ChIP-seq peaks 
with any other desired factor. Here, all Ncoa3-bound sites were plotted as a 2D matrix 
with each Ncoa3 peak plotted on the y-axis and the centre of each window (dark 
shading) corresponding to the maximum intensity of each peak (Figure 6.3). ChIP-seq 
peaks previously generated for Esrrb, Nanog, Oct4, Sox2 (Chen et al. 2008), Nr5a2 
(Heng et al. 2010), as well as the cofactor p300 and two histone modifications, 
H3K4me1 and H3K27ac (Chen et al. 2008; Creyghton et al. 2010) were then aligned with 
these Ncoa3-bound sites (Figure 6.3). This analysis potentiated the clustering of Ncoa3 
peaks into different classes, based on the combination of other factors also present 
(Classes I-III).  
 
From the spatial heatmap generated, it could firstly be seen that approximately 40% of all 
Ncoa3 peaks contained Esrrb (Class I), which could be further split into two subclasses 
based on the absence (Class Ia) or presence (Class Ib) of strong co-binding of other core 
pluripotency factors such as Oct4, Sox2 and Nanog (Figure 6.3). Strikingly, all class I 
sites contained strong enrichment for marks of active enhancers, which have previously 
been identified based on the presence of both H3K4me1 and H3K27ac (Figure 6.3) 
(Creyghton et al. 2010). Supporting this, p300 was also recruited to these Class I sites, 
suggesting a strong link between Ncoa3 and gene activation (Figure 6.3). Together, these 
data implied a close association between the presence of Ncoa3 and transcriptionally 
active ESC enhancers, as well as confirming that many Ncoa3-Esrrb peaks are part of 
large MTL containing other key pluripotency factors.   
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Figure 6.3 Spatial heatmap analysis of Ncoa3-bound peaks 
 Spatial heatmap showing the binding of Ncoa3 along with the indicated factors and two marks of 
enhancers, H3K27ac and H3K4me1 (Creyghton et al. 2010). All peaks are centred on the site of maximum 
Ncoa3 binding, with a window of 2Kb either side, using the K-means clustering function in Matlab. Sites 
were grouped into five distinct classes based on the combination of factors also present at Ncoa3 peaks; 
indicated on the right are example genes found within the vicinity of Ncoa3 peaks from each class.  
 
In addition to illustrating the recruitment of Ncoa3 to active enhancers, spatial heatmap 
analysis also allowed the detailed dissection of targets and gene ontologies associated 
with each separate class of Ncoa3 peaks. GO analysis of Class Ib identified, as expected, 
many key self-renewal genes such as Esrrb, Klf2/4/5, Pou5f1, Zfp42 and Sox2 (Figure 6.3) 
that were accordingly associated with processes such as blastocyst development and 
morphogenesis (Table A-I, Appendix). Importantly, the identification of targets such as 
Esrrb and Klf4 also corroborated previous chIP-qPCR data (Figure 4.6B). Interestingly, 
Class Ia –  Ncoa3-Esrrb peaks associated with reduced binding of OSN (most notably 
Oct4) – were uniquely associated with GO processes involving germ cell development, 
including targets such as Prdm14, an important molecule for PGC specification as well as 
EpiSC reprogramming (Figure 6.3A and Table A-II, Appendix) (Gillich et al. 2012). This 
select group of enhancers may therefore be important for driving expression of germ 
cell-related genes. Ncoa3 itself was additionally identified in Class Ia, suggesting that 
Esrrb-Ncoa3 may participate in an autoregulatory loop to enhance Ncoa3 expression.  
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Next, attention was turned to other classes of Ncoa3-bound sites as identified by spatial 
heatmap analysis. Notably, two classes of Ncoa3 peaks were not associated with Esrrb 
binding. The smaller of these two sets of peaks, Class II, was surprisingly associated with 
weak or absent Esrrb binding, yet still retained high enrichment for OSN, together with 
lower enrichment for H3K27ac and p300. Interestingly, another nuclear receptor 
important in ESCs, Nr5a2, was also detected at these sites (Figure 6.3) (Gu et al. 2005; 
Wagner et al. 2010). Given that no evidence was previously found to support a direct 
interaction between Ncoa3 and Oct4/Nanog (Figure 4.5), this data suggested that 
another factor could be recruiting Ncoa3 to a subset of genes. One candidate could 
therefore be Nr5a2, for example via interactions mediated by its own AF-2 region (Lee 
and Moore 2002). GO analysis showed that genes within the vicinity of these peaks were 
not ESC-related however, being instead largely associated with extra-embryonic 
development (Table A-III, Appendix). Agreeing with the reduced p300 and H3K27ac 
enrichment compared to Class Ib, these sites may therefore contain weaker enhancer 
activity and be functionally less relevant in ESCs. Finally, approximately 50% of Ncoa3-
bound peaks were not co-bound by Esrrb or any other pluripotency TF analysed, termed 
Class III (Figure 6.3 & Table A-IV & A-V, Appendix). However, these sites were not 
marked by p300 and H3K27ac, suggesting that they are not within active enhancers. In 
contrast, a small subset (Class IIIb) was enriched for H3K4me1 alone, potentially 
marking inactive or poised enhancers (Figure 6.3) (Creyghton et al. 2010). Many GO 
processes associated with both Class IIIa and IIIb were related to metabolism or 
biosynthetic pathways (Table A-IV & A-V, Appendix). Interestingly, a few terms for 
blastocyst development also appeared within Class IIIa; however, this was most 
frequently associated with Ncoa3 binding to the target Smarca5/SMARCA5, a gene that 
also appears in Class Ib and Class II (Figure 6.3). Thus, other peaks containing 
enrichment for Esrrb and/or OSN are also present in the vicinity of this Ncoa3 target, 
and could signify that Smarca5 is indeed not regulated by Ncoa3 alone, though this 
remains to be formally demonstrated. Overall, data for Class III genes implied that aside 
from its participation at actively transcribed, pluripotency relevant enhancers, Ncoa3 
might be additionally recruited by one or more unidentified TFs to inactive/poised 
regions in ESCs.  
6.2.3 Esrrb and Ncoa3 target genes are co-regulated in ESCs 
An important way of determining if the peaks identified by ChIP-seq are functionally 
relevant is to combine the data with transcriptome analysis and thus identify which genes 
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in the vicinity of peaks generated by a particular factor are significantly altered upon its 
knockdown. To gain a better understanding of the consequences of Ncoa3 recruitment 
to Esrrb target genes, microarray analysis was therefore performed on ESCs following 
shRNA-mediated Ncoa3 depletion. Comparison with Esrrb knockdown data taken from 
the same time point (Feng et al. 2009) revealed a significant correlation in gene regulation 
between these two factors, with approximately 40% of Esrrb-regulated targets also 
misregulated upon Ncoa3 knockdown (Figure 6.4A). To look specifically at targets bound 
by both Esrrb and Ncoa3, Class I genes were taken and their change in gene expression 
following either Esrrb or Ncoa3 knockdown plotted as a heatmap according to their 
change upon Esrrb depletion (Figure 6.4B). This demonstrated that most Esrrb-Ncoa3 
co-bound genes are regulated by both factors in the same direction (Figure 6.4B). 
Furthermore, the majority of these targets were downregulated upon Esrrb/Ncoa3 
knockdown. Overall these results pointed towards a high degree of similarity between 
Esrrb and Ncoa3 transcriptional circuitries and confirmed that the expression of both 
these factors is required for the full transcriptional activation of many Esrrb targets 
(Figure 6.4B). In further validation of these data, qRT-PCR was used to profile candidate 
Esrrb-Ncoa3 target genes from both Class Ia and Class Ib. Genes identified from these 
classes as being Esrrb-dependent based on significant downregulation upon Esrrb 
knockdown (P<0.05, Feng et al. 2009) were therefore profiled upon Ncoa3 knockdown, 
using the same RNA samples as prepared for microarray analysis. The majority of genes 
from both Class Ia (Figure 6.4C) and Class Ib (Figure 6.4D) were significantly 
downregulated upon Ncoa3 knockdown. This importantly confirmed that genes bound 
by Esrrb-Ncoa3 even at sites without high OSN enrichment are downregulated (Figure 
6.4C) highlighting the specific requirement for Ncoa3 in Esrrb-dependent gene 
activation. 
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Figure 6.4 Esrrb and Ncoa3 co-regulate Class I genes 
(A) Venn diagram indicating the degree of overlap of genes misregulated upon Esrrb or Ncoa3 knockdown 
as assessed via microarray analysis of ESC samples harvested 4 days after transfection with shScrambled or 
shNcoa3 #5 (3 days after addition of Puromycin). Significantly altered genes upon Ncoa3 knockdown 
(fold-change >1.5) were compared with genes at the same time-point after Esrrb knockdown, taken from 
(Feng et al. 2009). The Fisher’s exact test was used to measure the significance of the correlation of fold-
change. (B) Microarray heatmap showing the change in expression of Class I Ncoa3-bound ChIP-seq 
targets. First all the genes within 100Kb of the Class I region were taken and their fold-change upon Esrrb 
knockdown (left) or Ncoa3 knockdown (right) plotted according to the fold-change upon Esrrb 
knockdown. Note that most genes are downregulated. Green and red represent downregulation and 
upregulation, respectively. (A-B) Analysis performed in collaboration with Jia-Chi Yeo and Vibhor Kumar. 
(C-D) Validation of DNA microarray. qRT-PCR analysis was performed on the indicated genes from (C) 
Class Ia or (D) Class Ib following Ncoa3 knockdown. Candidates were selected from Ncoa3 GO analysis 
which were also significantly downregulated upon Esrrb knockdown in (Feng et al. 2009). Expression data 
is normalized to two housekeeping genes and shown as mean +/- SEM of three biological replicates. * P-
values <0.05, ** P-values <0.01, Student’s t-test. 
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Finally, further insight into Class III genes was also gained from microarray analysis upon 
Ncoa3 knockdown. To see if Ncoa3 binding to Class III genes was relevant for gene 
expression, targets within 100Kb of Ncoa3 peaks were assessed for significant expression 
change upon Ncoa3 depletion. Interestingly, this revealed that out of the small proportion 
of genes directly regulated by Ncoa3, the majority of them were upregulated upon Ncoa3 
knockdown (Figure 6.5). This was true for genes both with (IIIb) and without (IIIa) 
H3K4me1. Thus, on a select group of targets, Ncoa3 recruitment may surprisingly be 
associated with the repression of gene expression. Analysis of the occupancy of the 
Polycomb members Suz12 and Ezh2 showed no recruitment to Class III sites (Figure 
6.5), indicating that repression is not PRC2-mediated, and must be through other means. 
Further investigation into the mechanism of Ncoa3-mediated repression will be an 
interesting avenue to pursue in future, in order to understand the role of Ncoa3 in gene 
transcription under these distinct contexts. 
 
Figure 6.5 Analysis of Class III Ncoa3-bound loci 
(A) Spatial heatmap for Ncoa3 and the indicated marks and factors at Class III sites, revealing two 
subclusters based on the presence or absence of H3K4me1. Also included are the binding profiles for two 
Polycomb members, Suz12 and Ezh2. Genes within 100Kb of each site were analysed for significant fold-
change upon Ncoa3 knockdown, as assessed by microarray. The proportions of genes that are significantly 
downregulated or upregulated for each subcluster are displayed in a pie chart. Performed in collaboration 
with Jia-Chi Yeo and Vibhor Kumar.  
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6.2.4 Ncoa3 bridges Esrrb to the general transcription machinery 
Previous results have so far demonstrated that Esrrb-Ncoa3 are associated together at 
ESC enhancers. Furthermore, many genes in the vicinity of these sites are positively 
regulated by these two factors, as evidenced by their decreased expression upon Esrrb 
(Feng et al. 2009) or Ncoa3 (Figure 6.4) knockdown. Thus Esrrb and Ncoa3, along with 
core factors such as OSN, form an integral part of the ESC transcriptional network. 
However, what is the function of these individual factors in regulating transcription? 
Limited insight has been provided into the role of some molecules when recruited to 
target genes; for example Oct4 and Sox2 are associated with essential chromatin 
remodelling complex, esBAF (Ho et al. 2011), whilst Oct4 also interacts with and recruits 
Wdr5, an effector of the H3K4me modification (Ang et al. 2011). Both these 
associations would facilitate an ‘open’ chromatin state characteristic of ESCs/iPSCs, thus 
potentiating high levels of gene activation. In contrast to OSN, the role of Esrrb at ESC 
enhancers is unknown. Intriguingly, a recent proteomics analysis of Esrrb-associated 
proteins revealed that several components of the basal transcription machinery are 
associated with this nuclear receptor, as well as identifying an association with Ncoa3, in 
agreement with the work presented here (van den Berg et al. 2010). Thus, one role of 
Esrrb could be to interact with RNApol2, potentially assisting its recruitment or 
stabilization in transcription. Given the importance of Ncoa3 in Esrrb function, and 
reports that in human cells Ncoa3 is required to link ERα to the general transcription 
machinery (Shao et al. 2004; Wu et al. 2007) it was therefore investigated whether AF-2-
mediated Ncoa3 recruitment is required for Esrrb to interact with RNApol2 in ESCs.  
 
In order to test this hypothesis, a series of Co-IP experiments was therefore performed. 
It was first demonstrated that endogenous Esrrb is associated with RNApol2, via 
immunoprecipitating Esrrb in ESCs and probing for RNApol2 complexes, using 
antibodies recognizing total RNApol2. Two bands were indeed detected, both 
corresponding to RNApol2 (Figure 6.5A, top left). Next, to examine the LBD/AF-2 
dependency of this interaction, Co-IPs experiments were carried out on ESCs upon 
treatment for 24 hours with the AF-2 antagonist, DES. Functional AF-2 inhibition 
reduced the interaction between Esrrb and Ncoa3 (Figure 6.6A, top right), agreeing with 
previous results (Figure 4.4B). Strikingly, AF-2 inhibition also caused a reduction in the 
association between Esrrb and RNApol2 (Figure 6.6A, top left). Importantly, this was 
not due to a reduction in Esrrb immunoprecipitation, or a generalized disassembly of 
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Esrrb complexes, as both the Esrrb IP efficiency and Esrrb-Oct4 interaction remained 
unchanged following DES treatment (Figure 6.6A, bottom). These results suggested that 
AF-2-dependent Ncoa3 recruitment might be required for Esrrb to associate with the 
general transcription machinery. To support this, ESC extracts were next 
immunoprecipitated with anti-Ncoa3 antibodies and blotted for RNApol2, showing that 
these two proteins interact (Figure 6.6B). Finally, to determine whether Ncoa3 is required 
for Esrrb interactions with RNApol2, Co-IPs were performed with ESC extracts 
depleted of Ncoa3 protein by siRNA oligos (Figure 6.6C). Mirroring the effects of AF-2 
inhibition, Ncoa3 knockdown reduced the interaction between Esrrb and RNApol2 
(Figure 6.6D), while in contrast neither the Esrrb IP efficiency (Figure 6.6E) nor its 
interaction with Oct4 (Figure 6.6F) was altered. Taken together, these results imply a key 
role of Ncoa3 in mediating Esrrb-RNAPol2 associations in ESCs, bridging this receptor 
to the general transcription machinery. 
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Figure 6.6 Ncoa3 bridges Esrrb to the general transcription machinery 
(A) Co-IPs performed with extracts from ESCs treated with Ethanol or DES for 24 hours, then 
immunoprecipitated with anti-Esrrb antibodies and probed for RNApol2 (top left), Ncoa3 (top right), 
Esrrb (IP efficiency; bottom left) or Oct4 (bottom right), (A) in collaboration with Fabrice Lavial. (B) Co-
IP in ESCs immunoprecipitated with anti-Ncoa3 antibodies and immunoblotted for RNApol2. Although 
both RNApol2 bands were detected in Ncoa3-immunoprecipitated samples, the upper band was more 
weakly enriched, shown are two representative experiments (1. & 2.). (C) Western blot indicating depletion 
of Ncoa3 protein in ESC extracts used in Co-IP experiments in (D-F), harvested 48 hours after transfection 
with siControl or siNcoa3 oligos. (D-F) ESCs transfected with siControl or siNcoa3 as in (C) were 
immunoprecipitated with anti-Esrrb antibodies and immunoblotted for (D) RNApol2, (E) anti-Esrrb or 
(F) anti-Oct4. Blots shown are representative of at least two independent experiments. 
 
6.3 Summary and Conclusions 
In this final chapter, two powerful genomics approaches, ChIP-seq and microarray 
analysis, were utilized to determine the global functions of Ncoa3 in ESCs. These results 
together demonstrated that Ncoa3 is required for Esrrb activity not only on candidates 
such as Esrrb, Klf4, Nanog and Sox2, but also on many other genes regulated by Esrrb. 
Comparison of the ChIP-seq binding profiles for Esrrb and Ncoa3 demonstrate a 
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significant overlap in the peaks generated by these two factors, highlighting the 
generalized recruitment of Ncoa3 to Esrrb target sites. Many Esrrb-Ncoa3 targets are 
furthermore known for their roles in maintaining the ESC state, such as Pou5f1, Tbx3, 
Klf2 and Klf5, in agreement with the loss of self-renewal caused by Esrrb or Ncoa3 
depletion. It is notable, however, that it is possible to obtain Esrrb and Ncoa3 null mice, 
though this could be attributable to compensation by other isoforms (e.g. Ncoa1, Ncoa2, 
Esrra or Esrrg) or by interrelated paths and feedback loops that act to control gene 
expression. Despite the ability of development to proceed without Esrrb or Ncoa3, GO 
analysis of Esrrb-Ncoa3 bound targets nevertheless points towards a role for these 
factors in embryonic development, germ cells, and fertility. Interesting candidates have 
emerged from these data, such as PGC and EpiSC reprogramming factor, Prdm14, which 
was here revealed to be bound and transcriptionally activated by Esrrb-Ncoa3. It will be 
of great interest in future studies to examine the potential function of the Esrrb-Ncoa3 
partnership in reprogramming EpiSCs or PGCs in vitro or in vivo, respectively. 
 
In ESCs, spatial heatmap analysis further revealed that Ncoa3 and Esrrb are together at 
MTL that act as ESC enhancesomes. These loci contain enrichment for two marks that 
delineate active enhancers, H3K4me1 and H3K27ac, as well as the HAT, p300. Such 
colocalisation suggests that Esrrb and Ncoa3, both with and without strong OSN co-
binding (see Figure 6.3A, Class Ib and Ia, respectively) are associated with transcriptional 
activation of nearby genes. Importantly, these targets were confirmed via microarray 
analysis and qRT-PCR validation to be transcriptionally downregulated upon knockdown 
of Ncoa3, highlighting the requirement for this coactivator in Esrrb-dependent gene 
expression.   
 
Aside from illustrating the global extent of Ncoa3 recruitment to Esrrb, a second 
revelation from these data was that Ncoa3 binds many sites in the absence of Esrrb. As 
discussed further in Chapter seven, Ncoa3 is therefore likely to be recruited by other 
transcription factors to different sets of target genes. Despite its widely known role as a 
transcriptional coactivator in somatic cells, a small proportion of Class III genes bound 
by Ncoa3 were upregulated upon Ncoa3 knockdown. This furthermore suggests that 
Ncoa3 may serve to repress the expression of some genes – a phenomenon that if 
validated would certainly be intriguing to investigate in future studies. 
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Lastly, experiments were performed to provide further mechanistic insights into the role 
of Esrrb-Ncoa3 at active enhancers in ESCs. Here, Co-IP experiments revealed that the 
AF-2-dependent recruitment of Ncoa3 by Esrrb is required for the association of this 
receptor with RNApol2. An example of this has been previously documented in human 
cells for Ncoa3/SRC-3 and ERα – demonstrating that RNApol2 recruitment to ERα 
targets is reduced upon SRC-3 knockdown (Shao et al. 2004; Wu et al. 2007). In contrast, 
the mechanism of recruiting RNApol2 and the general transcription machinery to ESC 
target genes remains elusive. The identification of Ncoa3 as a factor bridging Esrrb and 
RNApol2 in ESCs thus suggests a function for Esrrb-Ncoa3 that is distinct from core 
factors such as OSN, which to date have not been directly linked to the general 
transcription machinery. Combining these data with the functional characterisation of 
Ncoa3 suggests that one reason for the essential requirement of Ncoa3 in ESC self-
renewal and reprogramming may be to recruit or stabilise RNApol2 at target genes, 
potentiating high gene transcription. Further characterisation of the role of Ncoa3 and 
Esrrb in recruiting RNApol2 to genes will be an interesting focus for future studies. 
Overall, these results support the identification of the Esrrb-Ncoa3 partnership as an 
essential component of the ESC transcriptional network, pointing towards a mechanistic 
explanation for their importance in maintaining ESC self-renewal and reprogramming.  
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Dreams of long life, 
What safety can you find? 
See the great unknown 
That shapes for miles 
Good eye 
… 
I have succeeded 
 
Interpol, Success 
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7.1 An essential requirement for the Esrrb LBD/AF-2 domain 
The work presented in this thesis represents the first mechanistic characterisation of 
Esrrb function in ESCs. Whilst this nuclear receptor is well known for its involvement in 
ESC self-renewal and reprogramming, to date no complimentary investigations have 
examined how Esrrb transcriptional activity is conferred. Here, a detailed analysis of 
Esrrb functional domains was first carried out, using a combination of mutagenesis and 
luciferase reporter assays in both somatic cells and ESCs. On a somatic luciferase 
reporter driven by the Pparα promoter, ERRE-Luc, Esrrb is absolutely dependent upon 
a functional LBD and AF-2 region to activate transcription, as previously described for 
other ERRs in in vitro assays. PGC-1α stimulation of the somatic ERRE-Luc reporter is 
thus completely abolished when using Esrrb AF-2 point mutants, in agreement with 
published crystal structures showing that PGC-1α interactions with Esrra is AF-2 
dependent (Kallen et al. 2004). Interestingly, the ability of PGC-1α to coactivate Esrrb is 
also reduced by 40-50% in a mutant lacking the AF-1 region. This functional domain is 
known to be important for conferring NR transcriptional activity in some cell types, for 
example in the ligand-independent recruitment of coactivator caveolin-1 to ERα, but not 
ERβ, in MCF-7 cells (Schlegel et al. 2001). The results here suggest that extra residues 
present in AF-1 could be important in stabilising Esrrb-PGC-1α interactions. 
Alternatively, another coactivator present in the COS-1 cells used for these assays may 
also be recruited to Esrrb AF-1 region and enhances its activity, which would 
subsequently be unable to bind the AF-1 deletion mutant. One example is PRNC2, 
which was previously demonstrated to be recruited to the AF-1 region of Esrrg 
(Hentschke and Borgmeyer 2003).  
 
In ESCs, Esrrb transcriptional activity in contrast relies solely on its LBD. As opposed to 
ΔLBD Esrrb, ΔAF-1 mutants are fully able to rescue the activity of ESC-specific Esrrb, 
Klf4, Nanog and Sox2 Enhancer-Luc reporters following endogenous Esrrb knockdown, 
demonstrating that the AF-1 region is dispensable in ESCs. Additionally, the ERR 
isoform Esrra, which shares a low LBD sequence homology with Esrrb and Esrrg, is 
transcriptionally inactive in ESCs. Together, these findings pointed towards the existence 
of essential protein-protein interactions mediated by the Esrrb LBD. The specific 
portion of the LBD required for Esrrb activity was found to be the AF-2 region, a 
domain critical for coactivator recruitment, as Esrrb AF-2 point mutants also display a 
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total loss in transcriptional activity in ESCs. Importantly, as well as being transcriptionally 
inactive as demonstrated by luciferase reporter assays, Esrrb AF-2 point mutants are 
functionally unable to sustain ESC self-renewal when overexpressed, unlike Wt Esrrb. 
Showing that the Esrrb AF-2 region is also necessary for maintaining the ESC state, the 
AF-2 antagonist DES triggers differentiation, a result similarly seen when Esrrb itself is 
acutely depleted in ESCs. Both these results, together with luciferase assays, confirm that 
the AF-2 region is essential for Esrrb to function as a component of the pluripotency 
network. 
 
What is the key cofactor or protein that is therefore recruited to Esrrb in an AF-2 
dependent fashion and must itself play an important role in ESCs? One hypothesis could 
feasibly have been that – unique to ESCs – the AF-2 region mediates specific contacts 
with other neighbouring pluripotency factors such as Oct4, Sox2 and Nanog. However, 
DES treatment has no negative impact upon the interaction between Esrrb and Oct4. 
Esrrb-Nanog interactions are also unlikely to be AF-2 dependent, as Esrrb’s association 
with Nanog was previously found to involve its N-terminus and DBD, not LBD (Zhang 
et al. 2008). Whilst this does not preclude that another TF not examined here could also 
be binding to AF-2, Oct4 and Nanog represent the only two proteins whose interactions 
with Esrrb have been fully characterised.  Instead, the protein found to be recruited to 
this specific domain is Ncoa3, which out of the PGC-1 and Ncoa families of ERR 
cofactors is the only coactivator that is highly expressed in ESCs. The interaction with 
Esrrb is here demonstrated both in overexpressed forms as well as crucially, using ESC 
extracts. Moreover, as expected, the Esrrb-Ncoa3 interaction is fully AF-2 dependent. 
This work is therefore the first characterisation of an interaction between Esrrb and 
Ncoa3 in a cellular context. Although previous reports have shown Esrrb can bind to all 
three Ncoa members, this was assessed via in vitro GST-pulldown experiments with 
ectopically expressed proteins (Xie et al. 1999). Here, in addition to Co-IP experiments it 
is demonstrated via ChIP assays that Ncoa3 is recruited via Esrrb to its target genes. 
Furthermore, as discussed in detail in 7.2, the Esrrb-Ncoa3 partnership is found to be 
essential for maintenance of the ESC state. Overall, this paints a clear picture of the 
importance of the Esrrb AF-2 region as a module that is critical for the recruitment of 
Ncoa3.  
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In light of the essential requirement for the AF-2 region, and its recruitment of Ncoa3, it 
is interesting to speculate why Esrra, and not Esrrg, is transcriptionally inactive in ESC 
luciferase assays. This result builds upon the findings of Feng and colleagues, who 
showed that Esrra is unable to substitute for Klf4 or Esrrb in somatic cell 
reprogramming, but did not look mechanistically into a reason behind this (Feng et al. 
2009). The inability of Esrra to rescue ESC Enhancer-Luc activity following endogenous 
Esrrb depletion suggests this may be due to differences in its LBD, as the DBD is highly 
conserved between ERRs (over 92% sequence conservation), and the AF-1 domain is 
dispensable in ESCs. In contrast, the Esrra LBD shares only 55% homology with Esrrb, 
whereas Esrrg is more similar (73%). An elegant way to test whether structural 
differences in the Esrra LBD are responsible for its lack of activity in ESCs would be to 
employ loss/gain-of-function LBD swaps. Here, exchanging the LBD of these two 
proteins could be used to determine whether an Esrra construct with the Esrrb LBD is 
now active in ESCs. Intriguingly, the identification of Ncoa3 as an Esrrb coactivator in 
ESCs suggests that Esrra might possibly have lower affinity for this coactivator, which 
could explain its inability to function in ESCs, as well as in reprogramming (Feng et al. 
2009). Indeed, whilst human Esrra (ERR1) and Ncoa3 have been shown to interact (Xie 
et al. 1999; Heck et al. 2009), some recent preliminary evidence suggests that, using the 
mouse forms of these proteins, Ncoa3 is unable to enhance the transcriptional activity of 
Esrra (Figure A-I, Appendix). It would certainly be interesting to investigate this further 
and determine whether an evolutionary divergence in ERR coactivator preference could 
explain differences in their transcriptional activity in certain tell types or target genes.  
 
7.2 Ncoa3 is an essential Esrrb coactivator 
Following the identification of Ncoa3 as a coactivator that interacts with Esrrb in an AF-
2 dependent fashion, its requirement for Esrrb activity was tested. Focusing on the 
candidate Esrrb target genes, Esrrb, Klf4, Nanog and Sox2, it has here been demonstrated 
that Ncoa3 is essential for Esrrb function. Depletion of Ncoa3 in ESCs closely 
phenocopies the effect of Esrrb depletion itself upon Enhancer-Luc reporters, indicating 
that the activation of these luciferase constructs is dependent on the presence of both 
proteins. Esrrb is additionally unable to rescue reporter activity in the absence of Ncoa3, 
providing a direct link between the presence of Ncoa3 and Esrrb activity. Furthermore, 
all four endogenous genes, Esrrb, Klf4, Nanog and Sox2 are downregulated upon Ncoa3 
knockdown in ESCs. Importantly, shRNA-mediated Ncoa3 depletion triggers ESC 
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differentiation, mirroring the effect of Esrrb knockdown itself. Taken together, these 
results confirm that Ncoa3 recruitment is essential for Esrrb function on these ESC-
relevant targets. Moreover, they show that, like Esrrb itself, Ncoa3 expression is essential 
for the maintenance of the ESC state. Complimentary to this, Ncoa3 overexpression can 
also enhance Esrrb-mediated LIF independence. Even without ectopically expressed 
Esrrb, Ncoa3 overexpression is sufficient to sustain short-term LIF independence. This 
result is associated with increased mRNA and/or protein levels for Esrrb, Klf4 and to a 
lesser extent, Nanog. One explanation for these results is that as a result of elevated 
Ncoa3 levels, enhanced expression of Esrrb and some of its downstream targets delays 
the onset of differentiation upon LIF-withdrawal. However, Ncoa3 alone is found to be 
insufficient long-term to sustain ESC self-renewal, implying that other factors or 
signalling pathways are required to maintain Esrrb expression. 
 
Interestingly, although these results have confirmed that Ncoa3 is co-recruited to all four 
candidate targets, it is notable that there is variation amongst their sensitivity to Esrrb 
and Ncoa3 levels. Esrrb and Klf4 transcripts, for example, are more strongly upregulated 
than Nanog and Sox2 in Ncoa3-overexpressing cells. ChIP assays also reveal differences 
in the amounts of Esrrb and Ncoa3 detected at these loci, with the enrichment of both 
proteins up to 10-fold higher at Esrrb and Klf4 than at Nanog and Sox2 loci. Thus, whilst 
all four targets show significant enrichment of Esrrb and Ncoa3 over a control region, 
the functional relevance of the variation between loci is unknown. Such differences may 
interestingly be due to the affinity with which Esrrb binds to ERREs at each locus. 
Comparison of the ERRE motif found at Esrrb, Klf4, Nanog and Sox2 indeed reveals that 
only Esrrb and Klf4 contain a perfect match to the consensus ERRE 5’-
n(G/C)AAGGTCA-3’ (Figure 7.1) (Dufour et al. 2007). More investigations are required 
to elucidate if ‘weaker’ ERREs are indeed associated genome-wide with lower Esrrb-
Ncoa3 enrichment, along with the functional relevance of such a differential recruitment 
of these proteins to target genes. 
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Figure 7.1 Comparison of ERREs found at candidate loci 
Diagram depicting the consensus ERRE (Dufour et al. 2007), shown in the 5’-3’ orientation. Below is the 
ERRE motif found the four indicated loci, aligned to the consensus ERRE. The ERRE found at Klf4 is 
depicted in the 3’-5’ orientation for clarity (5’-3’ sequence: TGACCTTGG). Bases not fitting the consensus 
ERRE are shown in red..  
 
An important step in determining whether Ncoa3 is globally required for Esrrb function 
has been to examine whether Ncoa3 recruitment to Esrrb – and thus Esrrb dependency 
upon this coactivator – is specific to Esrrb, Klf4, Nanog and Sox2, or is in fact a 
phenomenon for many Esrrb targets. For this, ChIP-sequencing and microarray 
experiments have been performed in collaboration with colleagues at the GIS, Singapore. 
This has pivotally revealed that on a genome-wide scale, Esrrb and Ncoa3 map to a 
significant number of the same sites, which are nearby many well-known ESC-associated 
genes. Consistent with this, GO analysis of Esrrb-Ncoa3 co-bound sites (termed Class I) 
identifies terms associated with embryonic and blastocyst development, in agreement 
with their important role in ESC biology. Importantly, coupling ChIP-seq data with 
microarray analysis following Ncoa3 depletion in ESCs shows that the majority of Esrrb-
Ncoa3 direct targets are similarly misregulated following knockdown. qRT-PCR 
expression analysis to validate these microarray data further confirm that many sites 
bound by Esrrb and Ncoa3 with or without the presence of strong enrichment for OSN 
are similarly downregulated upon Ncoa3 depletion. Taken together, these results confirm 
that Ncoa3 is indeed recruited to many Esrrb target genes important for development, 
and moreover that its expression is required for the full activation of these genes. 
Highlighting a role for Ncoa3 in gene activation, Class I sites are also enriched for p300 
and the marks of active enhancers, H3K4me1 and H3K27ac (Creyghton et al. 2010). The 
association between Ncoa3, Esrrb and these molecules overall suggests it could be an 
important functional component of such enhancers. 
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7.3 Assessing the specificity of the Ncoa3-Esrrb partnership 
7.3.1 Ncoa3-Esrrb interactions at pluripotency genes 
Substantial evidence has been provided in the work presented here to indicate that the 
primary role of Ncoa3 in ESCs is as a coactivator for Esrrb. ChIP experiments 
performed in ESCs have been used to show that the recruitment of Ncoa3 to candidate 
Esrrb targets is dependent upon the presence of this nuclear receptor (NR). In addition, 
DNA pull-down experiments confirm that Ncoa3 is associated via Esrrb at ERREs 
present in Esrrb, Klf4, Nanog and Sox2 (Figure A-IIA, Appendix, in collaboration with 
Nadine Martin). Mutating the consensus ERREs in these reporters abrogates both the 
binding of Esrrb to these DNA probes as well as their association with Ncoa3, 
demonstrating that this sequence is both sufficient and necessary to recruit both proteins. 
In agreement, an ERRE is significantly overrepresented at the top 500 Ncoa3-bound 
peaks as identified by ChIP-seq. This ERRE sequence was similarly identified at Esrrb 
peaks in ESCs (Chen et al. 2008) as well as at Esrra and Esrrg-bound sites in cardiac cells 
(Dufour et al. 2007). These results imply that the cis element for recruiting Esrrb and thus 
Ncoa3 to many sites in ESCs is indeed a canonical ERRE. 
 
Interestingly, an Oct-Sox element was additionally enriched at Ncoa3 peaks. This could 
be due to the well-known local clustering of OSN with Esrrb at ESC enhancers, or could 
also be because of the ability of Oct4/Sox2 to recruit Ncoa3 directly to some sites.  
Conditional deletion of either Oct4 or Nanog was shown to reduce binding of both Esrrb 
and Ncoa3 to candidate loci (Figure A-III, Appendix, in collaboration with Rute Tomaz). 
This is in agreement with findings by van den Berg and colleagues, who showed that 
Esrrb recruitment to the Nanog locus is lost upon conditional Oct4 deletion in ZHBTc4 
cells (van den Berg et al. 2008). Strongly arguing against the direct recruitment of Ncoa3 
by OSN however, no interaction could be detected between Ncoa3 and Oct4/Nanog in 
Co-IP experiments. Moreover, Ncoa3 recruitment to the Nanog probe in DNA pull-
down experiments is strictly dependent on Esrrb. Despite the presence of an Oct-Sox 
element adjacent to the Nanog ERRE, Oct4-Sox2 is unable alone to recruit Ncoa3 
(Figure A-IIB, Appendix). Thus, Oct4 and Nanog may instead function as ‘anchors’, 
acting to stabilise Esrrb and in association, Ncoa3. This could be particularly important 
at sites with a poor match to the consensus ERRE, such as within Nanog (van den Berg 
et al. 2008) (Figure 7.1). Overall, these results also provide insight into the workings of 
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multi transcription factor-binding loci (MTL), suggesting that at least one function of 
having multiple TFs present at an enhancer could be to enforce protein-protein 
interactions that cooperate in allowing a stable complex to form. It would be interesting 
to investigate the converse, for example to examine if the binding of Oct4, Sox2, or 
Nanog were themselves affected by Esrrb depletion, or whether it is predominantly the 
core factors which anchor other proteins to DNA. Finally, OSN are also likely to be 
involved in recruiting proteins or complexes to these enhancer loci, thus contributing to 
the activity of the Esrrb, Klf4, Nanog and Sox2 enhancers that were here examined. 
Indeed, whilst the activity of all four Enhancer-Luc vectors is consistently reduced by 
Esrrb depletion by 60-70%, the residual activity is still around 10 to 20-fold higher than 
that driven by the Oct4 proximal promoter alone (Feng et al. 2009). One protein-protein 
interaction recently identified as necessary for Oct4-Sox2 transcriptional activity is their 
recruitment of the coactivator XPC to activate a Nanog reporter (Fong et al. 2011). It will 
be important in the future to identify if other TFs similarly serve to recruit specific 
coactivators or complexes, or whether some of them predominantly act to stabilise other 
neighbouring factors at MTL. 
7.3.2 The potential interaction of Ncoa3 with other factors in ESCs 
One important finding to be uncovered from the global mapping of Ncoa3 DNA 
binding sites was that a distinct group of Ncoa3 peaks show only either weak (Class II) 
or undetectable (Class III) Esrrb binding. Thus, Ncoa3 may indeed be recruited to some 
sites by another factor(s) and not Esrrb. This is not surprising, given that although first 
characterized as a nuclear receptor coactivator, Ncoa3 has since been shown to be 
recruited to several TFs as well as NRs, including AP-1 (Yan et al. 2006b), CREB 
(Korzus et al. 1998), STAT6 (Arimura et al. 2004), NF-κB (Werbajh et al. 2000) and p53 
(Lee et al. 1999). One candidate Ncoa3-interacting protein at Class II sites is the nuclear 
receptor Nr5a2, which has been shown to be capable of binding Ncoa3 in HepG2 liver 
cells (Lee and Moore 2002). Nr5a2 is also found at Class Ib Ncoa3-bound sites, 
suggesting it might co-operate with Esrrb to recruit Ncoa3 to such loci, though this 
remains to be investigated. Importantly however, the Class II targets that are thus not 
enriched for Esrrb are not involved in ESC phenotypes, and instead are associated with 
extra-embryonic development. In agreement with these data, Ncoa3 null embryos suffer 
placental defects, furthermore suggesting that the analysis of Class II genes may provide 
clues to the mechanism behind the defective development in vivo in the absence of Ncoa3 
(Chen et al. 2010). Such examples include Nr2f2/CoupTF-II and Ttpa, genes whose 
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protein products have both been shown to be important for trophoblast or placental 
development (Jishage et al. 2005; Petit et al. 2007). 
 
In contrast to Classes I-II, Class III peaks containing Ncoa3 are not associated with any 
other factor examined here. Moreover, these sites contain no marks of active enhancers 
as denoted by the presence of p300 and H3K4me1 plus H3K27ac (Creyghton et al. 
2010).  Some of these sites may be false peaks, or again may represent loci at which an 
unidentified TF has recruited Ncoa3. Interestingly, a small set of sites within Class III, 
termed Class IIIb, is enriched for the mark of poised enhancers, H3K4me1 alone 
(Creyghton et al. 2010). Thus Class IIIb may represent silent or poised enhancers at 
genes that are perhaps not upregulated until later in differentiation. Interestingly, most of 
the Class III targets that are significantly changed upon Ncoa3 knockdown are in fact 
upregulated, furthermore suggesting that Ncoa3 may be performing the unusual function 
of assisting in repression of a small set of genes. Though rare, some precedence for the 
ability of the Ncoa family to function as corepressors does exist. For example, work from 
the Yamamoto laboratory has demonstrated that glucocorticoid receptor (GR)-mediated 
repression of some targets is actually enhanced by the recruitment of Ncoa2/GRIP1 
(Rogatsky et al. 2001). If the upregulation of some genes by Ncoa3 knockdown can be 
validated, Ncoa3-mediated repression would certainly be a novel phenomenon to 
investigate in further work. 
 
7.4 Ncoa3 is essential for somatic cell reprogramming 
Before the discovery of nuclear reprogramming, studying the establishment of 
pluripotency was only possible through examining embryos or via techniques such as 
SCNT, heterokaryons, or cell fusion experiments. In the past six years, the field of 
transcription factor-mediated reprogramming has grown exponentially, providing us with 
new tools with which to investigate this process. Moreover, iPSCs promise great hope 
for regenerative medicine, if the technical barriers to realizing their potential – such as 
the low efficiency of reprogramming – can be overcome. An increasing number of 
factors are being uncovered that are either essential for the induction of the pluripotent 
state, or conversely may enhance iPSC generation. The identification of such molecules 
has given us new insights into the genetic and epigenetic regulation of pluripotency, 
which may not have been uncovered using ESCs alone. For example, although Nanog 
null ESCs are viable, somatic cell reprogramming in the absence of Nanog reveals that its 
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re-expression is a critical step in the formation of fully reprogrammed iPSCs (Silva et al. 
2009). In agreement, ChIP-seq of partially vs. fully reprogrammed iPSCs reveals that 
many ESC-specific targets that are normally bound by OSKM plus Nanog in fully 
reprogrammed iPSCs are unoccupied by these factors in pre-iPSCs (Sridharan et al. 
2009). Thus Nanog may play a critical role in fully establishing correct gene expression 
profiles in reprogramming. Other proteins have been shown to be essential both in ESCs 
and iPSCs, such as TrxG component Wdr5 (Ang et al. 2011), which is demonstrated to 
have an important role in binding Oct4 and establishing H3K4me3 marks at 
pluripotency genes during reprogramming, as well as maintaining these modifications in 
ESCs.  
 
Similarly it is here demonstrated that Ncoa3 is essential for somatic cell reprogramming, 
with knockdown of this coactivator greatly reducing the efficiency of iPSC generation in 
Oct4GFP MEFs, as well as in MEFs resistant to senescence through the genetic ablation 
of p53. The striking upregulation of Ncoa3 mRNA and protein levels in iPSCs compared 
to somatic cells is in agreement with its requirement for reprogramming, together 
suggesting that Ncoa3 expression is essential in the establishment of transcription factor 
networks during reprogramming. For example, similar to its role as an Esrrb coactivator 
in ESCs, Ncoa3 may also be required by Esrrb during the reprogramming process to 
contribute to the full activation of ESC-related OSKM target genes. Additionally, Ncoa3 
could be part of a positive feedback loop involved in upregulating endogenous Esrrb 
during reprogramming, consistent with its ability to enhance Esrrb expression in ESCs. 
An important step to characterise fully the mechanism of Ncoa3 function in 
reprogramming would be to perform complimentary shRNA-mediated depletion 
experiments of Esrrb, to confirm that its downregulation also prevents nuclear 
reprogramming. Whilst this is not yet formally demonstrated, a recent study interestingly 
highlighted that Esrrb upregulation during reprogramming marked cells likely to go on to 
become iPSCs (Buganim et al. 2012). Here, reprogramming could also be carried out in 
the presence of DES, to establish whether AF-2 inhibition – and consequently Ncoa3 
recruitment – produces the same effect as Esrrb or Ncoa3 depletion. Rescue experiments 
following Ncoa3 depletion could furthermore be accomplished by co-expressing Wt or 
LxxLL mutant Ncoa3 forms, to test if reprogramming can only be recovered in proteins 
able to bind to Esrrb. This would establish mechanistically whether the essential 
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requirement for Ncoa3 in the reprogramming process does indeed relate to its key role in 
acting as an Esrrb coactivator. 
 
In 2009, it was demonstrated that Esrrb was capable of substituting for Klf4 in somatic 
cell reprogramming, in cocktails both with cMyc (OSEM) and without (OSE) (Feng et al. 
2009). This study showed however, that Esrrb was two-fold less efficient at 
reprogramming than Klf4, suggesting that there may be extra limiting factors restricting 
OSEM-mediated reprogramming. Given the ability of Ncoa3 to enhance ESC self-
renewal and its requirement in somatic reprogramming itself, it was therefore 
investigated whether low Ncoa3 levels could be behind the reduced efficiency of 
reprogramming with OSEM. However, in contrast to the unequivocal demonstration 
that Ncoa3 is essential for reprogramming, assessing the effect of overexpressing Ncoa3 
in reprogramming has not provided conclusive results. This is primarily due to the 
variable and very low efficiency of reprogramming with OSEM in this laboratory, despite 
reproducible success using OSKM.  One potential reason for this is that Klf4 may 
participate in other signalling pathways, or upregulate other sets of target genes not 
targeted as strongly by Esrrb. One key process targeted by Klf4 is mesencyhmal-to-
epithelial transition (MET), a shift in MEFs to an epithelial-like state that is an essential 
early step in reprogramming (Figure 7.2) (Li et al. 2010). Indeed, infecting MEFs with 
Klf4 retrovirus alone can be seen to stimulate growth and morphological changes in cells 
(Ana Banito, personal communication), which is not apparent when overexpressing 
Esrrb.  
 
Figure 7.2 Participation of Klf4 in MET during reprogramming 
Klf4 activates MET via E-cadherine upregulation, whilst OSM repress Tgfb, itself an inducer of the reverse 
process epithelial-to-mesenchymal transition (EMT). Thus Klf4 synergises with OSM to promote MET, an 
early requirement for reprogramming.  Diagram from (Li et al. 2010).  
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A potential inability of Esrrb to stimulate MET as effectively as Klf4 could therefore be 
one reason behind its reduced reprogramming efficiency. Klf4 is already known to be a 
key downstream target of Esrrb (Feng et al. 2009). Thus, reprogramming may rely on 
high levels of Klf4, which may only be upregulated by OSEM late in the reprogramming 
process, or with a low efficiency. It will be necessary in future experiments to first 
optimise culture conditions using OSEM to overcome these barriers, before the effect of 
Ncoa3 in enhancing iPSC generation can be fully understood. 
 
Finally, analysis of Ncoa3 ChIP-sequencing data has revealed a potential role for Esrrb 
and Ncoa3 in germ cell development, which itself is a form of reprogramming in vivo. By 
E6.25, a few post-implantation epiblast cells arrest their programme of somatic 
development and instead initiate the germ cell programme, driven by Blimp1/Prdm1. 
From E7.25, these PGCs undergo progressive reprogramming, demethylating 
pluripotency genes, reactivating the silenced X chromosome and reversing marks of 
imprinting, until their final fate as germ cells is reached around E11.5 (Figure 7.3) 
(Hayashi and Surani 2009).  
 
Figure 7.3 PGC reprogramming in v ivo 
Diagram illustrating the reprogramming in PGCs during embryogenesis, from (Hayashi and Surani 2009). 
 
In this way, the progressive in vivo reprogramming of PGC cells to totipotent germ cells 
in the developing embryo is very similar to somatic cell reprogramming. Supporting this, 
embryonic germ (EG) cells may be derived from PGCs after E8.5, which are nearly 
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identical to ESCs (Hayashi and Surani 2009). Interestingly, both Ncoa3 and Esrrb null 
animals display defects in germ cell development. Esrrb is highly expressed in PGCs and 
its deletion causes defects in the number of both male and female germ cells (Mitsunaga 
et al. 2004). Similarly, Ncoa3 null mice are subfertile (Xu et al. 2000). The ChIP-
sequencing results presented here furthermore support a role in the development of 
germ cells, with Class Ia Esrrb-Ncoa3 co-bound targets being uniquely associated with 
germ cell-related phenotypes. Expression analysis furthermore confirms that the Class Ia 
genes, Gadd45a, Fancc, Inhbb, Prdm14 and Smarcad1 are all significantly downregulated 
upon Ncoa3 knockdown. Prdm14 is a particularly interesting Esrrb-Ncoa3 target gene, 
which has been recently shown to be essential in PGC reprogramming and establishment 
of the germ cell lineage (Yamaji et al. 2008; Gillich et al. 2012). Thus, Esrrb-Ncoa3 may 
be involved in upregulating or maintaining the expression of targets such as Prdm14, 
which could contribute to an important role in germ cell development. 
 
7.5 Ncoa3 bridges Esrrb to RNA polymerase II complexes 
An unanswered question in the field of ESCs and reprogramming is of how individual 
factors function in the transcriptional networks that govern pluripotency. For example, 
whilst an Oct4/Sox2 coactivator absolutely required for activation of the Nanog locus 
was recently discovered (Fong et al. 2011), the reason for its essential role in transcription 
remains unclear. Conversely, components of the general transcription machinery such as 
TAFs and Mediator are highly enriched in pluripotent cells (Efroni et al. 2008) and some 
have already been shown to be essential in the maintenance of the ESC state (Kagey et al. 
2010), yet the factors which recruit them to the ESC TF network are unknown. In this 
context, recent data have suggested an important role for Esrrb, which by mass 
spectrometry was found to be physically associated with RNApol2, the TFIID complex, 
Trrap/p400 as well as Mediator subunits (van den Berg et al. 2010). The association with 
components of the general transcription machinery is interestingly unique to Esrrb, as 
these proteins were not detected in Oct4, Sall4, or Tcfcp2l1-associated complexes, 
suggesting a distinct role for this NR in ESC transcription. Here, the interaction between 
endogenous Esrrb and RNApol2 in ESCs has been confirmed in Co-IP experiments, and 
furthermore is demonstrated to be AF-2 dependent. Building on this, Ncoa3 is found to 
interact with RNApol2, and is essential to mediate the interaction between Esrrb and 
RNApol2. Ncoa3 may thus act as a coactivator ‘scaffold’, bridging Esrrb to the general 
transcription machinery (Figure 7.4). Such a function would be one explanation for the 
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recruitment of Ncoa3 by Esrrb to ESC enhancers, which may stabilise RNApol2 and 
potentiate high levels of transcription of ESC-associated genes. Depletion of Ncoa3 or 
Esrrb may consequently destabilise such complexes formed at enhancers, leading to a 
downregulation of pluripotency genes and the onset of differentiation.  
 
Figure 7.4 Proposed model 
Esrrb is recruited to MTL at ESC enhancers, and recruits Ncoa3 in an AF-2 dependent fashion. Ncoa3 
interacts with RNApol2 complexes, bridging Esrrb at these enhancers to the general transcription 
machinery. Such interactions, potentially in concordance with other factors such as Mediator, could act to 
stabilise RNApol2 at promoters and bring about transcription of ESC genes. 
 
Whilst mediating the interaction between Esrrb and RNApol2 is one important role of 
the Esrrb-Ncoa3 partnership in ESCs, it is also possible that there may be other 
functions of both Esrrb and Ncoa3 at MTL, which would add to their importance in the 
pluripotency network. In somatic cells for example, Ncoa3 is known to associate with the 
methyltransferase CARM1 (Feng et al. 2006) as well as the HAT, p300, as part of its role 
in enhancing NR activity (Chen et al. 1997b; de Mora and Brown 2000). In ESCs, ChIP-
sequencing results show that Ncoa3 is frequently associated with p300 at MTL at active 
enhancers, suggesting that p300 recruitment to these loci could be mediated or stabilised 
by Ncoa3. Moreover, Ncoa3 has also been shown to possess its own HAT activity, albeit 
weaker than p300/CBP (Yan et al. 2006b). Ncoa3 recruitment to Esrrb may therefore be 
one of several mechanisms that contributes to histone acetylation and epigenetic 
remodelling of the local chromatin at MTL. Finally, Mediator was also found to be 
associated with Esrrb by van den Berg and colleagues, a complex that is able to bind NRs 
directly (Yuan et al. 1998) as well as indirectly, through its interaction with core 
coactivators (Huang et al. 2003; Wallberg et al. 2003). Given the recent discovery of 
Mediator and Cohesin as factors that can facilitate looping between enhancers and 
promoters (Kagey et al. 2010), characterising the recruitment of Mediator to Esrrb 
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and/or Ncoa3 could provide novel insights into whether Esrrb itself is also a key factor 
linking transcriptional enhancers and promoters in ESCs. 
 
7.6 The Esrrb-Ncoa3 partnership as a target for signaling pathways 
An uninvestigated aspect of the regulation of Esrrb activity by Ncoa3 is the identification 
of proteins and signalling pathways upstream of these factors. Ncoa3 is highly expressed 
in undifferentiated ESCs, and downregulated alongside Esrrb and other pluripotency 
factors upon differentiation. However, the mechanism of downregulation of Esrrb, and 
indeed Ncoa3 itself, is unknown. Analysis of freely-available ChIP-seq data from (Chen 
et al. 2008) using websites such as www.dcode.org indicates that there may be OSN and 
Esrrb peaks upstream of the Ncoa3 gene, suggesting that like other pluripotency factors, 
Ncoa3 may also be positively regulated by the core pluripotency network and/or Esrrb. 
This is corroborated by the mapping of Ncoa3 DNA binding sites, which indicates that 
Ncoa3 as a Class Ia target bound by both Esrrb and Ncoa3 proteins.  
 
In somatic cells, orphan NR activity has often been described as being regulated at the 
level of coactivator availability. For example, Esrra activity is highly sensitive to levels of 
its coactivator, PGC-1α, which in turn is rapidly upregulated by external stimuli such as 
cold exposure. Thus, the activation of Esrra target genes is strictly controlled by the 
induction of PGC-1α expression (Puigserver et al. 1998). Similar to this, one explanation 
for the rapid downregulation of Esrrb upon differentiation could be that the expression 
of Ncoa3 decreases first, which in turn would inhibit Esrrb autoregulation. Arguing 
against this simple model, however, is the observation that Ncoa3 transcript levels 
decrease at roughly the same rate as Esrrb in EB-mediated differentiation, while the 
decrease in Esrrb protein levels following LIF-withdrawal is actually more rapid/striking 
than that of Ncoa3. Thus, the expression level of Ncoa3 does not seem to be a limiting 
factor in regulating Esrrb activity. Instead, there may be another means of regulating the 
Esrrb-Ncoa3 association, such as via post-translational modification of Ncoa3. This is 
often the case in somatic cells, where orphan NR-coactivator interactions are modulated 
via the phosphorylation, methylation or ubiquitinylation of one or more partners 
(Rosenfeld et al. 2006). Such modifications have all been shown to affect Ncoa3 function 
on multiple levels, including its association with other coactivators, its stability and even 
its subcellular localisation (Figure 7.5) (Rosenfeld et al. 2006; Han et al. 2009). With many 
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signalling pathways feeding directly into the function and expression of the core ESC 
pluripotency factors, the post-translational regulation of the Esrrb-Ncoa3 partnership 
would be an elegant mechanism to link both NR activity and external stimuli. This in 
turn would add another layer of regulation to the complex transcriptional networks that 
control pluripotency.   
 
Figure 7.5 Regulation of Ncoa3 by post-translational modification 
Diagram illustrating mechanisms of Ncoa3 post-translational regulation. In (A), CARM1 is recruited to 
NRs via Ncoa3 and contributes to epigenetic remodelling, but subsequently methylates Ncoa3 and p300, 
causing its dissociation from NRs and thus attenuating gene activation. (B) Selective phosphorylation of 
Ncoa3 by EGF signalling can trigger its translocation to the nucleus to activate gene expression. (C) GSK3β-
mediated phosphorylation of Ncoa3 leads to its ubiquitinylation and activation but is followed however by 
Ncoa3 degradation by the proteasome when the ubiquitin chain extends beyond five molecules. (D) Ncoa3 
phosphorylation by Pin-1 can invoke a conformational change in Ncoa3 that enhances its association with 
the HAT, CBP, enhancing its gene activation capacity. Diagram adapted from (Han et al. 2009). 
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Appendix A: Supplementary Figures and Tables 
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This is not the first time 
That I've watched the end 
Of the thing that had no end 
 
Trespassers William, What of me 
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Figure A-I Ability of Ncoa3 to enhance the activity of ERR isoforms 
Previously, human Ncoa and ERR members were shown to bind to and activate a reporter containing two 
Estrogen Response Elements (EREs) – sequence AGGTCACAGTGACCT (Hong et al. 1999). This is likely 
due to similarities between the consensus ERE and ERRE: i.e. note that the first six ERE bases are identical 
to a canonical ERRE. Therefore, to see if mouse Ncoa3 is able to act as a coactivator for all three ERRs, 
COS-1 cells were cotransfected with ERE-Luc along with mouse Esrra, Esrrb or Esrrg, with or without 
Ncoa3. Luciferase activity in cells minus any ERR (mock) in the absence of Ncoa3 is set as 1 (dotted line). 
Data are mean +/- SEM of three transfections; this experiment was repeated once with similar results. 
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Figure A-II Recruitment of Ncoa3 to ERREs by Esrrb 
(A) DNA pull-down experiments using previously described wile-type (Wt) or ERRE mutated (mut) 
sequences from Esrrb, Klf4, Sox2 (Feng et al. 2009) or Nanog (van den Berg et al. 2008). 40-50bp 
biotinylated probes were incubated with extracts from COS-1 cells transfected with Flag-Esrrb and Ncoa3 
expression vectors. DNA-protein complexes were recovered on streptavidin beads, washed, and the 
associated proteins eluted and visualised by western blotting. (B) DNA pull-down assay using the Nanog Wt 
or ERRE-mutated probe, which also contains an Oct-Sox motif adjacent to the ERRE. The Nanog probe 
was incubated together with extracts from COS-1 cells overexpressing Ncoa3, Oct4 and Sox2 and proteins 
recovered and visualised as in (A). Performed in collaboration with Nadine Martin. 
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Figure A-III Oct4 and Nanog dependency of Esrrb-Ncoa3 recruitment 
(A-left) Western blot for the indicated proteins in ZHBTc4 ESCs (Niwa et al. 2000) treated for 24 hours 
with 1μg/mL Doxyclicline (Dox) to delete Oct4. (A-right) ChIP assays in ZHBTc4 cells after 24 hours Dox 
treatment, expressed relative to input. Enrichment in cells minus Dox for each individual experiment is set 
at 100%. Data are mean +/- SD of at least two independent experiments. Dotted lines indicate background 
enrichment by control IgGs. (B-left) Western blot in RCNβHB ESCs (Chambers et al. 2007), treated with 
1μM Tamoxifen (OHT) for 24 hours to delete Nanog. (B-right) ChIP in RCNβHB ESCs performed after 24 
hours with or without OHT treatment. Data are mean +/- SD of at least three independent experiments 
and are expressed relative to input and control cells as displayed in (A). Performed in collaboration with 
Rute Tomaz.   
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Table A-I Significant GO terms associated with Class Ib genes 
 
Tables A-I to A-V contain terms, processes, phenotypes or pathways identified by GREAT Gene Ontology 
analysis for each class of Ncoa3-bound genes. Only significant GO terms, as defined by a Binomial FDR Q-
value of <0.05, are shown. 
 
Molecular Function   
# Term Name  
Binom 
FDR Q-Val Genes 
DNA binding 4.49E-020 
Pou5f1,Zfp57,Rfx2,Ddx11,Zfp161,Tgif1,Msh6,Foxn2,Zfp35,Pur
a,Tcf4,Smad7,Sall3,Rcor2,Klf9,Dmrt1,Rfx3,Uhrf2,1700113O17
Rik,Sp5,Phf21a,Ino80,Mga,Cbfa2t2,Top1,Mybl2,Olig3,Tcfap2c,
Myb,Hnf4g,Sox2,Mnd1,Klf4,Prdm1,Nfib,Snapc3,Foxd3,Hsf2,Id3
,Spen,SMARCA5,Tet1,Zfp518b,Rbpj,Klf3,Rest,Aff1,Mtf2,Arid5b
,Tbx3,Gtf2i,Tnrc18,Trim24,Smarcad1,Prdm5,Pole4,Zfml,Rybp,
Phc1,Sox5,Zfp667,Tead1,Zmat4,Spic,Zfp42,Klf2,Sall1,Zfp1,Pgr
,Zbtb44,Gata1,Ebf1,Sap30l,Ncor1,Hoxb13,Ubtf,Mycn,Npas3,Fa
ncm,Six4,Zfp36l1,Esrrb,Jarid2,Msx2,Gpbp1,Myst4,Otx2,Tcfcp2l
1,Gli2,Zfhx2,Klf5,Zic5,Trps1,Rbbp5,AK007269,Kdm5b,Etv5,Trp
63,Cggbp1 
transcription regulator 
activity 1.15E-011 
Sik1,Pou5f1,Zfp57,Rpl7l1,Rfx2,Tgif1,Foxn2,Pura,Tcf4,Smad7,
Rcor2,Klf9,Dmrt1,Rfx3,Mga,Cbfa2t2,Olig3,Tcfap2c,Myb,Hnf4g,
Sox2,Klf4,Nfib,Foxd3,Hsf2,Id3,Spen,SMARCA5,Sirt1,Rbpj,Rest
,Aff1,Tbx3,Trim24,Prdm5,Rybp,Sox5,C80913,Tead1,Spic,Klf2,
Sall1,Pgr,Gata1,Ebf1,Ncor1,Hoxb13,Mycn,Npas3,Six4,Esrrb,Ja
rid2,Id4,Msx2,Gpbp1,Fgf10,Myst4,Otx2,Tcfcp2l1,Gli2,Zfhx2,Klf
5,Trps1,Etv5,Trp63,Nrip1 
transcription 
repressor activity 3.26E-011 
Sik1,Pou5f1,Zfp57,Tgif1,Tcf4,Rcor2,Rfx3,Cbfa2t2,Klf4,Id3,Spe
n,Sirt1,Rest,Tbx3,Trim24,Prdm5,Rybp,C80913,Sall1,Ncor1,Jari
d2,Id4,Msx2,Myst4,Tcfcp2l1,Trp63,Nrip1 
chromatin binding 
1.80922E-
06 
Pou5f1,Tgif1,Msh6,Phf21a,Top1,Sox2,Rest,Trim24,Mkrn1,Phc
1,Eed,Cdyl2,Fancm,Jarid2,Gli2,Trp63 
transcription 
corepressor activity 
5.5632E-
05 
Pou5f1,Tgif1,Tcf4,Rcor2,Cbfa2t2,Spen,Sirt1,Rybp,C80913,Nco
r1,Nrip1 
   
   
Biological Process   
# Term Name  
Binom 
FDR Q-Val Genes 
negative regulation of 
macromolecule 
biosynthetic process 2.33E-011 
Sik1,Pou5f1,Zfp57,Tgif1,Pura,Tcf4,Smad7,Rcor2,Srp9,Cbfa2t2,
Klf4,Txn1,Foxd3,Id3,Spen,Sirt1,Rest,Tbx3,Trim24,Rybp,Sall1,A
dora2b,Ncor1,Ubtf,Ywhaq,Jarid2,Id4,Myst4,Tcfcp2l1,Gli2,Inhbb
,Mtdh,Trps1,Nrip1 
negative regulation of 
transcription 3.50E-011 
Sik1,Pou5f1,Zfp57,Tgif1,Pura,Tcf4,Smad7,Rcor2,Cbfa2t2,Klf4,
Txn1,Foxd3,Id3,Spen,Sirt1,Rest,Tbx3,Trim24,Rybp,Sall1,Ncor1
,Ubtf,Ywhaq,Jarid2,Id4,Myst4,Tcfcp2l1,Gli2,Mtdh,Trps1,Nrip1 
negative regulation of 
biosynthetic process 6.66E-011 
Sik1,Pou5f1,Zfp57,Tgif1,Pura,Tcf4,Smad7,Rcor2,Srp9,Cbfa2t2,
Klf4,Txn1,Foxd3,Id3,Spen,Sirt1,Rest,Tbx3,Trim24,Rybp,Sall1,A
dora2b,Ncor1,Ubtf,Ywhaq,Jarid2,Id4,Myst4,Tcfcp2l1,Gli2,Inhbb
,Mtdh,Trps1,Nrip1 
negative regulation of 
nucleobase, 
nucleoside, nucleotide 
and nucleic acid 
metabolic process 7.80E-011 
Sik1,Pou5f1,Zfp57,Tgif1,Msh6,Pura,Tcf4,Smad7,Rcor2,Cbfa2t
2,Klf4,Txn1,Foxd3,Id3,Spen,Sirt1,Rest,Tbx3,Trim24,Rybp,Sall1
,Ncor1,Ubtf,Ywhaq,Jarid2,Id4,Myst4,Tcfcp2l1,Gli2,Mtdh,Trps1,
Nrip1 
negative regulation of 
metabolic process 1.09E-010 
Sik1,Pou5f1,Zfp57,Tgif1,Msh6,Pura,Cidea,Tcf4,Smad7,Rcor2,
Srp9,Cbfa2t2,Klf4,Txn1,Foxd3,Gja1,Id3,Spen,Sirt1,Rest,Tbx3,T
rim24,Rybp,Sall1,Dusp6,Adora2b,Ncor1,Ubtf,Ywhaq,Jarid2,Id4,
Myst4,Tcfcp2l1,Gli2,Inhbb,Bnip3l,Mtdh,Trps1,Nrip1,Sod1 
negative regulation of 
RNA metabolic 
process 1.61E-010 
Sik1,Pou5f1,Zfp57,Tgif1,Pura,Tcf4,Smad7,Cbfa2t2,Klf4,Txn1,F
oxd3,Id3,Spen,Sirt1,Rest,Tbx3,Trim24,Rybp,Sall1,Ncor1,Ubtf,Y
whaq,Jarid2,Tcfcp2l1,Gli2,Mtdh,Trps1,Nrip1 
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negative regulation of 
cell proliferation 
1.19353E-
06 
Tgif1,Ctnna1,Lefty1,Klf4,Nfib,Gja1,Trim24,Kras,Pawr,Adora2b,
Ctla4,Becn1,Jarid2,Msx2,Fgf10,Spry2,Robo1 
embryonic 
morphogenesis 
2.22525E-
06 
Pou5f1,Tgif1,Lefty1,Enah,Acvr1,Ift52,Gja1,Macf1,Tbx3,Txnrd1,
Vegfc,Sall1,Tdgf1,Cobl,Socs3,Mycn,Six4,Esrrb,Msx2,Fgf10,Otx
2,Gli2,Spry2,Zic5,Sod1 
tissue morphogenesis 
2.74118E-
06 
Pou5f1,Tgif1,Smad7,Enah,Acvr1,Ift52,Frem2,Klf4,Gja1,Macf1,
Tbx3,Txnrd1,Vegfc,Sall1,Cobl,Ntn1,Hoxb13,Socs3,Fgf10,Gli2,
Zic5,Robo1 
stem cell 
differentiation 
1.28041E-
05 Pou5f1,Rif1,Klf4,Esrrb,Jarid2,Fgf10 
stem cell 
maintenance 
5.07832E-
05 Pou5f1,Rif1,Klf4,Esrrb,Fgf10 
ciliary neurotrophic 
factor-mediated 
signaling pathway 
0.0008211
83 Cntf,Il6st,Lifr 
blastoderm 
segmentation 
0.0065931
11 Tbx3,Pcsk6,Tdgf1,Gli2 
   
   
   
Pather Pathway   
# Term Name  
Binom 
FDR Q-Val Genes 
Regulation of 
Androgen receptor 
activity 8.45E-007 
Ccnd3,Tgif1,Svil,Tcf4,Sirt1,Trim24,Fkbp4,Pawr,Hoxb13,Hsp90
aa1,Lats2,Nrip1 
Coregulation of 
Androgen receptor 
activity 
1.56098E-
06 cnd3,Tgif1,Svil,Tcf4,Fkbp4,Pawr,Lats2,Nrip1 
Androgen-mediated 
signaling 
1.22775E-
06 
Ccnd3,Tgif1,Svil,Tcf4,Sirt1,Trim24,Fkbp4,Pawr,Hoxb13,Hsp90
aa1,Lats2,Nrip1 
Regulation of Wnt-
mediated beta catenin 
signaling and target 
gene transcription 
7.77532E-
05 Ccnd3,Tgif1,Svil,Tcf4,Klf4,Fkbp4,Pawr,Lats2,Nrip1 
Canonical Wnt 
signaling pathway 
7.4883E-
05 Ccnd3,Tgif1,Svil,Tcf4,Klf4,Fkbp4,Pawr,Fzd5,Lats2,Nrip1 
Noncanonical Wnt 
signaling pathway 
0.0005903
92 ,Tgif1,Svil,Tcf4,Klf4,Fkbp4,Pawr,Fzd5,Lats2,Nrip1 
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Table A-II Significant GO terms associated with Class Ia genes 
 
Mouse phenotype   
# Term Name  
Binom 
FDR Q-Val Genes 
decreased germ cell 
number 1.08E-004 
Dmrt1,Usp1,Hsf2,Sirt1,Kit,Smarcad1,Piwil4,Cyp19a1,Spag9,Prd
m14,Fancm,Fancc,Inhbb,Etv5,Qk 
abnormal germ cell 
morphology 3.78E-004 
Dmrt1,Usp1,Hsf2,Sirt1,Kit,Smarcad1,Piwil4,Cyp19a1,Spag9,Prd
m14,Fancm,Fancc,Inhbb,Etv5,Nrip1,Qk 
abnormal 
gametogenesis 3.05E-003 
Dmrt1,Usp1,Hsf2,Sirt1,Kit,Smarcad1,Piwil4,Cyp19a1,Spag9,Prd
m14,Fancm,Fancc,Inhbb,Etv5,Nrip1,Qk 
decreased male 
germ cell number 3.60E-003 
Dmrt1,Usp1,Hsf2,Sirt1,Kit,Piwil4,Cyp19a1,Spag9,Fancm,Fancc,
Etv5,Qk 
oligozoospermia 8.80E-003 
gif1,Dmrt1,Kif11,Ncoa3,Fxr1,Psip1,Usp1,Hsf2,Sirt1,Nsun7,Kit,S
marcad1,Gadd45a,Slc6a6,Cpe,Piwil4,Cyp19a1,Neo1,Zic3,Spag9
,Prdm14,Epha4,Fancm,Fancc,Fgf10,Inhbb,Etv5,Nrip1,Qk 
abnormal 
fertility/fecundity 8.28E-003 
Dmrt1,Ncoa3,Fxr1,Psip1,Usp1,Hsf2,Sirt1,Kit,Smarcad1,Piwil4,Cy
p19a1,Neo1,Spag9,Prdm14,Epha4,Fancm,Fancc,Fgf10,Inhbb,Et
v5,Nrip1,Qk 
abnormal 
reproductive system 
morphology 7.55E-003 
Dmrt1,Ncoa3,Fxr1,Psip1,Usp1,Hsf2,Sirt1,Kit,Smarcad1,Piwil4,Cy
p19a1,Neo1,Spag9,Prdm14,Epha4,Fancm,Fancc,Fgf10,Inhbb,Et
v5,Nrip1,Qk 
abnormal oocyte 
morphology 7.14E-003 
Dmrt1,Ncoa3,Fxr1,Psip1,Usp1,Hsf2,Sirt1,Kit,Smarcad1,Piwil4,Cy
p19a1,Neo1,Spag9,Prdm14,Epha4,Fancm,Fancc,Fgf10,Inhbb,Et
v5,Nrip1,Qk 
abnormal female 
germ cell morphology 7.37E-003 Usp1,Hsf2,Kit,Smarcad1,Fancc,Inhbb,Nrip1 
decreased oocyte 
cell number 7.62E-003 Usp1,Hsf2,Kit,Smarcad1,Fancc,Inhbb 
abnormal sex 
determination 1.67E-002 
Dmrt1,Ncoa3,Fxr1,Psip1,Usp1,Hsf2,Sirt1,Kit,Piwil4,Cyp19a1,Fan
cm,Fancc,Etv5 
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Table A-III Significant GO terms associated with Class II genes 
 
Molecular function   
# Term Name  
Binom 
FDR Q-Val Genes 
hormone activity 2.89E-006 Cga,Prl2c3,Inhba,Prl4a1 
receptor binding 2.61E-003 
Fgf1,Itln1,Smad7,Tcf7l2,Dpp4,Tgfb2,Il7,Cga,Spp1,Nr0b1,Dock2,
Prl2c3,Inhba,Prl4a1,Pdpk1 
   
   
Biological function   
# Term Name  
Binom 
FDR Q-Val Genes 
response to stimulus 3.46E-002 
H2-
M5,Esco1,Fgf1,Itln1,Smad7,Trpm6,Tjp2,Tcf7l2,Kynu,Dpp4,Tgfb2
,Snap25,Xrn2,Il7,Sis,Gstm2,Traf3ip2,Ttpa,Cga,Spp1,Egr2,Elk3,F
to,Bcar1,Olfr24,Sik2,Agtr2,Nr0b1,Hsfy2,Dock2,Abi2,Ahr,Eya1,Ug
t1a1,Prl4a1,Ndufs4,Rrm2b,Myc,Fgd4,Pdpk1 
nucleosome 
assembly 3.44E-002 Tspyl1,H2afz,SMARCA5,Hist1h2an 
nucleosome 
organization 2.47E-002  
   
   
Mouse Phenotype   
# Term Name  
Binom 
FDR Q-Val Genes 
abnormal placenta 
development 1.24E-003 SMARCA5,Nr2f2,Prl4a1,Klf5,Pdpk1 
abnormal trophoblast 
giant cells 8.95E-004 Ttpa,Nr2f2,Prl4a1 
abnormal trophoblast 
layer morphology 8.37E-004 Ttpa,Nr2f2,Prl4a1,Myc 
abnormal placenta 
morphology 7.91E-004 Ttpa,SMARCA5,Nr2f2,Prl4a1,Klf5,Rictor,Myc,Pdpk1 
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Table A-IV Significant GO terms associated with Class IIIa genes 
 
Molecular function   
# Term Name  
Binom 
FDR Q-Val Genes 
phosphatidylinositol-
3,4-bisphosphate 4-
phosphatase activity 2.17E-004 Inpp4b 
phosphatidylinositol-
4,5-bisphosphate 4-
phosphatase activity 2.17E-004 Inpp4b 
chitinase activity 8.63E-005 Chi3l3,Chi3l4 
15-
hydroxyprostaglandi
n dehydrogenase 
(NAD+) activity 5.29E-004 Hpgd 
N4-(beta-N-
acetylglucosaminyl)-
L-asparaginase 
activity 1.77E-003 Aga 
hormone activity 3.68E-002 Ins2,Prl2c2,Prl2c3,Prl4a1,Prl7a2,Prl7c1,Stc1 
   
Biological function   
# Term Name  
Binom 
FDR Q-Val Genes 
chitin catabolic 
process 6.83E-004 Chi3l3,Chi3l4 
chitin metabolic 
process 1.25E-003 Chi3l3,Chi3l4 
protein 
deglycosylation 8.43E-004 Aga 
asparagine 
catabolic process 
via L-aspartate 8.50E-004 Aga,Tasp1 
aminoglycan 
catabolic process 4.33E-003 Chi3l3,Chi3l4 
thrombin receptor 
signaling pathway 4.78E-003 F2rl3,Hpgd 
asparagine 
metabolic process 8.15E-003 Aga,Tasp1 
aminoglycan 
metabolic process 1.45E-002 A930038C07Rik,Chi3l3,Chi3l4,Il15,Spock3 
parturition 1.52E-002 Ednra,Hpgd 
ductus arteriosus 
closure 1.96E-002 Hpgd 
glutamine family 
amino acid catabolic 
process 4.17E-002  
aspartate family 
amino acid 
metabolic process 6.48E-002  
   
   
Mouse Phenotype   
# Term Name  
Binom 
FDR Q-Val Genes 
neurogenic bladder 2.11E-002 Aga 
abnormal lysosome 
morphology 2.04E-001 Aga,Atg5,Kif5b 
   
MGI-expression   
# Term Name  
Binom 
FDR Q-Val Genes 
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TS13_ectoplacental 
cone 7.20E-004 Prl2c2,Prl2c3,Prl4a1,Prl7c1 
TS13_trophoblast 3.78E-004 Prl2c2,Prl2c3,Prl4a1,Prl7c1 
TS24_extraembryon
ic component 1.30E-002 Prl2c2,Prl2c3,Prl4a1,Prl7a2,Prl7c1 
TS25_extraembryon
ic component 1.79E-002 Cr2,Ins2,Prl2c2,Prl2c3,Prl4a1,Prl7a2,Prl7c1 
TS21_extraembryon
ic component 2.69E-002 Cr2,Ins2,Mab21l2,Prl2c2,Prl2c3,Prl4a1,Prl7a2,Prl7c1 
TS26_extraembryon
ic component 3.65E-002 Prl2c2,Prl2c3,Prl4a1,Prl7a2,Prl7c1 
TS17_common 
atrial chamber; left; 
endocardial lining 4.92E-002 Tll1 
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Table A-V Significant GO terms associated with Class IIIb genes 
 
Molecular Function   
# Term Name  Binom 
FDR Q-Val 
Genes 
nucleic acid binding 1.07E-014 Thoc1,Pura,Rbm4b,Tle4,Btaf1,Hells,Mxi1,Zfp451,Csrnp3,Sp5,Zf
p217,Hdac2,Nfx1,Bnc2,Foxd3,Mier1,Zcchc11,Eif2b3,SMARCA5,
Gm13051,Gm13242,Gm13251,Gm13154,Gm13157,Ddx50,Polr2
b,Zscan21,Parp12,Igf2bp3,Zfp110,Zfp873,Lsm6,Zfp827,Smarca5
,Nfat5,Suhw4,Rfx7,Dhx30,Orc2l,Nop58,Bard1,Hbp1,Farsb,Utp14
b,C79407,Zbtb25,Zfp748,Pols,Rnf17,Dppa2,Cggbp1,Sfrs15,Qk 
zinc ion binding 4.58E-007 Rbm4b,Cpn1,Zfp451,March7,Sp5,Zfp217,Pdlim5,Nfx1,Bnc2,Zcc
hc11,Gm13051,Gm13242,Gm13251,Gm13154,Gm13157,MLL5,
Zscan21,Parp12,Lmcd1,Zfp110,Zfp873,Zfp827,Arih1,Suhw4,Bar
d1,Zbtb25,Zfp748,Trim23,Rnf17,Rims2,Sfrs2ip 
transition metal ion 
binding 
2.21647E-
06 
Cyp1b1,Rbm4b,Cpn1,Zfp451,March7,Sp5,Zfp217,Pdlim5,Nfx1,B
nc2,Zcchc11,Gm13051,Gm13242,Gm13251,Gm13154,Gm1315
7,MLL5,Zscan21,Parp12,Lmcd1,Zfp110,Zfp873,Zfp827,Arih1,Su
hw4,Bard1,Zbtb25,Zfp748,Trim23,Rnf17,Rims2,Sfrs2ip,Mfi2 
helicase activity 2.18175E-
05 
Btaf1,Hells,SMARCA5,Ddx50,Smarca5,Dhx30 
DNA binding 5.15041E-
05 
Thoc1,Pura,Tle4,Btaf1,Hells,Mxi1,Zfp451,Csrnp3,Sp5,Zfp217,Hd
ac2,Nfx1,Bnc2,Foxd3,Mier1,SMARCA5,Polr2b,Zscan21,Zfp110,
Zfp827,Smarca5,Nfat5,Suhw4,Rfx7,Orc2l,Hbp1,C79407,Zbtb25,
Pols,Cggbp1 
metal ion binding 7.22252E-
05 
Cyp1b1,Rbm4b,Cpn1,Nt5c2,Zfp451,Nudt5,March7,Sp5,Zfp217,S
100a3,Pdlim5,Nfx1,4930417M19Rik,Bnc2,Zcchc11,Mast2,Gm13
051,Gm13242,Gm13251,Gm13154,Gm13157,MLL5,Stim2,Polr2
b,Ubc,Zscan21,Parp12,Lmcd1,Zfp110,Zfp873,AK012880,Tktl2,Zf
p827,Arih1,Suhw4,Rasa2,Bard1,Farsb,Zbtb25,Zfp748,Trim23,Rn
f17,Rims2,Sfrs2ip,Mfi2 
cation binding 8.65329E-
05 
Cyp1b1,Rbm4b,Cpn1,Nt5c2,Zfp451,Nudt5,March7,Sp5,Zfp217,S
100a3,Pdlim5,Nfx1,4930417M19Rik,Bnc2,Zcchc11,Mast2,Gm13
051,Gm13242,Gm13251,Gm13154,Gm13157,MLL5,Stim2,Polr2
b,Ubc,Zscan21,Parp12,Lmcd1,Zfp110,Zfp873,AK012880,Tktl2,Zf
p827,Arih1,Suhw4,Rasa2,Bard1,Farsb,Zbtb25,Zfp748,Trim23,Rn
f17,Rims2,Sfrs2ip,Mfi2 
nucleotide binding 0.0002521
54 
Rbm4b,Btaf1,Kif11,Hells,Nt5c2,Rnd3,Pik3ca,Mccc1,4930417M1
9Rik,Mast2,SMARCA5,Ddx50,Yes1,Igf2bp3,Abcg2,Gucy2c,Ube2
s,Hpgd,Smarca5,Csnk2a2,Dhx30,Actr2,Farsb,Ripk1,Gfm2,Trim2
3,Kif2a,Myo10,Ikbke,Ptk2,Sfrs15,Tcp1 
   
   
Biological process   
# Term Name  Binom 
FDR Q-Val 
Genes 
regulation of 
macromolecule 
biosynthetic process 
2.39E-015 Thoc1,Paip2,Pura,Tle4,Hells,Mxi1,Zfp451,Csrnp3,Sp5,Ell3,Zfp21
7,Pdgfc,Cd1d1,Hdac2,Akirin2,Nfx1,Bnc2,Foxd3,Mier1,Zcchc11,
Mast2,SMARCA5,Gm13051,Gm13242,Gm13251,Gm13154,Gm1
3157,MLL5,Nrbf2,Ubc,Zscan21,Igf2bp3,Lmcd1,Zfp110,Ube3a,Mt
erfd3,Zfp827,Smarca5,Nfat5,Pawr,Neo1,Gtf2a2,Suhw4,Rfx7,Ww
c1,Hbp1,Ripk1,Zfp748,Fst,Supt16h,Rad21,Cggbp1,Qk 
regulation of 
macromolecule 
metabolic process 
1.20E-014 Birc6,Thoc1,Paip2,Pura,Tle4,Hells,Mxi1,Zfp451,Csrnp3,Sp5,Ell3,
Zfp217,Pdgfc,Cd1d1,Hdac2,Akirin2,Nfx1,Bnc2,Foxd3,Mier1,Zcch
c11,Faf1,Mast2,SMARCA5,Gm13051,Gm13242,Gm13251,Gm1
3154,Gm13157,MLL5,Nrbf2,Ubc,Zscan21,Igf2bp3,Lmcd1,Ube2s,
Zfp110,Ube3a,Mterfd3,Zfp827,Smarca5,N4bp1,Nfat5,Pawr,Neo1
,Gtf2a2,Suhw4,Rfx7,Wwc1,Hbp1,Ripk1,Zfp748,Fst,Supt16h,Rad
21,Cggbp1,Qk 
regulation of cellular 
biosynthetic process 
8.44E-015 Thoc1,Paip2,Pura,Tle4,Hells,Mxi1,Zfp451,Csrnp3,Sp5,Ell3,Zfp21
7,Pdgfc,Cd1d1,Hdac2,Akirin2,Nfx1,Bnc2,Foxd3,Mier1,Zcchc11,
Mast2,SMARCA5,Gm13051,Gm13242,Gm13251,Gm13154,Gm1
3157,MLL5,Nrbf2,Ubc,Zscan21,Igf2bp3,Lmcd1,Zfp110,Ube3a,Mt
erfd3,Zfp827,Smarca5,Nfat5,Pawr,Neo1,Gtf2a2,Suhw4,Rfx7,Ww
c1,Hbp1,Ripk1,Zfp748,Fst,Supt16h,Rad21,Cggbp1,Qk 
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regulation of 
transcription 
7.41E-014 Thoc1,Pura,Tle4,Hells,Mxi1,Zfp451,Csrnp3,Sp5,Ell3,Zfp217,Hda
c2,Akirin2,Nfx1,Bnc2,Foxd3,Mier1,Zcchc11,SMARCA5,Gm13051
,Gm13242,Gm13251,Gm13154,Gm13157,MLL5,Nrbf2,Ubc,Zsca
n21,Lmcd1,Zfp110,Ube3a,Mterfd3,Zfp827,Smarca5,Nfat5,Pawr,
Neo1,Gtf2a2,Suhw4,Rfx7,Wwc1,Hbp1,Ripk1,Zfp748,Fst,Supt16h
,Rad21,Cggbp1 
regulation of gene 
expression 
1.08E-013 Thoc1,Paip2,Pura,Tle4,Hells,Mxi1,Zfp451,Csrnp3,Sp5,Ell3,Zfp21
7,Hdac2,Akirin2,Nfx1,Bnc2,Foxd3,Mier1,Zcchc11,SMARCA5,Gm
13051,Gm13242,Gm13251,Gm13154,Gm13157,MLL5,Nrbf2,Ub
c,Zscan21,Igf2bp3,Lmcd1,Zfp110,Ube3a,Mterfd3,Zfp827,Smarca
5,Nfat5,Pawr,Neo1,Gtf2a2,Suhw4,Rfx7,Wwc1,Hbp1,Ripk1,Zfp74
8,Fst,Supt16h,Rad21,Cggbp1,Qk 
regulation of primary 
metabolic process 
1.55E-013 Birc6,Thoc1,Paip2,Pura,Tle4,Hells,Mxi1,Zfp451,Csrnp3,Sp5,Ell3,
Tbc1d20,Zfp217,Pdgfc,Hdac2,Akirin2,Nfx1,Bnc2,Foxd3,Mier1,Zc
chc11,Faf1,SMARCA5,Gm13051,Gm13242,Gm13251,Gm13154
,Gm13157,MLL5,Nrbf2,Ubc,Zscan21,Igf2bp3,Lmcd1,Ube2s,Zfp1
10,Ube3a,Mterfd3,Zfp827,Smarca5,N4bp1,Nfat5,Pawr,Neo1,Gtf2
a2,Suhw4,Rfx7,Wwc1,Hbp1,Ripk1,Zfp748,Fst,Supt16h,Rad21,C
ggbp1,Qk 
regulation of cellular 
metabolic process 
2.32E-013 Thoc1,Paip2,Pura,Tle4,Hells,Mxi1,Zfp451,Csrnp3,Sp5,Ell3,Tbc1
d20,Zfp217,Pdgfc,Cd1d1,Hdac2,Akirin2,Nfx1,Bnc2,Foxd3,Mier1,
Zcchc11,Mast2,SMARCA5,Gm13051,Gm13242,Gm13251,Gm13
154,Gm13157,MLL5,Nrbf2,Ubc,Zscan21,Igf2bp3,Lmcd1,Ube2s,Z
fp110,Ube3a,Mterfd3,Zfp827,Smarca5,N4bp1,Nfat5,Pawr,Neo1,
Gtf2a2,Suhw4,Rfx7,Wwc1,Bard1,Hbp1,Ripk1,Zfp748,Fst,Supt16
h,Rad21,Cggbp1,Qk 
   
   
Mouse phenotype   
# Term Name  Binom 
FDR Q-Val 
Genes 
inner cell mass 
degeneration 
2.3424E-
06 
SMARCA5,Smarca5,Bard1 
mottled coat 3.19925E-
06 
SMARCA5,Smarca5 
variegated coat color 5.65521E-
06 
SMARCA5,Smarca5 
cellular phenotype 5.20829E-
06 
Birc6,Thoc1,Pura,Hells,Mxi1,Pik3ca,Hdac2,Foxd3,SMARCA5,Sti
m2,Ubc,Ube3a,Mterfd3,Ate1,AK012880,Smarca5,Nfat5,Pawr,Ra
pgef6,Bard1,Sdc1,Scamp1,Ercc8,Ikbke,Ptk2,Ehhadh 
abnormal cell 
physiology 
7.00317E-
06 
Birc6,Thoc1,Pura,Hells,Mxi1,Pik3ca,Hdac2,Foxd3,SMARCA5,Sti
m2,Ubc,Mterfd3,Ate1,AK012880,Smarca5,Nfat5,Pawr,Rapgef6,B
ard1,Sdc1,Scamp1,Ercc8,Ikbke,Ptk2 
abnormal inner cell 
mass 
0.0001520
46 
Thoc1,SMARCA5,Smarca5,Bard1 
abnormal 
trophectoderm 
morphology 
0.0001565
9 
SMARCA5,Smarca5 
irregular coat 
pigmentation 
0.0001586
18 
SMARCA5,Smarca5 
abnormal blastocyst 
morphology 
0.0008710
79 
Thoc1,SMARCA5,Smarca5,Bard1 
embryonic growth 
arrest 
0.0017809
14 
Kif11,Pik3ca,Rapgef2,SMARCA5,Ate1,Smarca5,Qk 
abnormal cell death 0.0025098
8 
Birc6,Thoc1,Hells,Hdac2,Foxd3,SMARCA5,Ubc,Smarca5,Nfat5,
Pawr,Ercc8 
   
   
Pathway   
# Term Name  Binom 
FDR Q-Val 
Genes 
Nucleosome 
assembly 
4.85906E-
06 
SMARCA5,Smarca5 
Deposition of New 
CENPA-containing 
Nucleosomes at the 
4.85906E-
06 
SMARCA5,Smarca5 
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Centromere 
Chromosome 
Maintenance 
1.7269E-
06 
SMARCA5,Smarca5 
Cell Cycle 
Checkpoints 
0.0332747
22 
Psmb7,Anapc1,Anapc10,Orc2l,Psma3,Rad21 
G2/M DNA damage 
checkpoint 
0.0304168
28 
Psmb7,Anapc1,Anapc10,Orc2l,Psma3 
Autodegradation of 
Cdh1 by 
Cdh1:APC/C 
0.0290073
47 
Psmb7,Anapc1,Anapc10,Psma3 
APC/C:Cdh1 
mediated 
degradation of Cdc20 
and other 
APC/C:Cdh1 
targeted proteins in 
late mitosis/early G1 
0.0265439
25 
Psmb7,Anapc1,Anapc10,Psma3 
Conversion from 
APC/C:Cdc20 to 
APC/C:Cdh1 in late 
anaphase 
0.0236627
74 
Psmb7,Anapc1,Anapc10,Psma3 
Netrin-1 signaling 0.0252827
04 
Neo1,Myo10,Ptk2,Robo1 
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Cloning primer Primer Sequence (5’3’) 
ΔAF-1 Esrrb 
Fw: CAATGGATCCATGTCGTCCGAAGACAGGCA 
Rv: ATTGTCTAGATCATGGGGAAATCGGCAGGTTCA 
ΔLBD Esrrb 
Fw: CAATGGATCCAAGCGCCTGTGCCTCGTGT 
Rv: ATTGTCTAGATCACACCTTGGCCTCCAGCAT 
Mutagenesis primer  
Esrrb-RNAi rescue 
Fw: CCTCGCCAACTCAGATTCGATGTATATAGAAAACCTGGAGGCGG 
Rv: CCGCCTCCAGGTTTTCTATATACATCGAATCTGAGTTGGCGAGG 
Esrrb DBD mut 
(C120G/C123G) 
Fw: GAGTGGCCTCCGGCGAGGCTGGCAAGGCGTTC  
Rv: GAACGCCTTGCCAGCCTCGCCGGAGGCCACTC 
Esrrb AF-2 mut1    
(K259A) 
Fw: CCTCATCAACTGGGCCGCGCACATCCCAGGCTTC 
Rv: GAAGCCTGGGATGTGCGCGGCCCAGTTGATGAGG 
Esrrb AF-2 mut2 
(L424A/F425A) 
Fw: GCAGGGCAAGGTGCCCATGCACAAAGCCGCCCTGGAGATGCTG 
Rv: CAGCATCTCCAGGGCGGCTTTGTGCATGGGCACCTTGCCCTGC 
 
 
qPCR primer  Primer sequence (5’3’) 
Actin Fw: CGAGGCCCAGAGCAAGAG Rv: CGTCCCAGTTGGTAACAATGC 
B2m Fw: TGGTGCTTGTCTCACTGACC Rv: TATGTTCGGCTTCCCATTCT 
Ccnd3 Fw: ACCTTTGCGATGTATCCTCC Rv: TTCGATCTGTTCCTGGCAGG 
Cdx2 Fw: TCAACCTCGCCACAACCTTCCC Rv: TGGCTCAGCCTGGGATTGCT 
Esrrb Fw: GCACCTGGGCTCTAGTTGC Rv: TACAGTCCTCGTAGCTCTTGC 
Epha4 Fw: AGATGTGATCAAAGCCATCG Rv: TCTAACAAGGCTGTGTTTGG 
Fancc Fw: TGAGAGTCCCAGTGGAGACC Rv: GTGATCTGTACAAGGTCTGG 
Fgf5 Fw: TGTGTCTCAGGGGATTGTAGG Rv: AGCTGTTTTCTTGGAATCTCTC 
Gadd45a Fw: AAGTGCTCAGCAAGGCTCGG Rv: CACGGATGAGGGTGAAATGG 
Gata3 Fw: AGTCGAGGCCCAAGGCACGA Rv: GCTGCCGACAGCCTTCGCTT 
Gata6 Fw: GAGCTGGTGCTACCAAGAGG Rv: TGCAAAAGCCCATCTCTTCT 
Inhbb Fw: GCGTCTCCGAGATCATCAGC Rv: CTTGACCCGTACCTTCCTCC 
Hsf2 Fw: TCAACATGTGTCAGAAGAGG Rv: GGCACAACTTCTGACGATGC 
Klf2 Fw: CTTGCAGCTACACCAACTGC Rv: TCCTTCCCAGTTGCAATGAT 
Klf4 Fw: GTGCCCCGACTAACCGTTG Rv: GTCGTTGAACTCCTCGGTCT 
Klf5 Fw: GGATCTGGAGAAGCGACGTA Rv: TGAGTCCTCAGGTGAGCTTTT 
L19 Fw: TGATCTGCTGACGGAGTTG Rv: GGAAAAGAAGGTCTGGTTGGA 
Mixl1 Fw: GACAGACCATGTACCCAGAC Rv: GCTTCAAACACCTAGCTTCAG 
Nanog Fw: CTTACAAGGGTCTGCTACTGA Rv: TCTGCTTCCTGGCAAGGACC 
Ncoa1 Fw: AGATGGAAACCAGGTCAGTAAGA Rv: TCCAGAGTGATCGAATCTGCC 
Ncoa2 Fw: ATCTCGAAAATTGCTGACCCTG Rv: TGGCAACACAAAGAGACGCA 
Ncoa3 Fw: TCTCAGCGACATCGACAACTT Rv: GCCTGTAGTAAAAGCGGTCCTA 
Oct4 Fw: CGTGGAGACTTTGCAGCCTG Rv: GCTTGGCAAACTGTTCTAGCTCCT 
PGC-1α Fw: CCCTGCCATTGTTAAGACC Rv: TGCTGCTGTTCCTGTTTTC 
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PGC-1β Fw: CCACAGCCCACTTCCAGAGA Rv: CTTGCCAAGAGAGTCGCTTTGT 
Pou5f1 Fw: CGTGGAGACTTTGCAGCCTG Rv: GCTTGGCAAACTGTTCTAGCTCCT 
Prdm5 Fw: GCATGTAAAGCCTTGTTCCG Rv: GTGTGTCTTCTTATGACTCC 
Prdm14 Fw: GCATCCTGGTTCCCACAGAG Rv: CTGCAGAACACGCCAAAGTG 
PRC Fw: GGCCCAGCACAGGAGTAGTC Rv: CAAGAAAGGAGGCGAGAGAA 
Sall3 Fw: AGAAGCCCTTTGGCTGCACC Rv: ATCTCAGAGAACTTGAGAGC 
Smarcad1 Fw: CTCTTGTCAACTAAAGCTGG Rv: CTCTTCAATAGTTCCTTGGC 
Sox2 Fw: AAAACCACCAATCCCATCCA Rv: CGAAGCGCCTAACGTACCAC 
T Fw: GCTTCAAGGAGCTAACTAACGAG Rv: CCAGCAAGAAAGAGTACATGGC 
Tbx3 Fw: GAACCTACCTGTTCCCGGAAA Rv: CAATGCCCAATGTCTCGAAAAC 
Tcfap2c Fw: GGCTGACTATTTAACGAGACC Rv: CAGTTTTGTATGTTCGGCTCC 
Tcfcp2l1 Fw: GAGTCTTGTTTTATCCTCAGC Rv: ACAGCAGCTGACAGTGGTGC 
Tgif1 Fw: CCCTCAGAGCAAGAGAAAGC Rv: GGAAATCGTGAACTGATTTGG 
Trim24 Fw: AAGCCTGAAGACTTTGTAGC Rv: ACAGTCTTCTGCTTCATGCC 
Zfp42 Fw: CTCCTAGCCGCCTAGATTTCCA Rv: CGTGTCCCAGCTCTTAGTCCATT 
Zfp57 Fw: GTCAGAAACCTTCAAGAACC Rv: CTGGTGATTAAAGAGGAAGG 
 
ChIP primer  Primer sequence (5’3’) 
Esrrb-ERRE Fw: ATAGAACCCACAACGTGACC Rv: AGTGGTCAAAGCCACTCTGC 
Klf4-ERRE Fw: TAGATAGCTAAAGCAGGGGG Rv: TGTCTTTGCAACTGGCCTCC 
Nanog-ERRE Fw: TCGCCAGGGTCTGGAGGTGC Rv: TCCCACCTGCAGGGTCCACC 
Sox2-ERRE Fw: ACTTCTCAACCTCACTGACC Rv: TGGAGTTTGGGAAATTCGACC 
Intergenic-Chr.8 Fw: AAGGGGCCTCTGCTTAAAA Rv: AGAGCTCCATGGCAGGTAGA 
 
shRNA shRNA sequence / reference 
pLKO.1 shScrambled CAACAAGATGAAGAGCACCAA 
pLKO.1 shNcoa3 #1 CGGCAGGCACTTGAAATGAAA 
pLKO.1 shNcoa3 #2 GCCGATTACAGTGCCACTTTA 
pLKO.1 shPRC GAGAGCTGCTAGTGTGGAAA 
pSUPER.shScrambled GACGTTAGCAATCGAGCTC 
pSUPER.puro-shGFP (Loh et al. 2006) 
pSUPER.puro-shEsrrb (Loh et al. 2006) 
 
DNA Probe Sequence (ERREs are underlined with mutated bases in 
lowercase; Oct-Sox element is in bold) 
Esrrb-Wt CCTGCAGCATCCCTGCTTCAAGGTCAACTGAAAAGCCTGGGCTCCAGCAG 
Esrrb-mut CCTGCAGCATCCCTGCTTCAAaaTCAACTGAAAAGCCTGGGCTCCAGCAG 
Klf4-Wt TGCTTTTGACCTTGGAGGCCCCAGGGCACTGTTATTTTCC 
                                                                                                                 Appendix 
 195 
Klf4-mut TGCTTTTGAttTTGGAGGCCCCAaaGCACTGTTATTTTCC 
Nanog-Wt CCAGTCTGGGTCACCTTACAGCTTCTTTTGCATTACAATGTCCATG 
Nanog-mut CCAGTCTGaacCACCTTACAGCTTCTTTTGCATTACAATGTCCATG 
Sox2-Wt CCACCACTTGCAAGGGCAGGCAGAGGTCGAATTTCCCAAA 
Sox2-mut CCACCACTTGCAAaaGCAGGCAGAaaTCGAATTTCCCAAA 
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Ncoa3 functions as an essential Esrrb
coactivator to sustain embryonic stem
cell self-renewal and reprogramming
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United Kingdom
Embryonic stem cell (ESC) pluripotency depends on a well-characterized gene regulatory network centered on
Oct4, Sox2, and Nanog. In contrast, little is known about the identity of the key coregulators and the mechanisms
by which they may potentiate transcription in ESCs. Alongside core transcription factors, the orphan nuclear
receptor Esrrb (estrogen-related receptor b) is vital for the maintenance of ESC identity and furthermore is
uniquely associated with the basal transcription machinery. Here, we show that Ncoa3, an essential coactivator, is
required to mediate Esrrb function in ESCs. Ncoa3 interacts with Esrrb via its ligand-binding domain and bridges
Esrrb to RNA polymerase II complexes. Functionally, Ncoa3 is critical for both the induction and maintenance
of pluripotency. Through chromatin immunoprecipitation (ChIP) sequencing and microarray experiments, we
further demonstrate that Ncoa3 shares overlapping gene regulatory functions with Esrrb and cooperates genome-
wide with the Oct4–Sox2–Nanog circuitry at active enhancers to up-regulate genes involved in self-renewal
and pluripotency. We propose an integrated model of transcriptional and coactivator control, mediated by Ncoa3,
for the maintenance of ESC self-renewal and somatic cell reprogramming.
[Keywords: Ncoa3; Esrrb; embryonic stem cells; coactivator; pluripotency; reprogramming; SRC-3]
Supplemental material is available for this article.
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Embryonic stem cells (ESCs) are derived from the inner
cell mass of early embryos and can be propagated for
extended periods of time in culture while retaining their
pluripotency; i.e., the capacity for multilineage specifica-
tion and differentiation (Smith 2001). Coordinating with
essential components of the LIF and BMP signaling path-
ways (Niwa et al. 1998; Matsuda et al. 1999; Ying et al.
2003), intrinsic transcription factors are crucial for spec-
ifying the undifferentiated state of mouse ESCs. Oct4 is
essential for establishing and maintaining pluripotency
(Nichols et al. 1998; Niwa et al. 2000; Boiani et al. 2005)
and interacts with Sox2 (Avilion et al. 2003; Chew et al.
2005) in ESCs, where both factors cotarget multiple genes
through cooperative binding at Oct–Sox sequence ele-
ments (Boyer et al. 2005; Loh et al. 2006). Moreover, Oct4
and Sox2, along with Klf4 and cMyc, can mediate repro-
gramming of mouse embryonic fibroblasts (MEFs), gen-
erating ESC-like induced pluripotent stem cells (iPSCs)
(Takahashi and Yamanaka 2006). A third well-character-
ized core pluripotency factor is Nanog, which is notably
capable of promoting ESC self-renewal even in the ab-
sence of LIF (Chambers et al. 2003; Mitsui et al. 2003).
Recent work has begun to identify new components of
the ESC core transcriptional network. Along with Oct4,
Sox2, and Nanog (OSN), these factors participate in auto-
and cross-regulation to activate each other’s expression as
well as downstream self-renewal regulators while simul-
taneously repressing genes that promote differentiation
(Chambers and Tomlinson 2009). Perturbation of these
factors collapses the self-renewal circuitry and triggers
specific or mixed-lineage differentiation (Ivanova et al.
2006; Loh et al. 2006). Whole-genome mapping of DNA-
binding sites further revealed that the OSN triad colo-
calizes with a variable yet overlapping set of pluripotency-
associated transcription factors at many promoters and
enhancers (Chen et al. 2008). Clusters with a relatively high
number of factors correlate with expression of nearby genes
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(Kim et al. 2008). It remains less clear, however, how this
well-established network functionally interacts with basal
transcription machinery complexes to activate transcrip-
tion and, most importantly, which factors mediate such
interactions. While the list of ESC-specific transcription
factors is rapidly expanding, relatively little is known about
the identity of essential coregulators (Fong et al. 2011) and
themechanisms bywhich theymay potentiate transcription.
To gain greater insight into how transcription factors
function mechanistically in ESCs, we focused here on
estrogen-related receptor b (Esrrb). This orphan nuclear
receptor binds many target sites that are co-occupied by
OSN and Klf4 in ESCs and up-regulates the expression
of these factors themselves (Chen et al. 2008). Levels of
Esrrb decline rapidly upon differentiation (Xie et al. 2009),
and its depletion results in a loss of ESC characteristics
(Ivanova et al. 2006; Loh et al. 2006). Overexpression of
Esrrb inhibits lineage commitment toward the meso- and
neuro-ectodermal paths and allows robust self-renewal
in the absence of LIF (Zhang et al. 2008). In addition, Esrrb
can substitute for Klf4 in somatic cell reprogramming
(Feng et al. 2009), further highlighting a pivotal role in
both maintaining and inducing pluripotency. In somatic
cells, the activity of estrogen-related receptors (ERRs) is
known to be regulated through the recruitment of coac-
tivators to the AF-2 portion of their ligand-binding domain
(LBD) (Giguere 2008); for example, PGC-1 in metabolic
tissues (Lin et al. 2005; Charest-Marcotte et al. 2010).
These coactivators in turn act as scaffolds for other protein
complexes required to bring about transcription (Rosenfeld
et al. 2006). Although well studied within the context of
adult somatic systems, little is known about the mecha-
nisms by which Esrrb function is conferred in ESCs.
In this study, we show that Esrrb transcriptional and
self-renewal activity is absolutely dependent on protein–
protein interactions mediated via its LBD/AF-2 domain.
Despite this, we found that the coactivators PGC-1a and
PGC-1b commonly required for ERR activity are not
expressed in ESCs and instead identify Ncoa3 (also known
as SRC-3/AlB1) as an essential coactivator of Esrrb. We
show that Ncoa3 expression positively correlates with
the undifferentiated ESC state and itself is required for
both the induction andmaintenance of pluripotency.Ncoa3
binds to Esrrb specifically via its AF-2 region in ESCs and
thus is corecruited to Esrrb, Klf4, Nanog, and Sox2 en-
hancer regions as a critical step to trigger Esrrb-dependent
gene activation. Through chromatin immunoprecipita-
tion (ChIP) sequencing (ChIP-seq) and transcriptome
analysis in Ncoa3 knockdown ESCs, we further establish
that Ncoa3 and Esrrb have overlapping gene regulatory
functions and cooperate genome-wide with the Oct4–
Sox2–Nanog circuitry at active enhancers to up-regulate
genes involved in self-renewal and pluripotency. Finally,
we demonstrate mechanistically that Ncoa3’s presence
links Esrrb to RNA polymerase II (RNApol2) complexes,
identifying a crucial role for the Ncoa3–Esrrb partnership
in the ESC core transcriptional network and shedding
new light on how pluripotency transcription factors may
be bridged to the general transcription machinery to ac-
tivate transcription.
Results
The LBD and AF-2 regions are essential for Esrrb
transcriptional activity in ESCs
How the assembly of transcription factor clusters leads to
active transcription and which essential mediating com-
ponents contribute to this process are yet to be fully in-
vestigated in ESCs. Combining mutagenesis and lucifer-
ase reporter assays, we here asked whether Esrrb activity
is conferred in ESCs through specific protein recruitment.
Flag-tagged Esrrb mutants lacking either the entire LBD
(DLBD) or N-terminal AF-1 (DAF-1) domain—regions
key for mediating nuclear receptor protein–protein
interactions—were generated (Supplemental Fig. S1A),
and their expression was verified alongside wild-type
Esrrb in ESCs (Supplemental Fig. S1B). To test these de-
letion mutants, we initially took advantage of previously
described constructs that carry luciferase downstream
from a minimal Oct4 promoter, together with ERR re-
sponse element (ERRE)-containing regulatory fragments
found at the Esrrb, Klf4, or Sox2 loci (Fig. 1A; Feng et al.
2009), and an additional Esrrb-dependent Nanog-Luc re-
porter (Rodda et al. 2005; van den Berg et al. 2008). These
Enhancer-Luc vectors all show a loss of luciferase activity
following knockdown of endogenous Esrrb in ESCs, an
activity readily regained by coexpressing RNAi-resistant
wild-type Esrrb cDNA (Supplemental Fig. S1C). As op-
posed to wild-type control, we found that the DLBD mu-
tant failed to restore transcription from Esrrb, Klf4,
Nanog, and Sox2 reporters. In contrast, deleting the AF-1
domain had no such suppressive effect on Esrrb activity
(Supplemental Fig. S1C). Unlike other nuclear receptors,
ERR activity is not thought to be ligand-dependent but
nevertheless involves the recruitment of essential coac-
tivators to the AF-2 region, a domain of 12 helices forming
a unique protein-binding surface within the LBD (Wurtz
et al. 1996). Accordingly, we repeated these experiments
using Esrrb point mutants in either helix 3 (AF-2 mut1) or
helix 12 (AF-2 mut2)—two analogous mutations previ-
ously found to inactivate the AF-2 region of the estrogen
receptor (Danielian et al. 1992; Henttu et al. 1997)—along
with a DNA-binding domain (DBD) mutant unable to bind
DNA generated as a control (Fig. 1B). Despite equal expres-
sion to wild-type Esrrb in ESCs (Fig. 1C), all three point
mutants were similarly unable to rescue the luciferase
activity of Esrrb, Klf4, Nanog, and Sox2 reporters (Fig. 1D),
unequivocally demonstrating that Esrrb in ESCs requires
an active LBD/AF-2 domain to trigger transcription.
AF-2 region inactivation results in a loss
of self-renewal in ESCs
Overexpressing Esrrb is sufficient to allow robust self-
renewal in ESCs, negating the need for LIF to prevent
differentiation (Zhang et al. 2008). To link the AF-2
dependence of Esrrb transcriptional activity with its
self-renewal function, we next generated stable ESC lines
that constitutively express Flag-tagged wild-type, AF-2
mut1, or AF-2 mut2 Esrrb (Fig. 1E). Cells were plated at
low density and cultured for 5 d in the absence of LIF, then
Ncoa3 is an Esrrb coactivator in ESCs
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stained for alkaline phosphatase (AP) to score the number
of undifferentiated, mixed, and differentiated colonies
formed under these conditions (Supplemental Fig. S1D).
Strikingly, and in contrast to overexpressing wild-type Esrrb
cells, we observed a near-complete absence of compact,
AP-positive colonies in both AF-2 mut1 and AF-2 mut2
ESC cultures (Fig. 1F,G), indicating a loss in the ability of
Esrrb point mutants to confer LIF independence. To sup-
port this, we also examined the effect of treating ESCs
with an ERR-specific AF-2 antagonist, diethylstilbestrol
(DES). As previously reported, this compound interacts
with all three ERR isoforms to block coactivator binding
and thereby prevent their transcriptional activity (Sup-
plemental Fig. S1E; Tremblay et al. 2001; Greschik et al.
2004). We demonstrated that DES treatment consistently
inhibited transcription from Esrrb-dependent reporters in
ESCs (Supplemental Fig. S1F) and significantly impaired
the self-renewal ability of these cells in a dose-dependent
fashion (Supplemental Fig. S1G,H). Taken together, these
findings reveal the importance of the AF-2 region to
potentiate Esrrb function and imply a crucial role for a
cognate Esrrb coactivator in ESCs.
Ncoa3 is highly expressed in undifferentiated ESCs
In somatic cells, the best-characterized ERR coactivators
belong to the PGC-1 family. PGC-1a and PGC-1b both
potentiate ERR activity in various adult cell types to ac-
tivate genes involved in processes such as cellular energy
metabolism and homeostasis (Huss et al. 2002; Kamei
et al. 2003; Charest-Marcotte et al. 2010). Most recently,
a third member of the PGC-1 family, PRC, was iden-
tified as a regulator of NRF-1 and mitochondrial function
(Vercauteren et al. 2009). Among all three PGC-1 mem-
bers, only PRC was expressed in ESCs (Supplemental Fig.
S2A), and thus its role as a putative Esrrb coactivator was
further investigated. Knockdown of PRC in ESCs did not,
however, compromise Esrrb transcriptional activity or ESC
Figure 1. The AF-2 region is essential for Esrrb activity in ESCs. (A) Schematic of Esrrb, Klf4, and Sox2 reporters used in luciferase
assays. Enhancer fragments containing ERREs from the indicated genes are inserted downstream from luciferase (Feng et al. 2009). An
additional Nanog-Luc reporter was also used (Rodda et al. 2005). (B) Diagram indicating Flag-tagged wild-type (Wt) and Esrrb point
mutants. (DBD mut) C120G/C123G; (AF-2 mut1) K259A; (AF-2 mut2) L424A/F425A. (C) Expression of Flag-tagged wild-type Esrrb or
point mutants in ESCs. (D) Luciferase assays for Esrrb-bound enhancers. ESCs were transfected with the indicated reporter plus either
control (shScrambled) or shRNA to endogenous Esrrb (shEsrrb) and with or without RNAi-resistant Esrrb rescue constructs as depicted
in B. Data are the mean 6 SEM of three transfections. Three experiments were performed with similar results. (E) Levels of CAG-Flag-
Esrrb construct expression in ESCs following stable transfection with wild-type, AF-2 mut1, or AF-2 mut2 Esrrb forms. (F,G) Ability of
wild-type or Esrrb point mutants to confer LIF independence in stably transfected ESCs. Each cell line was plated at low density in
normal ESC medium and, the following day, cultured in medium minus LIF for 5 d. Colonies were fixed and stained for AP and scored
as undifferentiated, mixed, or differentiated. Data are the mean 6 SEM of three independent experiments. Student’s t-test was used to
compare numbers of undifferentiated colonies in wild-type and either AF-2 mutant ESCs or empty vector control; (*) P-value < 0.05.
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self-renewal, as seen upon depletion of Esrrb itself (Sup-
plemental Fig. S2B–E). We next turned to the SRC/p160
family that comprises Ncoa1, Ncoa2, and Ncoa3, three
alternative coactivator proteins also capable of interact-
ing with the ERR family in mammalian cell models (Hong
et al. 1999; Zhang and Teng 2000; van den Berg et al. 2010).
Ncoa3 notably emerged as an interesting candidate, being
highly expressed in self-renewing ESC cultures, in contrast
to Ncoa1 and Ncoa2 (Fig. 2A), and promptly down-regu-
lated alongside Esrrb and other pluripotency factors during
differentiation, as assessed upon addition of retinoic acid
and/or LIF withdrawal (Fig. 2B,C). A sharp decline inNcoa3
transcript levels was also confirmed upon embryoid body
(EB)-mediated differentiation, further pointing to a close
association between Ncoa3 expression and the undiffer-
entiated ESC state (Fig. 2D).
Ncoa3 acts as an Esrrb coactivator in pluripotent ESCs
To establish a functional link between Ncoa3 and Esrrb,
we first checked whether these two protein factors could
indeed interact. Coimmunoprecipitation (co-IP) experi-
ments were performed in COS-1 cells coexpressing
Ncoa3 and Flag-Esrrb, readily demonstrating an Ncoa3–
Esrrb interaction (Fig. 2E). As expected, this interaction
was mediated via the Esrrb AF-2 region, as AF-2 mutants
failed to bind to Ncoa3 (Supplemental Fig. S2F). Co-IPs
were next performed using ESC extracts and, impor-
tantly, confirmed that endogenous Ncoa3 and Esrrb pro-
teins interact in ESCs (Supplemental Fig. S2G). Moreover,
Ncoa3 binding to Esrrb was abrogated in the presence of
DES (Fig. 2F), a result that reflects the decreased self-
renewal ability of DES-treated ESCs (Supplemental Fig.
S1). To test the requirement for Ncoa3 on Esrrb-depen-
dent enhancers, ESCs were cotransfected with a pool of
siRNAs targeting Ncoa3 together with Esrrb, Klf4,
Nanog, and Sox2 luciferase vectors. Ncoa3 loss closely
phenocopied the suppressive effect of Esrrb depletion
itself (Fig. 2G; Supplemental Fig. S2H). Furthermore,
restoring Esrrb expression in depleted ESCs failed to
rescue luciferase reporter activity in the absence ofNcoa3
Figure 2. Ncoa3 acts as Esrrb coactivator in
ESCs. (A) Expression profiling of Ncoa1, Ncoa2,
and Ncoa3 transcripts in ESCs as assessed by
qRT–PCR and normalized to two housekeeping
genes. Expression levels in immortalized brown
adipose tissue (IMBAT) cells are shown as a con-
trol. Data are the mean 6 SEM of three biological
replicates. (B) Immunofluorescence staining of
ESCs maintained in proliferative conditions or
induced to differentiate via addition of 1 mM
retinoic acid (atRA) and removal of LIF for 96 h.
Bars, 50 mm. (C) Western blotting showing Ncoa3
down-regulation along with Esrrb, Nanog, and
Oct4 upon LIF withdrawal. Tubulin is shown as
a loading control. (D) Relative expression levels of
Ncoa3 and other pluripotency factors during EB-
mediated differentiation. Data are normalized to
housekeeping genes and expressed relative to EB
day 0 as the mean 6 SEM of three independent
experiments. (E) Co-IP experiments performed in
COS-1 cells cotransfected with Flag-Esrrb and
Ncoa3. (F) Interaction of endogenous Esrrb and
Ncoa3 proteins in ESC extracts following 24 h of
treatment with ethanol or 12.5 mM DES. At least
two experiments were performed with similar
results. (G) Loss of ESC-specific luciferase re-
porter activity 48 h after depletion of endogenous
Esrrb or Ncoa3 in ESCs. Data are the mean 6
SEM of three transfections. Three experiments
were performed with similar results.
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(Supplemental Fig. S2I), indicating that Ncoa3 is indeed
essential for the activation of these ESC-specific en-
hancers by Esrrb. We next demonstrated that Ncoa3 is re-
cruited by Esrrb to genomic fragments containing ERREs
using DNA pull-down experiments with biotinylated
wild-type or ERRE mutated probes incubated together
with Ncoa3 and Flag-Esrrb (Fig. 3A). These proteins both
readily purified with Esrrb, Klf4, Sox2, and Nanog DNA
fragments. Furthermore, point mutations in ERREmotifs
that abrogated Esrrb binding also reduced Ncoa3 detec-
tion (Fig. 3A), confirming that Ncoa3 associates via Esrrb
at ERREs in the vicinity of target genes. Similarly, Ncoa3
and Esrrb were corecruited to endogenous Esrrb, Klf4,
Nanog, and Sox2 target genes in ESCs, as assessed by ChIP
and quantitative PCR (qPCR) (Fig. 3B). Ncoa3 recruitment
was also verified here to be Esrrb-dependent, as transient
depletion of Esrrb protein reduced Ncoa3 enrichment at
these sites (Fig. 3C). Importantly, both Ncoa3 and Oct4
protein levels remained unaltered at this time point (Fig.
3D), excluding the possibility that the loss of Ncoa3 bind-
ing is due to ESC differentiation. Given the co-occupancy
of many ERRE-containing enhancers with the core pluri-
potency factors (Chen et al. 2008), we next examined the
Oct4 and Nanog dependency of Ncoa3–Esrrb recruitment.
As previously reported for the Nanog locus (van den Berg
et al. 2008), removing Oct4 protein prevented the detec-
tion of Esrrb at all four ESC candidate loci, and this was
strictly mirrored by a loss of Ncoa3 recruitment (Supple-
mental Fig. S3A,B), a trend also observed to a lesser extent
upon conditionalNanog deletion (Supplemental Fig. S3C,D).
However, while Ncoa3 and Esrrb readily interact (Fig. 2;
Supplemental Fig. S2), we could find no evidence for an
interaction between Ncoa3 and Oct4/Nanog themselves
(Supplemental Fig. S3E–H), thus highlighting the speci-
ficity of the Ncoa3–Esrrb association at these sites. In line
with this, DNA pull-down assays further demonstrated
that although Oct4 and Sox2 bind to an Oct–Sox site also
contained within the Nanog probe, they were unable
alone to recruit Ncoa3 (Fig. 3E). Collectively, these re-
sults identify Ncoa3 as an important Esrrb coactivator in
ESCs and point toward a critical role for the Ncoa3–Esrrb
partnership in regulating pluripotency.
Ncoa3 contributes to the maintenance
of pluripotency in ESCs
To explore the functional requirement for Ncoa3 in ESCs,
we next knocked down Ncoa3 using two independent
puromycin-selectable shRNA vectors. The extent of the
knockdown was validated by qRT–PCR (Fig. 4A) and
Western blot (Fig. 4B) and, strikingly, resulted in a clear
and rapid loss of ESC characteristics. By day 4 post-se-
lection, colonies displayed a flattened or spread morphol-
ogy and stained negative for AP (Fig. 4C), and no stable
Ncoa3 knockdown ESC clones could be established.
Ncoa3 depletionwas promptly accompanied by a decrease
Figure 3. Ncoa3 is recruited via Esrrb to ERREs at target loci. (A) DNA pull-down assays using previously described wild-type (Wt) or
ERRE mutated sequences from Esrrb, Klf4, Sox2 (Feng et al. 2009), or Nanog (van den Berg et al. 2008). Biotinylated probes (40–50 base
pairs [bp]) were incubated with extracts from COS-1 cells transfected with Flag-Esrrb and Ncoa3 and recovered on streptavidin beads,
and DNA-associated proteins were visualized by Western blotting. (B) Esrrb and Ncoa3 enrichment levels at Esrrb, Klf4, Nanog, and
Sox2 ERREs and an intergenic (Inter.) control region in ESCs as assessed by ChIP and qPCR and expressed relative to input. Data are the
mean 6 SEM of three biological replicates. (C) Ncoa3 and Esrrb enrichment levels at candidate loci following Esrrb depletion in ESCs,
expressed relative to input. Enrichment for shGFP transfected cells is set at 100% in each individual experiment. Data are the mean 6
SD of at least two independent experiments. Dotted lines in B and C indicate background enrichment by control IgGs (Santa Cruz
Biotechnology). (D) Western blotting showing specific Esrrb protein depletion 48 h after transfection with shEsrrb. Note that Ncoa3 and
Oct4 levels are unchanged at this time. (E) DNA pull-down assays using Nanog wild-type or ERRE mutated probe, which also contains
a neighboring Oct–Sox site (van den Berg et al. 2008), and cell extracts from COS-1 transfected with Ncoa3, Oct4, and Sox2.
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in self-renewal gene expression (Fig. 4D) and concomitant
derepression of lineage-associated markers (Fig. 4E), sup-
porting an effect of Ncoa3 on differentiation. Conversely,
we asked whether, through the potentiation of Esrrb
activity, elevated levels of Ncoa3 could enhance resis-
tance to differentiation in ESCs. For this, we established
a series of stable ESC lines that overexpress either Esrrb
(ESCEsrrb), Ncoa3 (ESCNcoa3), or both factors together
(ESCEsrrb+Ncoa3) alongside control cells (ESCcontrol) through
two sequential rounds of transfection and selection, as
depicted in Figure 4F. To compare the behavior of these
lines, cells were plated at low density and cultured minus
LIF for 5 d as previously performed (Fig. 1). The ESCEsrrb+Ncoa3
line showed a significant increase in the number of un-
differentiated colonies relative to ESCEsrrb cells (Fig. 4G),
demonstrating the additive effect conferred by overex-
pressingEsrrbandNcoa3 together. Interestingly, a consistent
increase in the number of undifferentiated and mixed
colonies was also observed in ESCNcoa3 as compared with
control cells (Fig. 4G,H), suggesting that overexpressing
Ncoa3 alone could support the self-renewal capacity of
ESCs. This was confirmed in ESCs stably expressing
Ncoa3 using an alternative (pPyCAGIP) episomal vector
(Supplemental Fig. S4A; Chambers et al. 2003). These
cells similarly exhibited lower levels of differentiation
when cultured in the absence of LIF as well as under self-
renewing conditions—an effect associated with increased
expression of Esrrb targets Esrrb and Klf4 (Supplemental
Fig. S4B; Feng et al. 2009). Following several passages,
however,Ncoa3-overexpressing ESCs cultured minus LIF
eventually differentiated due to the down-regulation of
endogenous Esrrb (data not shown). Furthermore, these
cells were capable of EB-mediated differentiation (Sup-
plemental Fig. S4C). Collectively, these results show that
Figure 4. Ncoa3 plays critical roles in the
maintenance of ESC self-renewal. (A,B) Spe-
cific knockdown ofNcoa3 in ESCs. ESCs were
transfected with two independent puromycin-
selectable shRNA vectors targeting Ncoa3,
and, 48 h after transfection, Ncoa3 expres-
sion was quantified by qRT–PCR (A) and
Western blotting (B). (C) AP staining following
Ncoa3 knockdown. ESCs were transfected
with shScrambled or shNcoa3 vectors, and,
24 h later, puromycin was added. Selection
was maintained for 4 d, then cells were fixed
and stained for AP. (D,E) Quantitative gene
expression analysis of cells 4 d post-selection
for Ncoa3 depletion. Data are the mean 6 SD
of at least two independent experiments. (F)
Generation of stable ESC lines overexpressing
combinations of Esrrb and Ncoa3. E14Tg2A
(E14) ESCs were first transfected with linear-
ized CAG-Control or CAG-Esrrb vectors and
selected with puromycin. Pooled clones for
each stable cell line were then transfected
with linearized control vector, pCDNA4/TO-
GFP, or pCDNA4/TO-Ncoa3, and overexpress-
ing cells were selected using Zeocin. (G) ESC
lines generated in F were plated at low density
and cultured for 5 d without LIF. Colonies were
fixed and stained for AP; shown are three
independent experiments. The statistical sig-
nificance of the difference in undifferentiated
colonies between the indicated cell lines was
calculated using Student’s t-test; (*) P-value <
0.05, (**) P-value < 0.01. (H) Representative
colony morphology for each cell line from G.
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Ncoa3 plays critical roles in maintaining an intact ESC
state and a self-renewal phenotype but, consistent with
its role as a coactivator, is insufficient alone to maintain
Esrrb levels and block differentiation.
Ncoa3 is required for somatic cell reprogramming
Interestingly, Ncoa3 was found to be up-regulated during
iPSC generation alongside Esrrb and Nanog (Supplemen-
tal Fig. S5A; Mikkelsen et al. 2008), suggesting that Ncoa3
may also be important for the induction of pluripotency by
reprogramming. Detection of high levels of Ncoa3 protein
was confirmed in two independently derived iPSC clones
(Fig. 5A) from Oct4GFP MEFs. These MEFs carry a GFP
transgene downstream from the Oct4 distal enhancer,
which becomes selectively activated during successful
somatic cell reprogramming (Fig. 5B; Supplemental Fig.
S5B; Yeom et al. 1996). To test the functional importance
of Ncoa3 in this process, we specifically depleted Ncoa3
in Oct4GFP MEFs by RNAi (Fig. 5C; Supplemental Fig.
S5C) prior to transduction with Oct4, Sox2, Klf4, and
cMyc (OSKM) reprogramming retroviruses (Supplemental
Fig. S5D). Both scrambled and Ncoa3 knockdown MEFs
showed no difference in cell proliferation (Supplemental
Fig. S5E) or apoptosis (Supplemental Fig. S5F) at the time of
reprogramming and infected equally highly with retrovi-
ruses (Fig. 5D). In contrast, Ncoa3 depletion induced a
drastic reduction in reprogramming efficiency, as judged
by the significantly lower number of GFP-positive (Fig. 5E-
F) and AP-positive (Fig. 5G) colonies generated. We next
asked whether Ncoa3 knockdown might inhibit repro-
gramming simply by inducing MEF senescence, a known
impediment of reprogramming. For this, experiments were
repeated in MEFs lacking p53, which allows enhanced
speed and efficiency of reprogramming without cMyc
(Banito et al. 2009; Kawamura et al. 2009; Marion et al.
2009). p53/ MEFs transduced with OSK, however,
showed similarly striking reductions in the number of
AP-positive colonies following Ncoa3 depletion (Fig. 5H),
indicating that the observed reprogramming defect was
not due to p53-mediated senescence. Taken together,
these findings demonstrate that as well as being critical
for themaintenance of ESCs,Ncoa3 is furthermore required
for the induction of pluripotency upon reprogramming.
Ncoa3 participates genome-wide with Esrrb
and OSN at active ESC-specific enhancers
To gain greater understanding of how Ncoa3 functions in
ESCs, Ncoa3 DNA-binding sites were next mapped by
ChIP-seq. We first verified that Ncoa3 (this study) and
Esrrb (Chen et al. 2008) data sets showed strong overlap at
Esrrb, Klf4, Nanog, and Sox2 target genes and local bind-
ing profiles (Supplemental Fig. S6A). Focusing on ESC-
Figure 5. Essential requirement for Ncoa3 in somatic cell reprogramming. (A) Ncoa3 protein is up-regulated in fully reprogrammed
iPSC lines. Western blotting depicts two independently generated iPSC clones from two different Oct4GFP genetic backgrounds (clone
1: 129/Ola; clone 2: MF1/B6) (Yeom et al. 1996) in comparison with uninfected proliferative MEFs. (B) Immunofluorescence confirming
Ncoa3 and GFP expression in iPSC clone 1. Bars, 50 mm. (C) Efficient Ncoa3 knockdown in MEFs analyzed 3 d after infection with
lentiviral particles expressing shScrambled or shNcoa3 shRNA. Data are the mean 6 SEM of three independent experiments. (D) Equal
retroviral mCherry infection of scrambled or Ncoa3 knockdown MEFs. (E) Typical GFP-positive colonies arising from transduction of
shScrambled-treated Oct4GFP MEFs with OSKM reprogramming factors. Bars, 100 mm. (F) Inhibition of reprogramming following
depletion of Ncoa3, analyzed by quantifying GFP-positive colonies 12–14 d after infection with OSKM vectors. The number of colonies
produced from shScrambled-infected MEFs is set as 100% for each individual experiment. Three experiments were performed using
different batches of MEFs and viruses. (**) P-value < 0.01, (***) P-value < 0.001, Student’s t-test. (G) AP staining of iPSC colonies 14
d after infection with OSKM reprogramming factors. (H) AP staining of iPSC colonies generated in p53/ shScrambled or shNcoa3
MEFs using OSK reprogramming factors.
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relevant loci, we next compared all Ncoa3–Oct4–Sox2
cobound sites with Esrrb–Oct4–Sox2 and found signifi-
cant overlaps between these groups (P-value = 1.11 3
1016) (Fig. 6A). In contrast, the insulator-binding tran-
scription factor CTCF did not show any significant over-
lap (P-value = 0.84). Using a de novo motif discovery
algorithm (Heng et al. 2010), we identified, as expected,
a canonical ERRE motif among significantly overrepre-
sented binding sequences found at Ncoa3 peaks (Fig. 6B;
Supplemental Fig. S7). Oct–Sox elements were also de-
tected at these sites, reflecting the frequent colocaliza-
tion of Esrrb with Oct4 and Sox2. GREAT gene ontology
Figure 6. Ncoa3 is an integrated component of the ESC transcriptional network. (A) Significant overlap between Esrrb and Ncoa3
peaks within 200 bp at Oct4–Sox2-bound sites. The intersection with CTCF is shown for comparison. (B) MEME de novo motif
discovery analysis of top Ncoa3-bound sequences. (C) Spatial heat map depicting binding peak intensity of indicated factors, centered
on the peak of maximum Ncoa3 binding for each site. The two-dimensional matrix was provided as input for the K-mean clustering
program in Matlab to determine the classes of each position. (D) Venn diagram showing the overlap of genes that are significantly
regulated by Ncoa3 and Esrrb, as determined by microarray following Ncoa3 (this study) and Esrrb (Feng et al. 2009) knockdown in
ESCs (fold change >1.5). The Fisher’s exact test P-value for the correlation of fold change is indicated. See also Supplemental Table 5. (E)
Heat map of class I genes bound by Ncoa3 and Esrrb. First, all of the genes regulated by Esrrb within 100 kb of the class I region were
taken, then their fold change upon Esrrb (left) or Ncoa3 (right) knockdown was plotted according to Esrrb knockdown. Shades of green
and red indicate down-regulation and up-regulation, respectively. Note that the majority of genes is down-regulated. (F) Co-IP of Esrrb
in ESCs treated for 24 h with ethanol or 12.5 mM DES, immunoblotted for the indicated proteins. (G) Co-IP in ESCs showing the
interaction of endogenous Ncoa3 and RNApol2. Two representative blots are shown. (H) Co-IP of Esrrb immunoblotted for RNApol2 in
ESCs following 48 h of transfection with siControl or siNcoa3 oligos. The square brackets in F–H indicate bands corresponding to
RNApol2. All co-IPs were performed at least twice with similar results.
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(GO) analysis at Ncoa3–Esrrb cobound sites revealed
significant enrichment for developmental processes and
embryonic phenotypes (Supplemental Fig. S6B). In addi-
tion, abnormal fertility and organ size were also enriched,
agreeing with published mouse knockout models for
Ncoa3 and/or Esrrb (Luo et al. 1997; Mitsunaga et al. 2004;
Chen et al. 2010). Taken together, these data suggest a high
degree of similarity between Ncoa3 and Esrrb transcrip-
tional networks in ESCs. To look more widely at the
different types of transcription factor clusters associated
with Ncoa3 peaks, we next used spatial heat map anal-
ysis (Fig. 6C). This distinguished three main classes of
Ncoa3 targets based on their co-occupancies by Esrrb
and/or OSN as well as Nr5a2, p300, H3K27ac, and
H3K4me1. Here we confirmed that ;40% of all Ncoa3
peaks colocalized with Esrrb at active enhancers, as de-
noted by the presence of p300, H3K27ac, and H3K4me1
(Fig. 6C; Heintzman et al. 2007; Creyghton et al. 2010).
Sites bound by both Esrrb/Ncoa3 and OSN (class Ib)
represented key self-renewal regulators that are actively
transcribed in ESCs, such as Esrrb, Klf2/4/5, Zfp42,
Tcfcp2l1, Oct4, and Sox2, and included GO processes
involving stem cells and blastocyst development (Sup-
plemental Table S1). In contrast, sites containing Esrrb
and Ncoa3 but with reduced binding for OSN (class Ia)
(Fig. 6C) were uniquely associated with developmental
phenotypes involving germ cell integrity and fertility
(Supplemental Table S2), including Prdm14, a recently
described factor critical for germ cell lineage (Yamaji et al.
2008; Gillich et al. 2012). To closely investigate transcrip-
tional regulation by Ncoa3 and Esrrb, microarray analysis
was performed on ESCs following Ncoa3 knockdown and
compared with Esrrb knockdown at the same time point
(Feng et al. 2009). Notably, 62.5% of the misregulated
genes in Esrrb-depleted ESCs were also misregulated in
Ncoa3 knockdown ESCs (Fig. 6D), most often in the same
direction (Fig. 6E), showing that gene regulation by Ncoa3
and Esrrb is significantly correlated (P-value = 3.92 3
1049). Among them, many target genes with (class Ib) or
without (class Ia) high OSN enrichment were significantly
down-regulated upon Ncoa3 depletion, as validated by
qRT–PCR (Supplemental Fig. S8A), confirming that Ncoa3
is strictly required for Esrrb-dependent gene activation.
Interestingly, at some sites, Ncoa3 also colocalized with
Nr5a2—another orphan nuclear receptor previously in-
volved in stem cells and reprogramming (Gu et al. 2005;
Heng et al. 2010)—together with (class I) and without
(class II) Esrrb and/or OSN (Fig. 6C). GO analysis of class II
genes, however, consisted of targets associated with extra-
embryonic development (Supplemental Table S3), indicat-
ing that althoughNr5a2 could potentially recruit Ncoa3 to
a set of genes, these targets may be less relevant in ESCs.
Finally, the last class identified (class III) (Supplemental
Table S4) included Ncoa3-bound sites that were not co-
occupied by Esrrb, Nr5a2, or OSN (Fig. 6C), suggesting that
Ncoa3 may also be recruited by other factors. While marks
of active enhancers—p300, H3K27ac, and H3K4me1—were
absent at the majority of these sites (class IIIa), a small
subset (class IIIb) colocalized with H3K4me1 alone (Fig.
6C), potentially delineating inactive/poised Ncoa3-bound
enhancers in ESCs (Creyghton et al. 2010). Interestingly,
microarray analysis of class IIIb revealed that out of the
genes that are misregulated upon Ncoa3 knockdown, all
were up-regulated (Supplemental Fig. S8B).
Ncoa3 bridges Esrrb to the general
transcription machinery
Recently, Esrrb, among other pluripotency factors, was
identified as being uniquely associated with RNApol2
complexes (van den Berg et al. 2010), suggesting a critical
function for Esrrb, distinct from OSN, in activating tran-
scription. Thus, we investigated the importance of the
Esrrb AF-2 domain and Ncoa3 for this function. We first
demonstrated by co-IP that RNApol2 does indeed interact
with endogenous Esrrb in ESCs (Fig. 6F, top left). Strik-
ingly, however, upon short treatment with DES, we ob-
served a reduction of the Esrrb–RNApol2 interaction (Fig.
6F, top left). This appeared to be specifically associated
with loss of Ncoa3 binding (Fig. 6F, top right), as neither
the interaction between Esrrb and Oct4 (van den Berg
et al. 2008) nor the efficiency of anti-Esrrb immunopre-
cipitation itself was affected (Fig. 6F, bottom). These
results suggested that Ncoa3 could mediate the interac-
tion between Esrrb and RNApol2. To test this further, we
performed co-IPs between RNApol2 and Ncoa3 itself and
demonstrated an interaction between these proteins in
ESCs (Fig. 6G). Finally, to confirm that Ncoa3 is required
for the association between Esrrb and RNApol2, co-IPs
were repeated in cells treated with siControl or siNcoa3
oligos to deplete endogenous Ncoa3 protein. Transfection
with siNcoa3 specifically reduced the interaction be-
tween endogenous Esrrb and RNApol2 (Fig. 6H; Supple-
mental Fig. S8C–E). Taken together, these findings reveal
Ncoa3 as a key limiting factor that bridges Esrrb to the
general transcription machinery in ESCs.
Discussion
Here, we present the first detailed characterization of
a nuclear receptor coactivator in the maintenance of ESC
pluripotency. Although it is not a tissue-specific factor,
we observed that elevated Ncoa3 expression is a defining
property and essential requirement of ESCs and iPSCs.
Numerous transcription factors have been well charac-
terized in this context. In contrast, there exist few match-
ing studies for critical coactivators. Our work notably
complements recent findings by Fong et al. (2011) identi-
fying a novel Oct4/Sox2 coactivator, the XPC nucleotide
excision repair complex, which is essential to activate
Nanog and support the ESC state while also safeguarding
genome integrity.
In this study, we provide significant data to suggest that
Ncoa3 action in ESCs is primarily mediated through Esrrb
function. We show that Ncoa3 binds to Esrrb specifically
via its AF-2 domain and that Ncoa3 recruitment is strictly
required to potentiate Esrrb activity in ESCs. AF-2 domain
inactivation in ESCs or depletion of Ncoa3 itself both
suppress transcription from Esrrb-dependent gene report-
ers and result in a loss of ESC self-renewal. Conversely,
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overexpressing Ncoa3 in ESCs enhances Esrrb-mediated
resistance to differentiation but is not sufficient alone to
block differentiation, in agreement with Ncoa3 acting as
an Esrrb coactivator and not a transcription factor. Through
genome-wide ChIP-seq analysis, we demonstrate the
presence of Ncoa3 at a large number of active Esrrb-
bound enhancers that are shared with the OSN triad and
enriched for p300, H3K27ac, and H3K4me1 (Heintzman
et al. 2007; Creyghton et al. 2010). GO analysis at this set
of targets shows enrichment for key self-renewal regula-
tors whose expression is significantly reduced in Ncoa3
knockdown ESCs, as determined bymicroarray and qRT–
PCR, identifying Ncoa3 as an integrated component of
the ESC transcriptional network.
A distinct group of Ncoa3- and Esrrb-bound loci show-
ing reduced OSN occupancies is exclusively associated
with germ cell and fertility-related phenotypes. This cor-
roborates with a primordial germ cell (PGC)-specific de-
fect observed in vivo in the absence of Esrrb (Mitsunaga
et al. 2004) and an infertility phenotype in Ncoa3 knock-
out mice (Xu et al. 2000). It furthermore suggests that
Esrrb and Ncoa3 might also act in synergy during PGC
reprogramming. Consistently, we found that germ cell-
relevant targets such as Prdm14 are significantly down-
regulated upon Ncoa3 knockdown (Supplemental Fig.
S8A), supporting a putative role for the Ncoa3–Esrrb
partnership in this process. Aside from Esrrb, it is still
possible that other nuclear receptors or transcription
factors may also recruit Ncoa3 to some genes. Nr5a2,
for example, maps in ESCs to many Esrrb-, Ncoa3-, and
OSN-bound targets (Heng et al. 2010; this study) and
could potentially interact with Ncoa3 via its LBD, al-
though this remains to be formally demonstrated. In con-
trast, we could find no evidence to support a direct role for
OSN in recruiting Ncoa3 at these sites, although these
core factors most likely stabilize the Esrrb–Ncoa3 com-
plex through protein–protein interactions with Esrrb at
multitranscription factor clusters (Supplemental Fig. S3;
van den Berg et al. 2008).
Critically, we shed new light on how the Ncoa3–Esrrb
self-renewal function is conferred in ESCs. A recent study
reported the Oct4 interactome of 166 proteins, including
many transcription factors and chromatin-modifying
complexes not previously known to associate with the
ESC network (van den Berg et al. 2010). Among these
Oct4 partners, Esrrb was uniquely found to be associated
with the basal transcription machinery. An association
between Ncoa3 and Esrrb was also observed there. Our
mechanistic work on Ncoa3 thus elucidates the func-
tional importance of this interaction and further high-
lights the relevance of Oct4’s broad range of interaction
partners. Here, we confirm that endogenous Esrrb and
RNApol2 are physically associated in ESCs and demon-
strate that Ncoa3 mediates this association. We propose
that Ncoa3 functionally bridges Esrrb and RNApol2 at
loci co-occupied by Oct4 as well as Sox2, Nanog, and
additional pluripotency factors (see Fig. 7), highlighting
a distinct role for the Ncoa3–Esrrb partnership to the core
ESC transcription factors. Ncoa3 is also established in
this study as being required for efficient somatic cell
reprogramming—a property shared with other Oct4/Esrrb
partners, including core members of Trithorax/MLL
complexes (Ang et al. 2011). These chromatin-modifying
complexes are essential for open chromatin and pluripo-
tency and may therefore open the path to the reprogram-
ming process by facilitating Oct4 occupancy at genomic
loci encoding self-renewal genes. Esrrb–Ncoa3–RNApol2
bridging would in turn perpetuate strong transcriptional
activation at Oct4/Esrrb-bound sites, allowing for the
full establishment of iPSCs or the maintenance of ESC
self-renewal.
In summary, our work elucidates a previously unrec-
ognized functional link between the core ESC transcrip-
tional network and a nuclear receptor coactivator and,
importantly, provides novel mechanistic insights into the
role of Ncoa3–Esrrb in sustaining both ESC self-renewal
and reprogramming. It would be of interest in future
studies to elucidate whether coactivator recruitment is
indeed a general requirement for many ESC pluripotency
factors. Moreover, acting as ‘‘sensors,’’ these cofactors
could also be capable of integrating stimuli from mul-
tiple signaling pathways, thus adding another layer of
control to the complex network governing pluripotency
and differentiation.
Materials and methods
Cell culture and RNAi experiments
Mouse E14Tg2A (E14) ESCs were cultured on 0.1% gelatin as
previously described (Azuara et al. 2006). COS-1 and 293T were
grown in DMEM supplemented with 10% FCS, penicillin/
streptomycin, and L-glutamine. MEFs and iPSCs were cultured
as previously described (Feng et al. 2009). RNAi experiments
followed by puromycin selection were performed using pLKO.1
or pSuper vectors. Transfection of ESCs was performed with
Lipofectamine 2000 according to the manufacturer’s protocols.
See Supplemental Table S6 for shRNA sequences.
Antibodies
The primary antibodies used in this study for immunofluores-
cence, Western blotting, and ChIP were as follows: anti-Esrrb
(R&D Systems, H6705 and H6707), anti-Nanog (Cosmo,
Figure 7. Proposed model. Esrrb interacts with Nanog and Oct4/
Sox2 at ESC enhancers and recruits Ncoa3 via its AF-2 region.
Ncoa3 interacts with RNApol2 and bridges Esrrb at enhancers to
the general transcriptional machinery. These factors would thus
act, together with other factors such as chromatin proteins and
Mediator (Kagey et al. 2010), to bring about transcription of ESC-
associated genes.
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RCAB0002P), anti-Ncoa3 (Santa Cruz Biotechnology, M-397;
BD Biosciences, #611105), anti-Oct4 (Santa Cruz Biotechnology,
C-10), anti-Sox2 (Abcam, ab97959), anti-Flag (Sigma, M2), anti-
RNApol2 (SantaCruz Biotechnology,N-20), anti-Gapdh (Millipore),
anti-Tubulin (Sigma), anti-cleaved Caspase-3 (Cell Signaling,
#9664), and anti-BrdU (Abcam, ab6326).
Co-IP and ChIP
For co-IP experiments performed with ectopically expressed
proteins, COS-1 cells in 10-cm dishes were transfected with
3–5 mg of each expression vector using Fugene HD (Roche),
according to the manufacturer’s guidelines. Cells were collected
48 h later and lysed in RIPA buffer. Eight hundred micrograms of
protein extract was precleared with protein A Sepharose beads
(Sigma, P3391) for 2 h at 4°C, then incubated overnight at 4°C
with the indicated antibodies. Protein A beads were added for
2 h, then washed with RIPA and TSE buffer (2mM EDTA, 20 mM
Tris at pH 8, 150 mM NaCl) three times and loaded on 7%
acrylamide gels. Detection of endogenous interactions was
performed using 1-mg extracts similarly prepared from untrans-
fected E14 ESCs. Anti-Ncoa3 (#611105; mouse monoclonal) was
used to coimmunoprecipitate Ncoa3 expressed in COS-1 cells
when examining interactions with Nanog (rabbit polyclonal); all
other co-IP, immunofluorescence, and ChIP experiments were
performed with M-397. ChIP experiments were carried out with
chromatin prepared from E14 cells as previously described (Stock
et al. 2007) using 8–10 mg of primary antibody and 600 mg of
precleared chromatin per immunoprecipitation. Immunoprecip-
itated DNA fragments were purified and analyzed via SYBR
Green qPCR.
DNA pull-down assays
COS-1 cells were transfected with Ncoa3 together with Flag-
Esrrb or Oct4 and Sox2 expression vectors. Forty-eight hours
after transfection, cells were lysed in HKMG buffer (10 mM
HEPES at pH 7.9, 100 mM KCl, 5 mM MgCl2, 10% glycerol,
0.5% NP-40, 1 mM DTT, protease inhibitors [Complete EDTA-
free; Roche]) and lysates precleared for 1 h with pre-equilibrated
streptavidin-coupledDynabeads (Invitrogen,M-280). Pairs of com-
plementary DNA oligonucleotides with the sense oligonucleotide
biotinylated at the 59 end (Sigma) were annealed and incubated for
2 h at 4°C with precleared cell lysates. DNA-bound proteins were
collected by incubation for 1 h at 4°C with streptavidin-coupled
Dynabeads (Invitrogen), washed four times in HKMG buffer, and
separated by SDS-PAGE. Ncoa3, Flag-Esrrb, Oct4, and Sox2 were
detected by Western blot. See Supplemental Table S6 for probe
sequences.
Luciferase assays
ESCs were plated on gelatin-coated 96-well plates at a density
of 2 3 104 cells per well and, 5 h later, transfected with the
indicated luciferase reporters and expression constructs using
Lipofectamine 2000. For knockdown experiments, either 30 ng
of shRNA vector or 2–3 pmol of siRNA was cotransfected per
well. pCmv.Renilla or pCDNA4/TO.eGFP was used to normal-
ize luciferase values in each well. Firefly and Renilla luciferase
activities weremeasured 48 h post-transfection using the Steady-
Lite Plus kit (PerkinElmer).
Retroviral production
For reprogramming experiments, PlatE cells were used to pro-
duce pMXs-based retroviruses containing the cDNA for Pou5f1/
Oct4, Sox2, Klf4, or cMyc, as previously described (Feng et al.
2009). PlatE-generated mCherry retrovirus was used to monitor
MEF infection efficiency in each experiment.
iPSC generation
Embryonic day 13.5 (E13.5) Oct4-GFP MEFs were derived from
embryos produced via the intercross between wild-type MF1
females and homozygous Oct4-GFP B6 males (Yeom et al. 1996).
For iPSC induction, 2 3 104 Oct4-GFP MEFs were seeded per
well of a 24-well plate and, 5 h later, infections were performed
using equal amounts of each indicated retrovirus in the presence
of 8 mg/mL polybrene. Medium was exchanged for MEF medium
24 h post-infection, and, 48 h after infection, MEFs were col-
lected and reseeded onto inactivated feeders in iPSC medium.
Emerging iPSC colonies were monitored until day 12–14 when
cells were harvested or individual colonies were picked for
further analysis.
ChIP-seq and microarray analysis
ChIP-seq and microarray analysis were performed on mouse
ESCs as previously described (Chen et al. 2008; Feng et al. 2009).
Detection of Ncoa3 sequenced peaks was carried out using
MACS with a P-value cut-off of 1.0 3 105.
Accession numbers
ChIP-seq and microarray data are accessible at the Gene Expres-
sion Omnibus database under accession number GSE40193.
Detailed Materials and Methods, antibodies, and sequences
are available in the Supplemental Material.
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You stay the same through the ages 
Your love never changes 
There may be pain in the night 
But joy comes in the morning 
 
Chris McClarney, Your love never fails 
 
 
 
 
